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Abstract 
The chaperonin proteins form a ubiquitous family of molecular chaperones and are 
absolutely required for correct folding or assembly of a subset of proteins in the cell.  
They are divided into two groups based on phylogeny: Group 1 found in bacteria and 
eukaryotic-organelles and Group 2 found in eukaryotic-cytoplasma and archaea.  The 
two groups share a significant degree of conservation but differ in structure and 
mechanism and are believed to have evolved to serve specific client proteins.  Using 
archaeal chaperonin from M. maripaludis (MmCCT) as a representative, we report here 
for the first time that a Group 2 chaperonin can partially replace the function of a Group 
1 chaperonin from E. coli (GroEL).  We have also identified and characterized two 
functional variants of MmCCT that show better GroEL complementation and have 
utilized them for a preliminary mutational analysis of potential client binding residues 
of MmCCT. We further demonstrate an initiative using a tagging approach for 
identification of bacterial proteins that interact with MmCCT in vivo.  We suggest that 
our findings provide a novel platform for genetic dissection of MmCCT using a 
comparatively simple host, E. coli, which in turn can help identify properties of this 
archaeal chaperonin and provide insights for structure-function co-relations of Group 2 
chaperonins in general. 
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1.1 Molecular chaperones 
1.1.1 Protein folding 
Almost every biological process depends upon proteins.  Protein functionality is 
inevitably associated with its specific three-dimensional (3D) conformation.  Knowledge 
of how protein folding occurs, hence, is central to understanding of the nature of living 
systems. 
1.1.1.1 ‘Sequence determines structure’ 
The groundwork for protein folding was laid in early 1960s with classic studies carried 
out by Christian Anfinsen and colleagues.  Bovine pancreatic ribonuclease, containing 
four disulfide linkages in its native structure, was reduced and denatured using urea and 
β-mercaptoethanol giving eight sulfahydral (-SH) moieties.  When this denatured 
protein was allowed to oxidise using molecular oxygen under physiological milieu, the 
enzymatic activity was regained slowly.  Once freed from the denaturing agent, almost 
all of the protein was recovered with no changes in activity as compared to the native 
protein.  The study established for the first time that the information needed for folding 
of a protein into its native state is inherently present in its own sequence (Anfinsen et 
al., 1961).  Further experimentation was carried out to study what guides the selection 
of the unique set of four disulphide bonds out of 105 possible combinations.  Different 
non-native forms of RNAse that were similar in physical properties to native forms were 
made using pH changes, varying denaturing conditions or using modified amino-acids.  
The re-oxidation of such molecules to their native state was studied under various 
conditions (Haber and Anfinsen, 1962) and it was conceived that the process is driven 
entirely by free energy of conformation (Epstein et al., 1963).  This series of experiments 
3 
 
gave rise to the thermodynamic hypothesis which states that “the native conformation 
of the protein under physiological conditions is that in which the Gibbs free energy of 
the whole system is the lowest;  that is the structure is determined by the totality of 
inter-atomic interactions and hence by the amino acid sequence in a given environment” 
(Anfinsen, 1973).  
1.1.1.2 Levinthal’s paradox and the principle of self-assembly of proteins 
Cyrus Levinthal pointed out that if a protein was to attain its correctly folded state by 
sequentially sampling all possible conformations, it would require an astronomical 
amount of time to reach its correct native conformation (Levinthal, 1968).  For example 
a polypeptide chain consisting of 100 amino acid residues would have to go through at 
least 2100 or in an order of 1030 different conformations (assuming that there are only 
two possible conformations per residue) before attaining its native conformation.  
Assuming that a protein can explore new conformations at the same rate that bonds can 
reorient (1011 structures/second), it would take nearly 1019 seconds or 1011 years for 
the polypeptide chain to go through all the possible conformations.  However, it takes 
less than a minute for a protein to fold in vitro to its native state.  Levinthal speculated a 
kinetic control over protein folding considering the biological time scale and the 
available phase space.  In answer, he put forward a model wherein protein folding is 
speeded by the rapid formation of partially stable intermediates that in turn determine 
the further folding of the peptide (Levinthal, 1968).  The concept that a protein folds into 
a structure dictated by the fastest folding pathway and not necessarily by its state of 
lowest free energy slowly emerged (Levinthal, 1969). 
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A number of studies hence followed in search of pathway-intermediates and 
investigation of the underlying folding kinetics (Ikai and Tanford, 1971; Tsong et al., 
1971; Wetlaufer, 1973; Creighton, 1974; Kim and Baldwin, 1982).  These studies 
described various models explaining the proceedings of protein folding.  However the 
next landmark in protein folding was not until the late 1980’s when two groups 
independently published papers describing amalgamation of thermodynamic and 
kinetic concepts (Dill, 1985; Bryngelson and Wolynes, 1987).  According to their 
proposed model, the folding is directed within funnel-like energy landscape (Figure 1.1).  
The width of funnel indicates the entropy associated with a particularly folded form of 
the protein while the depth is related to the free energy difference between the unfolded 
and fully folded forms of protein.  The number of possible intermediates gets fewer as 
the funnel gets narrower, finally attaining the desired stable native conformation 
(Wolynes et al., 1995; Dill and Chan, 1997; Onuchic et al., 2000).  
The present view for protein folding has revealed the ruggedness of the then accepted 
smooth energy landscape (Onuchic and Wolynes, 2004; Jahn and Radford, 2005).  It 
suggests that some intermediates along with being the on-pathway stepping stones 
towards the native state are also susceptible to formation of non-native yet more stable 
conformations.  Such intermediates typically expose at least some hydrophobic residues 
and regions of unstructured polypeptide backbone, that are buried in the native state.  
By interacting amongst themselves, the intermediates can either form inactive non-
soluble amorphous structures or highly ordered toxic amyloid aggregates.  These 
structures are non-native but thermodynamically more stable and form the so-called 
‘kinetic trap’ in the energy landscape (Figure 1.1) (Hartl and Hayer-Hartl, 2009).  Hence 
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the folding pathways for different proteins vary and depend on the fate of the folding 
intermediates. 
Nonetheless, Anfinsen’s hypothesis remains correct stating that all the information for a 
protein chain to reach its native structure is encoded in its amino acid sequence and the 
folding process is driven thermodynamically even though more stable states do exist 
than the native form.  The folding proceeds by formation of well-defined partially 
structured intermediates, some of which are transient while others are significantly 
populated before converging into the final correct conformation (Dobson and Karplus, 
1999), the concept on the whole accepted as the ‘principle of self-assembly’.  
1.1.1.3 Folding and assembly of some proteins requires assistance 
It was pointed out that the conclusions drawn from in vitro studies, perhaps, cannot be 
generalized to the in vivo proteins (Creighton, 1983).  In vivo protein folding differs in 
many ways from the in vitro folding.  Firstly, folding takes place within a complex 
environment crowded with high concentrations of wide variety of molecules.  This 
increases the probability of unwanted intra-molecular interactions between unfolded/ 
partly folded peptides resulting into formation of aggregates.  Aggregation occurs when 
folding intermediates become trapped in partially misfolded states that themselves 
associate to form stable and less soluble oligomeric complexes  (Ben-Zvi and 
Goloubinoff, 2001; Ellis, 2007).  Secondly, stable conformation requires at least complete 
polypeptide chain to be present.  With the ~30 aminoacids restricted to the ribosomes 
during the polypeptide synthesis, aggregation-sensitive nascent chains form a large 
population in the actively dividing cell (Hartl, 1996; Ellis, 2007). 
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Moreover in vivo, some proteins have to be transported to distant regions from 
ribosomes bypassing membranes that, in some cases, cannot let large 3D protein 
structures pass through.  The fact that proteins have to be temporarily maintained in a 
non-native state until translocated was reported long ago (Rothman, 1989), raising the 
question of what holds the proteins from spontaneous folding until they reach their 
destination.  Furthermore, the cells in vivo are exposed to constant physiological stresses 
like temperature fluctuations, pH variations, osmotic changes etc. threatening the 
integrity of the already folded protein molecules.  How and with what mechanism, the 
stress-exposed proteins are protected, renatured or degraded allowing the cell to regain 
its original functioning was an intriguing question unresolved by any in vitro studies 
(Hartl and Hayer-Hartl, 2002).  All these facts accounted for anticipation that protein 
folding in the cell might be ‘aided’ by some additional means, the inkling that eventually 
led to the discovery of molecular chaperones.  
 
 
 
 
 
 
 
7 
 
 
Figure 1.1  
The energy landscape scheme for protein folding and aggregation. 
(Hartl and Hayer-Hartl, 2009) 
The figure represent hypothetical energy landscape scheme for protein folding.  The purple 
area (left) shows the ensemble of conformations that are funnelled to the native state via 
intra-molecular contacts.  The pink area (right) denotes the conformations that can 
culminate into formation of non-native aggregates formed by inter-molecular interactions of 
the intermediates, more stable than the native conformations. Both parts of the energy 
surface overlap. 
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1.1.2 Molecular chaperones 
1.1.2.1 Emergence of the ‘molecular chaperone’ concept 
The thought that the proteins are perfectly capable of folding on their own both in vitro 
and in vivo was believed until the starting years of 1980s.  However, in 1980, it was 
reported that the enzyme RuBisCO (Ribulose-1,5-bisphosphate carboxylase oxygenase)    
was dependent on a chloroplast-binding-protein (now identified as a HSP60 chaperone) 
for correct assembly (Barraclough and Ellis, 1980).  In another study, it was shown that 
a protein named BiP (now identified as a HSP70 chaperone) transiently binds to 
immunoglobulins in the endoplasmic reticulum (Haas and Wabl, 1983).  Both the studies 
indicated a potential role of additional proteins that helped in the assembly of the client 
protein.  At about the same time, a paper reported the mandatory role of an acidic 
nuclear protein, nucleoplasmin in assembly of histones and DNA to form nucleosomes in 
extracts of Xenopus eggs.  The role of nucleoplasmin was described as the role of 
‘chaperone’ (literal meaning: escort or safeguard) (Laskey et al., 1978).  Such studies 
prompted ideas about some sort of protein function in the cell that could possibly be 
associated with assembly of other proteins (Musgrove and Ellis, 1986). 
The idea was further strengthened by a study that described the role of heat shock 
proteins (HSPs), the then identified families HSP70 and HSP90, in the cell.  These 
proteins were required in increased amounts when cell proteins were damaged by 
stress, to help unscramble the aggregates of impaired proteins and to prevent further 
damage by binding to exposed hydrophobic surfaces (Pelham, 1986).  Gathering the 
above discussed facts under one umbrella, John Ellis in 1987 proposed the notion of 
molecular chaperones as a generalized concept to describe “a class of proteins that 
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functions to ensure that the folding of other polypeptide chains and their assembly into 
oligomeric structures occurs correctly” (Ellis, 1987).  
1.1.2.2 Molecular chaperones  
The chaperone concept, although maintaining Anfinsen’s principle of self assembly, 
clearly originated the picture of ‘assisted folding’ in vivo.  Undoubtedly a protein folds 
spontaneously according to the information encoded in its sequence; however, 
chaperones ensure that proteins can do so by overcoming the in vivo threats posed to 
the non-native proteins such as molecular crowding, misfolding and aggregations during 
de novo protein synthesis, constant stress, and need of conformational flexibility for 
transport among others.  The emergence of the concept elicited enormous research on 
discovering the chaperoning proteins, their functioning and chaperone-assisted folding 
mechanisms in general.  At present over 50 types of molecular chaperones and 
chaperone cofactors are known; the functions of these broadly falling into one or more 
of the following categories (Bukau and Horwich, 1998; Leroux and Hartl, 2000; Ellis, 
2006):  
1. Transient stabilization of the polypeptide while being synthesized. 
2. Assistance in de novo protein folding and assembly. 
3. The unfolding and refolding of the proteins during the transport across membranes. 
4. Prevention of protein aggregation and misfolding. 
5. Unscrambling of the aggregates and renaturation of proteins under stress 
conditions.  
6. Facilitation of the apoptotic activity of the cell by guiding the unstable proteins to 
degradation. 
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Most of the chaperones were discovered by their increased synthesis after the cell has 
undergone a stress like a heat shock and further by finding the homologues in the same 
species or other related/unrelated species.  Such proteins were initially named as heat 
shock proteins (HSPs), however, it is worth noting that many chaperones are not HSPs 
and many HSPs are not chaperones.  Subsequently, with the emergence of a horde of 
chaperone proteins, they were classified into various families. 
1.1.3 Families of Molecular chaperones 
Although chaperone proteins differ in size, shape, mechanisms and abundance, all of 
which can form the basis of classification, the most widely accepted classification of 
chaperones is based on sequence similarity.  Presently, based on phylogenetic similarity, 
chaperones that are involved in protein folding are classified into ten major families as 
shown in Table 1.1.  Discussing about every chaperone in detail is outside the scope of 
this assignment and also disrupts the narrative flow of the story of the chaperonins class 
which is the subject of this project, nonetheless key functions are outlined in the Table 
1.1. 
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Table1.1: Representative classes of molecular chaperones 
Note: ‘m’ stands for mitochondria, ‘c’ for cytosol, ‘er’ for endoplasmic reticulum 
Chaperone Family Organism  Chaperone (compartment) Function References 
HSP100 
Caseinolytic protease (Clp) 
family 
Bacteria 
Eukaryotes 
ClpA, ClpB, ClpC, ClpX, HslU 
Hsp78, mcxI (m) 
Hsp101, Hsp104 (c) 
Prevention of aggregation, 
disassembly of aggregates, refolding of 
denatured proteins, maintenance and 
propagation of Prions (yeast) 
Schirmer et al., 
1996; Santagata et 
al., 1999; Maurizi 
and Xia, 2004; 
Hodson et al., 2012 
HSP90 Bacteria 
Eukaryotes 
 
HtpG  
Grp94 (er) 
TRAP1 (m) 
Hsp90, Hsp82, Hsp83 (c)  
In Bacteria: thermotolerance, cold 
acclimation, swarming, regulation of 
chemotaxis 
In eukaryotes: Essential proteins 
involved in activation and stabilization 
of proteins, organelle integrity, cellular 
homeostasis and assistance in protein 
degradation  
Potential drug targets for 
neurodegenerative diseases and 
cancer 
Pearl and 
Prodromou, 2006; 
Richter and 
Buchner, 2006; 
Salminen et al., 
2011; Altieri, 2013 
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HSP70 Bacteria 
Eukaryotes 
 
DnaK 
BiP (er) 
SSc (m) 
Hsc (c) 
Versatile chaperonins involved in a 
variety of protein folding processes 
like prevention of aggregation of 
unfolded/newly translated/newly 
imported proteins, assembly and 
disassembly of oligomeric complexes, 
regulation of stability and activity of 
certain natively folded proteins, 
regulation of heat shock response 
among others 
Hartl and Hayer-
Hartl, 2002; Mayer 
and Bukau, 2005; 
Meimaridou et al., 
2009 
HSP60 Bacteria 
Archaea 
Eukaryotes 
 
GroEL 
Thermosomes, Cpn60, 
TRiC (c) 
Cpn (m) 
Essential proteins for specific protein 
folding of newly translated and newly 
imported proteins by encapsulation 
mechanism.   
Subject of this study 
HSP40 Bacteria 
Eukaryotes 
(Absent in many 
bacterial species) 
DNAJ 
HSP40, Ydj1 (c) 
Essential co-chaperones for Hsp70: 
Stimulation and regulation of ATPase 
activity of Hsp70 proteins and 
transient stabilization of aggregation-
prone proteins 
Cheetham and Caplan, 
1998; Qiu et al., 2006) 
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HSP10 E. coli 
Eukaryotes 
Hsp10  
Cpn10 (m) 
Essential for co-chaperoning function 
for HSP60 proteins 
This study 
 
Small HSPs All organisms sHSPs Stabilisation of unfolded proteins, 
prevention of protein aggregation. 
Potential role in protection from 
Alzheimer’s amyloid formation.  
Jakob et al., 1993; 
Van Montfort et al., 
2001; Haslbeck et 
al., 2005 
Trigger Factor E. coli TF Binds and assists folding of nascent 
ribosome-bound polypeptides using 
hydrophobic interactions 
 Maier et al., 2005; 
Hoffmann et al., 
2010; O'Brien et al., 
2012 
Nascent polypeptide 
complexes 
Archaea 
 
Eukaryotes 
Nascent polypeptide 
associated complex (NAC)  
Ribosome associated 
complex (RAC) 
Similar function as the trigger factor in 
E. coli, however absence of sequence 
homology between the two families of 
chaperones.  
Rospert et al., 2002; 
Wegrzyn and 
Deuerling, 2005 
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1.2 Chaperonins 
Chaperonins are one of the ubiquitous, well-studied, sequence-related class of 
chaperones.  The term chaperonin was coined by Hemmingsen et al, to represent a 
specific class of proteins that helped in assembly of other proteins (Hemmingsen et al., 
1988).  They are present in all organisms studied to date (with the exception of certain 
strains of Mycoplasma and Ureaplasma) and are found to be essential in all cases tested 
(Fayet et al., 1989; Stoldt et al., 1996; Kapatai et al., 2006).  The chaperonins are 
phylogenetically divided into two main groups by alignment of chaperonin sequences 
from three domains of life.  The sequence identity between Group 1 and Group 2 
chaperonins is in the order of 20-25% and sequence similarity in the order of 40% 
(Horwich et al., 2007) 
A. GROUP 1 chaperonins 
These chaperonins are found in all bacteria except certain strains of Mycoplasma and 
Ureaplasma (Lund, 2009).  They are also found in organelles of endosymbiotic origins 
i.e. in chloroplast (Ellis, 1990), mitochondria (Reading et al., 1989) and related 
organelles such as hydrogenosomes and mitosomes (Bui et al., 1996). 
B. GROUP 2 chaperonins 
These chaperonins are found in the eukaryotic cytosol and in archaea, with archaeal 
proteins being phylogenetically distinct from the eukaryotic ones but significantly more 
similar to them than they are to the Group 1 chaperonins (Trent et al., 1991; Frydman et 
al., 1992). 
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1.2.1 Nomenclature 
Group 1 - Bacterial chaperonins are generally referred to as chaperonin60 or Cpn60 
(Coates et al., 1993).  However, they are analogously also often named as GroEL (which 
actually refers to E. coli chaperonin).  The proteins that help chaperonins to carry out 
their function are referred to as co-chaperonins, GroES (in E. coli) or Cpn10.  The 
mitochondrial and chloroplast chaperonins are usually called Hsp60 and Rubisco-
binding protein respectively.  
Group 2- Eukaryotic chaperonins were originally called TCP-1 (for tailless complex 
polypeptide1) (Silver et al., 1980), which actually referred to only one of its subunits.  
Hence, now they are more generally referred to as TRiC (for TCP-1 containing ring 
complex) or CCT (chaperonin containing TCP-1).  Archaeal chaperonins are mostly 
termed thermosomes as they were first studied in Thermoplasma species (Phipps et al, 
1993); however, they are sometimes also referred to as CCT or archeosomes.  They have 
also been described as rosettasomes for the typical arrangement reported in S. shibatae 
species (Trent et al., 1991).   
In this report the convention used refers eukaryotic chaperonins as TRiC, the archaeal 
chaperonins as CCT, and the E. coli chaperonins as GroEL.  The substrate proteins that 
the chaperonin refolds are called clients because the natural substrate of chaperonins is 
ATP. 
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1.2.2 General chaperonin architecture 
The domain architecture of the chaperonin complex is largely conserved across both the 
groups.  They are large protein assemblies (800-1000 kDa) containing two rings stacked 
back to back giving rise to a hollow barrel like structure (Figure 1.2) (Hendrix, 1979).  
Each ring is made-up of seven to nine subunits each approximately weighing 60kDa and 
encloses a central cavity of expandable volume (Braig et al., 1994; Xu et al., 1997).  The 
chaperonin complex may be homo-oligomeric or hetero-oligomeric.  Unfolded client 
proteins are encapsulated into the chaperonin cavity with the help of either a co-
chaperonin (in the case of Group 1 chaperonins) or by extensions of the chaperonin 
complex itself (in the case of Group 2 chaperonins).  Once inside the cavity, the client 
protein is shielded from the risks faced by a non-native protein in the crowded 
environment of the cells, and thus can fold productively.  The mechanisms of folding are 
discussed at length individually for both the groups later in this section.  
Each chaperonin subunit consists of three domains (Braig et al., 1994; Ditzel et al., 1998) 
(Figure 1.2 and Figure 1.3).  These domains undergo extensive conformational 
rearrangements to function as a highly allosteric folding machine for the client proteins. 
Apical domain: This domain forms the part of the complex that harbours the client 
binding site and hence interacts with the client proteins and co-chaperonins (Figure 1.3, 
red coloured domain) (Sigler et al., 1998).  In Group 1 chaperonins the apical domains 
expose the hydrophobic residues at the rim of the central cavity and these residues bind 
to both clients and the co-chaperonin GroES (Fenton et al., 1994; Buckle et al., 1997; Xu 
et al., 1997; Chen and Sigler, 1999).  In Group 2 chaperonins the function of co-
chaperonin is replaced by the flexible helical protrusion that expands from the tip of the 
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apical domain and serves as a cap to the cavity when a client protein is enclosed (Figure 
1.3) (Klumpp et al., 1997; Ditzel et al., 1998; Iizuka et al., 2004).  The client binding sites 
for Group 2 chaperonins have not been explicitly defined however the regions analogous 
to GroEL client-site have been proposed to play a role in client interaction (Gomez-
Puertas et al., 2004; Pereira et al., 2010). 
The equatorial domain: This is the largest domain compose of amino acid residues 
from both N-terminal and C-terminal of the protein (Figure 1.3, green coloured domain)   
.  The domain is mainly involved in binding and hydrolysing ATP thereby bringing about 
conformational changes in the complex.  The nucleotide binding site (Sequence: 
GDGTTT) is located at the top of the domain and is conserved in almost all chaperonins 
with a few identified exceptions like chaperonin homologues of Chlamydia trachomatis 
(Cpn60.2 and Cpn60.3) that are thought to have diverged for other functions (Lund, 
2009).  The domain also forms a site for functional inter-ring and intra-ring interactions 
(Fenton et al., 1994) .  
The intermediate domain: This domain is the most flexible region of the chaperonin 
complex and lies between the apical and the equatorial domain (Figure 1.3, blue 
coloured domain).  The two hinges of the intermediate domain relay the allosteric signal 
generated by the nucleotide binding to the equatorial domain to the apical domain.  This 
signal is important in driving conformational changes in the chaperonin oligomer which 
in turn influence the binding and encapsulating of clients (Kawata et al., 1999). 
 
 
18 
 
 
 
Figure 1.2 
General architecture of Group 1 and Group 2 chaperonins. 
Crystallographic ribbon diagrams of Group 1 chaperonin GroEL from E. coli (left) and Group 2 
chaperonin TaCCT from archaeon T. acidophilum (right) are shown.  A single subunit is 
coloured in each chaperonin.  The insets represent a schematic of general chaperonin 
architecture - back to back stacked two rings (shaded red and green) capped by co-
chaperonin GroES for Group 1 and by inbuilt helical protrusions for Group 2 chaperonins. 
Note: Figure adapted from Horwich et al., 2007. 
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Figure 1.3 
Domain architecture of single subunits of Group 1 and Group 2 chaperonins. 
Ribbon diagrams of single subunits of Group 1 chaperonin GroEL from E. coli (left) and Group 
2 chaperonin MmCCT from archaeon M. maripaludis (right) are shown. The apical domain is 
shown in red (A), the intermediate domain in blue (I), and the equatorial domain in green 
(E). The helical protrusion in case of MmCCT is coloured orange (H). Diagrams are drawn in 
PYMOL software using crystal structures of GroEL (PDB ID- 1AON) and MmCCT (PDB ID-3KFK) 
submitted to protein data bank.  
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1.2.3 Group 1 chaperonins 
The chaperonin GroEL and its co-chaperonin GroES from E. coli have been extensively 
studied and used as common models to study Group 1 chaperonins.   Hence, to 
understand the general architecture and mechanism of the Group 1 chaperonins, 
archetypal GroEL-ES system is described.  Both GroEL and GroES are essential for cell 
viability under all conditions (Fayet et al., 1989). 
1.2.3.1 Structure of the GroEL-GroES complex 
The first crystal structure of the GroEL was solved at 2.8 Å in an unliganded state (Braig 
et al., 1994; Braig et al., 1995).  It established a near-atomic model of the double-ring 
architecture of GroEL previously observed by cryo-electron microscopy and negative 
staining (Langer et al., 1992; Braig et al., 1993; Chen et al., 1994).  The GroEL complex is 
a cylindrical protein-assembly comprising of two rings stacked back to back as 
previously described for all chaperonins (Figure 1.4).  Principle dimensions of the 
double-ring cylinder are roughly 150 Å in height and 140 Å in width enclosing an 
approximately 50 Å wide central cavity.  Each ring is composed of 7 homologous 
subunits (543 amino acids) arranged with nearly exactly 7-fold rotational symmetry and 
characteristically folded into three distinctive subunits (Braig et al., 1994).   The crystal 
structures of GroEL complexed with non-hydrolyzable ATP analogue recognized the 
details of highly conserved ATP-binding pocket in the equatorial domain and the 
resulting conformational shifts, thought to facilitate protein folding (Boisvert et al., 
1996).   
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The crystal structure of GroES was solved around the same time and the details of its 
architecture were presented (Hunt et al., 1996).  GroES is also a heptamer formed of 
approximately 10 KDa subunits and displaying a 7-fold rotational symmetry.  Each 
subunit is folded into a single domain and has a core β-barrel structure with two β-
hairpin loops on the top and bottom of the barrel (Figure 1.5).  A long mobile loop 
extends out from the bottom β-hairpin (containing residues Glu 16 to Ala 32).  The 
mobile loop segments are precisely visualized in GroEL-bound complex but are hidden 
in all but one subunit in a stand-alone GroES heptamer.  These segments have been 
confirmed structurally and by mutagenesis to interact with GroEL and form the GroEL-
GroES interface (Landry et al., 1993; Xu et al., 1997)  
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Figure 1.4 
Architecture of Group 1 chaperonins: Crystallographic models of E. coli GroEL and GroES.  
GroEL structures shown in open (left) and GroES-bound closed (right) conformations 
determined by Xray crystallography (Braig et al., 1994). One subunit has been coloured: 
apical domain in red, intermediate domain in green and equatorial domain in blue.  
Note: Figure has been taken from Horwich et al., 2007. 
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Figure 1.5 
Structure of co-chaperonin GroES.  
Ribbon diagrams of single subunit of GroES (above) and GroES-heptamer (below) are shown.  
The residues that link the β-hairpin of the mobile loop and the core barrel are coloured in 
yellow to describe the positioning of the mobile loop in all but one subunit in the GroES-
heptamer. 
Note: Figure has been adapted from Hunt et al., 1996. 
 
 
 
24 
 
1.2.3.2 General mechanism of working for Group 1 chaperonins 
The mechanism of GroEL-GroES machinery has been extensively studied by structural 
and mutational analysis (Martin et al., 1993; Braig et al., 1994; Fenton et al., 1994; 
Boisvert et al., 1996; Wang and Boisvert, 2003; Ranson et al., 2006) and widely reviewed 
(Sigler et al., 1998; Walter, 2002; Horwich et al., 2007; Hartl and Hayer-Hartl, 2009; 
Saibil et al., 2013).  The basic reaction cycle is thus well established and is discussed 
stepwise below (Figure 1.6): 
1. Polypeptide binding: 
The non-native polypeptide binds to one of the GroEL rings in the open state (the ring 
now becomes the cis ring) at the hydrophobic amino acids rich patch exposed around 
the central rim of the cavity.  Also, at physiologic concentrations of ATP (~1 mM) the 
seven subunits of cis ring bind to ATP cooperatively in a concerted manner.  It was 
believed that the client binding of the complex is followed by ATP binding (Hartl and 
Hayer-Hartl, 2009), however, a recent study reports that the ATP binds before the client 
polypeptide and in turn enables more efficient capture of the client (Tyagi et al., 2009). 
2. Polypeptide encapsulation:  
The ATP binding to the cis ring brings about a small degree of elevation and a counter 
clockwise twist.  Such a conformational change triggers GroES association and client 
disassociation from the apical domain.  The hydrophobic sites on GroEL apical domains, 
required for client binding, are also involved in GroES binding (Chen et al., 1994; Fenton 
et al., 1994).  The binding of GroES produces upward and outward rigid whole body 
movement in the chaperonin expanding the volume of the central cavity, attaining the 
closed conformation of the complex.  The movements bury the hydrophobic residues of 
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the binding site causing the bound peptide to be released.  Because the GroES now caps 
the cavity, the bound peptide moves towards the inside.  Some changes also take place in 
the internal surface of the cavity (e.g. making it more hydrophilic) and have been 
stipulated to facilitate the folding of the client peptide (Horwich and Fenton, 2009).  
3. Polypeptide folding:   
The polypeptide now folds within the confines of the cis ring till the bound ATP is 
hydrolyzed (usually 8-10 seconds).  ATP hydrolysis is triggered by ATP-binding to the 
opposite trans ring that in turn lowers the affinity for ATP in cis ring.  Hydrolysis of ATP 
weakens the interaction between GroEL and GroES and prepares the cis ring for 
releasing GroES.   
4. Polypeptide release:  
The GroES-release leads to a conformational change in the complex that brings the ring 
back into its open conformation.  Subsequently the polypeptide is released either in fully 
folded condition, or partially folded states that may undergo further cycles of binding 
and release.  The trans ring now becomes the new cis ring and the cycle repeats.  
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Figure 1.6: Illustration of a basic GroES-GroEL reaction cycle. 
1) Binding: Polypeptide is normally accepted into the open ring of the asymmetric complex (the ring now is called cis ring). Whether ATP 
binding is synchronous, ahead or later to polypeptide binding is still controversial.  
2) Encapsulation: GroES binding to the ATP-occupied open ring is associated with large rigid body movements and release of 
polypeptide into the cavity.  
3) Folding: The folding of the polypeptide is triggered in the encapsulated chamber. This is longest step of the reaction cycle and lasts 
for approximately 10 s.  
4) Release: ATP hydrolysis in the cis ring weakens the cis complex. This gates entry of ATP into the trans ring, which in turn triggers 
release of the cis ligands (GroEL and native or partially folded intermediates) in less than 1 s. This at the same time enables binding of 
GroES to the other ring forming a new folding-active cis complex and the cycle continues. 
Note: T denotes ATP and D denotes ADP 
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1.2.3.3 Different models of folding 
Three different models have been put forward for the folding mechanism of GroEL 
(Horwich et al., 2007; Horwich and Fenton, 2009; Jewett and Shea, 2010).  They are 
described as follows: 
1. Anfinsen cage model: 
 According to this model the client is encapsulated in the cavity.  The cavity acts as a 
passive nanocage – an isolated microenvironment that provides a ‘non-stick’ surface to 
the clients allowing spontaneous folding without any general or client-specific 
involvement (Rye et al., 1999; Brinker et al., 2001; Horwich et al., 2009).  Hence the 
native state is reached by following the intrinsic folding pathway according the 
Anfinsen’s principle of folding.    
2. Iterative annealing model (Forced unfolding model):   
A range of GroEL client proteins consists of aggregation-prone proteins that can form 
irreversible kinetically trapped states.  Such client proteins are unable to refold 
spontaneously.  A number of studies have suggested that client proteins that are 
kinetically trapped in a non-native state are unfolded by GroEL before undergoing a 
folding cycle.  Such an effect gives the aggregation-prone proteins a fresh opportunity to 
fold, starting from a higher point in the energy landscape of the nascent chain (Todd et 
al., 1996; Shtilerman et al., 1999; Sharma et al., 2008).  It is believed that GroEL exerts a 
stretching force, presumably due to allosteric transitions resulting from ATP binding, 
that brings about forced unfolding of the client (Shtilerman et al., 1999; Thirumalai and 
Lorimer, 2001).  It has also been suggested that the hydrophobic region of the apical 
domain around the client-GroEL interaction site catalyzes the partial unfolding of the 
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clients (Lin et al., 2008).  Thus the transient ternary complex of GroEL-ATP-client can 
have two fates – 1) release of the partially unfolded client into the cytosol (bulk 
solution) for another cycles 2) release inside the cavity for a passive folding.  The 
iterative annealing model stipulates that repeated cycles of binding and release free the 
proteins from the kinetic traps and hence further allows spontaneous folding (Todd et 
al., 1996).  The more the number of cycles, the faster is the folding.  Such a model also 
explains GroEL-mediated folding of the higher molecular weight clients that cannot be 
encapsulated inside the cavity.  The concept has been further extended to ‘stationary 
iterative annealing’ which means that even when the bound client protein proceeds 
towards passive folding inside the cavity, it is not released inside the cavity (Jewett and 
Shea, 2010).  This is supported by a recent study that suggests that client remains bound 
to the apical domain even when it has proceeded for folding inside the cavity (Motojima 
and Yoshida, 2010).  In sum, the model puts forward a mechanism for kinetically-
trapped clients and clients that cannot encapsulate inside the cavity; however whether 
every GroEL-client undergoes forced unfolding before encapsulating and whether 
complete folding can occur without encapsulation still remains a speculation especially 
when the importance of encapsulation has been shown biophysically (Jewett and Shea, 
2008). 
3. Active cage model:  
This model suggests that the cavity actively contributes to accelerate the folding process 
by at least two ways – 1) Nature of the residues facing towards the inside and 2) 
confinement of the clients in the folding chamber.  The inside of the GroEL cavity is 
hydrophilic and consists of a higher proportion of negatively charged residues (Horwich 
et al., 2007; Cong et al., 2010).  It was suggested that a hydrophilic inner could favour the 
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burial of hydrophobic surfaces in the encapsulated client.  Although experimental 
evidence for such a proposition is lacking but it has been shown that changing six 
negatively charged residues of the cavity-inside to positively charged residues has 
considerable negative effects on folding of the client protein Rubisco (Tang et al., 2006; 
Tang et al., 2008).  Next, it is proposed that the closed confinement of the client inside 
the cavity reduces the number of possible intermediates of the energy landscape and 
hence speeds up folding thermodynamically.  For example closed confinement would 
not allow extended conformations and elimination of such will help the protein to reach 
its native state, faster (Brinker et al., 2001).  Experiments with extended C-terminal-tail 
variants of GroEL that hypothetically should make the cavity more compact indeed 
resulted in 50% acceleration of folding of rhodanese (33KDa) suggesting an active 
involvement of cavity and optimization for accelerated folding.  The results have been 
disputed however, where the same effect could not be reproduced for malate 
dehydrogenase protein, also 33KDa (Farr et al., 2007).  Current view of folding continues 
to remain debated. 
1.2.3.4 Clients interacting with GroEL 
GroEL recognizes interacts with ~10% of the cellular proteins and binds them mostly 
post-translationally (Ewalt et al., 1997).  Using radio-labelling, 2D gel analysis and co-
immunoprecipitation studies, clients that bind to GroEL were identified in vivo (Houry et 
al., 1999).  The sizes of majority of these proteins were <60 KDa.  Proteins of this range 
of sizes can be encapsulated in the cavity.  However, larger proteins e.g., MetE (82 kDa), 
RNA polymerase β (151 kDa), phosphate acetyltransferase (77 kDa), and DNA gyrase A 
subunit (97 kDa) were also identified.  The same research group further determined the 
range of client proteins bound to GroEL using affinity purification of his-tagged GroES-
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client complexes and mass spectrometry (Kerner et al., 2005).  They reported that ~250 
of the total ~2400 cytosolic proteins interact with GroEL-GroES and classified them into 
three classes: class I (38 proteins) that interact but do not require GroEL for folding, 
class II (126 proteins) that prefer GroEL and GroES but can also fold with assistance of 
DnaK system and class III (84 proteins) that stringently require GroEL and GroES for 
folding.  More recently a study that characterized GroEL-clients by decreasing the level 
of GroE to under 10% modified the classification.  They found that not all class III 
proteins were dependent on GroEL for folding and introduced a fourth class that 
contained 49 of class III proteins plus eight others that absolutely required GroEL and 
GroES for folding (Fujiwara et al., 2010). 
It was observed that most of client proteins had complex topologies more prone to 
kinetic-trapping and requiring long-range interactions for stabilization barrel fold 
(Kerner et al., 2005).  Such an observation indicates the involvement of GroEL in binding 
the proteins post-translationally and prevention of aggregates rather than folding of 
newly formed peptides.   
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1.2.4 Group 2 chaperonins 
Group 2 chaperonins are found in the eukaryotic cytosol and in archaea.  The eukaryotic 
TRiC complex is composed of eight different yet structurally related subunits 
(Rommelaere et al., 1993) while in the archaeal thermosomes, each ring is made up of 
eight (Andra et al., 1996) or nine subunits (Knapp et al., 1994) that are products of one 
to five genes (Large and Lund, 2009). 
Despite the similar architectural outline with the Group 1 chaperonins, the sequence 
similarity between the two groups is largely limited to the equatorial domain.  
Significant differences are seen in the sequences of the apical domain and intermediate 
domains (Kim et al., 1994; Dekker et al., 2011b).  An important difference between the 
two classes lie in the apparent absence of a GroES-like co-chaperonin to seal off the 
cavity formed by the stacked double rings.  Instead, a hydrophobic stretch of 27 residues 
in the apical domain forms a 25 Å long flexible helix-turn-helix motif that extends as a 
helical protrusion and acts as a lid in capping the central cavity (Klumpp et al., 1997; 
Reissmann et al., 2007) (Refer to Figure 1.3).  The lid region is dispensible for 
polypeptide binding and encapsulation, however is essential for folding of the client 
proteins (Iizuka et al., 2004; Reissmann et al., 2007) 
1.2.4.1 Group 2 chaperonins: Eukaryotic view 
The eukaryotic TRiC is made up of hetero-oligomeric rings containing eight different 
albeit homologous subunits (30% identity) (CCT α, β, γ, δ, ε, ζ, η, and θ) in each of its 
rings and hence attaining eight fold symmetry.  All the eight subunits are encoded by 
eight distinct and independent genes (Rommelaere et al., 1993).  Moreover, these genes 
have been proved to individually essential, at least in yeast (Stoldt et al., 1996).  
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Phylogenetic analysis suggests a common ancestor to all these genes and they are 
thought to have evolved through multiple gene duplications very early in the eukaryotic 
lineage (Archibald et al., 2000; Fares and Wolfe, 2003).  This suggests that the 
complexity in the structure is a parallel consequence with the complexity in structure 
attained from the transition from prokaryotes to eukaryotes. 
The crystal structure of eukaryotic chaperonins was not available until very recently 
when Dekker et al. resolved by crystallography the closed form of yeast CCT at 3.8 Å 
(Dekker et al., 2011a).  However, previously various electron microscopy and 
biochemical studies provided structural insights for TRiC complex.  The specific 
arrangement of the individual subunits within the TRiC complex has remained 
controversial.  Based on biochemical data and cryo-EM constructions, it was shown that 
TRiC complex exhibited an asymmetric organization with a specific sequence of its 
subunits in the two rings (Liou and Willison, 1997; Martin-Benito et al., 2007).  This was 
argued by a study which, on the basis of high-resolution cryo-EM maps of bovine TRiC, 
proposed a different arrangement with a 2-fold symmetry between the subunits (Figure 
1.7A) (Cong et al., 2010).  The group with the former view however solved the crystal 
structure of yeast CCT at 3.8 Å that displays the same sequence of subunits as they 
initially proposed albeit now with a 2-fold symmetry (Figure 1.7B) (Dekker et al., 
2011a). 
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Figure 1.7 
Specific arrangement of subunits within each ring of the eukaryotic chaperonin complex-
TRiC 
The arrangement of subunits within each ring remains controversial with two different 
models: (A) proposed by (Cong et al., 2010) using cryo-EM structure of bovine TRiC and (B) 
proposed by (Dekker et al., 2011a) using crystal structure of yeast CCT. Circular arrows show 
the orientation of the rings and double arrows highlight the difference between the homo-
typic interations between the two proposed models. 
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As compared to GroEL and archaeal chaperonins, eukaryotic chaperonins are relatively 
less abundant.  Also, they are generally not heat induced as GroEL or archaeal 
chaperonins; basal levels are always found to be present in the cell (Horwich et al., 
2007).  This observation correlates with the finding that TRiC is required to fold ~10% 
of newly synthesized cellular proteins (Thulasiraman et al., 1999).  Initial data of co-
immunoprecipitation studies with chaperone specific antibodies identified actin and 
tubulin as the major clients for TRiC complex (Gao et al., 1992; Yaffe et al., 1992).  This 
was supported by the mutational studies in cct genes that lead to cytoskeletal and other 
defects in a variety of organisms (Ursic et al., 1994; Vinh and Drubin, 1994).  Although, it 
was first thought that only the cytoskeletal proteins are major clients for TRiC complex, 
a number of putative TRiC clients involved in a range of cellular activities were gradually 
identified.  This list includes cyclin E (Won et al., 1998), SMRT-histone deacetylation 
complex (Guenther et al., 2002), Von Hippel-Lindau (VHL) tumor suppressor (Feldman 
et al., 1999), anaphase-promoting complex (Camasses et al., 2003), G-beta folding 
intermediates (Kubota et al., 2006) among others.  
Proteome-wide analysis to identify bona fide interactors of yeast CCT and mammalian 
TRiC complex further identified a range of potential clients (Dekker et al., 2008; Yam et 
al., 2008).  Yam et al., showed that 90% of the TRiC interactome consisted of proteins 
belonging to homo or hetero oligomeric complexes and 40% of them are essential 
proteins.  Their sizes ranged from 40-75 kDa which is in agreement with the predicted 
normal range for the chaperonin cavity (Ditzel et al., 1998).  However, certain larger 
proteins with even >100KDa of size were also found, prompting the idea that some 
proteins are not fully encapsulated in the complex during their folding.  Indeed this has 
been the case for certain GroEL client proteins and mechanisms of folding-without-
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encapsulation or folding in the bulk solution have been proposed (Farr et al., 2003; 
Motojima and Yoshida, 2010).  An enrichment of hydrophobic sequences was also noted 
amongst the potential TRiC-interactors  (Yam et al., 2008).  Such observations along 
with oligomeric nature of the clients reinforces the proposition that eukaryotic 
chaperonins mainly fold proteins belonging to oligomeric assemblies and may serve as a 
reservoir to stabilize them against aggregation or degradation prior to complex 
formation (Spiess et al., 2004; Yam et al., 2008).  
1.2.4.2 Group 2 chaperonins: Archaeal view 
The general architecture of archaeal chaperonins is similar to that of the eukaryotic TRiC 
or GroEL.  They possess one to five subunits (Archibald and Roger, 2002b; Large and 
Lund, 2009) that assemble as octameric (Ditzel et al., 1998) or nonameric (Trent et al., 
1991) complexes of repeating subunits as compared to eight distinct subunits of 
eukaryotic TRiC. 
1.2.4.2.1 Structural information about archaeal chaperonins 
The first crystal structure for archaeal chaperonins was solved for CCT from 
thermophilic archeaon Thermoplasma acidophilum (Ditzel et al., 1998).  The T. 
acidophilum CCT complex is hexadecameric with alternating α and β subunits and forms 
a spherical complex as compared to rather cylindrical GroEL-GroES complex (Refer to 
Figure 1.2) (Nitsch et al., 1997).  The volume of the cavity is ~25% smaller than that of 
GroEL-ES, thereby reducing the upper size limit of the clients to be encapsulated.  The 
domain arrangement resembles to that of the GroEL-ES cis ring except the helical 
protrusions from the apical domain that form the lid.  There is a 46% of sequence 
similarity between the T. acidophilum CCT and GroEL, mainly in the regions of equatorial 
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and intermediate domains (Waldmann et al., 1995a).  The nucleotide binding site 
(containing the GDGTTT motif) in the equatorial domain is conserved suggesting a 
common mechanism of ATP hydrolysis between two groups of chaperonins.  These 
conclusions were further validated and generalized by a study that presented crystal 
structure of an archaeal chaperonin from thermococcus strain KS-1 (Shomura et al., 
2004).  However, the structures derived from both the studies were in nucleotide-bound 
closed form of the chaperonins restricting the study of client binding and the 
conformational changes that take place during the folding cycle.   
A significant amount of work was further done to understand the various folding-
conformations of archaeal chaperonins from the species Sulfolobus shibatae (Schoehn et 
al., 2000a; Schoehn et al., 2000b) and Methanococcus maripaludis (Clare et al., 2008) 
using cryo-electron microscopy and 3D-reconstructions.  However the crystal structures 
of archaeal chaperonins in their open conformation were available only recently when 
two groups independently presented their studies for CCTs from species M. maripaludis 
(Pereira et al., 2010) and Acidianus tengchongenesis (Huo et al., 2010).  Because the 
archaeal chaperonin from M. maripaludis (MmCCT) has been used as a model organism 
for this thesis, the conclusions from the former study are discussed in more detail below.  
The open forms of MmCCT were solved using its lidless-variant (MmCCT-∆lid) because 
of the disorder that the highly flexible helical protrusions have been reported to cause in 
the open state (Heller et al., 2004).  MmCCT-∆lid retain the ability to bind clients, 
hydrolyze ATP and has been shown to achieve a functionally open state (Reissmann et 
al., 2007).  For comparison, closed forms of MmCCT with and without lid were also 
derived.  The closed states of MmCCT and MmCCT-Δlid display a height of 162 Å and 148 
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Å respectively, and a diameter of 161 Å (Figure 1.8) (Pereira et al., 2010), similar to 
previously obtained for other archaeal chaperonins (Ditzel et al., 1998; Shomura et al., 
2004).  However the open form of MmCCT-∆lid shows an increase in height to 178 Å 
while maintaining the diameter of 159 Å (Figure 1.8).  A model reconstruction of full 
length wildtype MmCCT protein in its open conformation shows a remarkable height of 
204 Å.  Hence the volume of folding chamber in its open form is much higher compared 
to the closed form explaining the ability of Group 2 chaperonins to fold relatively higher 
molecular weight clients.  The change in the dimensions between the two forms occurs 
due to radical domain movements: The equatorial domain rotates outwards at an angle 
of 35 degrees when transitioning from an open state to a closed state, while the apical 
domain moves inwards (Figure 1.8).  The entire subunit rotates anti-clockwise as a rigid 
body around a pivot point identified near the residue P41 at the ATP binding site in the 
equatorial domain (Pereira et al., 2010).  The functional implications of these changes 
are discussed at length in the next section of mechanisms of folding of Group 2 
chaperonins.  
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Figure 1.8 
Overall architecture of lidless version of M. maripaludis chaperonin (MmCCT)  
Ribbon diagrams of single subunit (top panel) and the whole oligomeric complex (bottom 
panel) for lidless versions of MmCCT in their open (left panel) and closed (right panel) states 
are shown. The conformational change for a single subunit from the open state to the closed 
state can be seen as a rigid body movement by ~35⁰ anti-clockwise around a pivot point 
(coloured in yellow). 
Note: Figure adapted from Pereira et al., 2010. 
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1.2.4.2.2 Clients interacting with archaeal chaperonins 
The knowledge about the client range of archaeal chaperonins was limited until recently 
when Hirtreiter et al. in 2009 elucidated an interactome for archaeal chaperonins from 
Methanosarcina mazei .  M. mazei has copies of both Group 1 (MmaGroEL) and Group 2 
chaperonins (MmaCCT-α, β and γ) (Klunker et al., 2003) and hence provides an 
illustrative model to compare the client range for both groups simultaneously.  Using co-
immunoprecipitation assays and mass spectrometry of client-chaperonin complexes, 
they found that the archaeal chaperonins interacted with about 13% of the total cellular 
proteins i.e. ~333 proteins out of ~2500 soluble proteins in M.mazei.  Out of these, 182 
proteins (10 of them being essential) interacted with MmaGroEL-GroES chaperonin and 
252 proteins (14 of them being essential) interacted with the MmaCCT chaperonins.  
While a fraction of client proteins showed an exclusive interaction with either 
MmaGroEL-GroES or MmaCCTs, almost 100 proteins (out of total 333) were found to be 
interacting with both types of chaperonins (Figure 1.9).  Additionally, most of the 
overlapping proteins were found to be equally abundant in the isolated fractions of 
MmaGroEL-GroES and MmaCCTs.  Indeed certain proteins like citrate synthase were 
found to be enriched in fractions of MmaCCTs compared to MmaGroEL-GroES 
suggesting a gradual transition to becoming chaperonin-specific clients.  The molecular 
mass of most of the interacting proteins was in the range of 10-50 KDa, however certain 
high molecular proteins (in the range of 80-210 KDa) were detected and interestingly, 
were found to be interacting with MmaCCTs and not MmaGroEL-GroES.  This 
observation is consistent with the suggestion that large multi-domain proteins are more 
compatible with Group 2 chaperonins (Yam et al., 2008).  Another difference was that 
the MmaGroEL-interactors were relatively more hydrophobic and less charged 
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compared to the interactors of MmaCCTs.  This supports the proposition that client-
binding for Group 2 chaperonins, unlike Group 1, might not be solely governed by 
hydrophobic interactions (Gomez-Puertas et al., 2004).  Such an observation however 
differs from the TRiC-interactome data where a higher hydrophobicity quotient has 
been reported (Yam et al., 2008) and with studies that show hydrophobic interactions to 
be prime for client binding in Group 2 chaperonins (Spiess et al., 2006; Pereira et al., 
2010).  Also it was observed that the MmaGroEL-selective clients shared more complex 
topologies and were relatively slow evolving than the structurally diverse MmaCCT-
selective clients, speculating folding to be a more pronounced effect of MmaCCT than 
preventing aggregation.  Lastly, it was reported that the client-selectivity was 
independent of the phylogenetic origin of the clients.  Approximately 16% of M. mazei 
genes have been acquired by horizontal gene transfer, and hence were expected to be 
MmaGroEL-selective.  Surprisingly though, 93% of these proteins including MmaGroEL 
were found to be interacting with MmaCCTs for folding, speculating an influence of 
structural topology rather than an evolutionary control over differential client-
specificity (Hirtreiter et al., 2009). 
.  
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Figure 1.9 Relative distributions of M. mazei chaperonins’ interactors. 
Figure adapted from Hirtreiter et al., 2009 
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1.2.5 Mechanisms of folding: Group 1 Vs Group 2 chaperonins 
The mechanisms of folding for Group 1 and Group 2 are thought to follow a similar basic 
flow that is: binding to the client proteins through a client-binding site, ATP binding, 
client encapsulation and ATP hydrolysis, folding of the client and finally the release.  A 
number of differences however exist at each level making Group 1 and Group 2 
chaperonins distinct in their folding methodology.  For ease of understanding, the 
varying aspects of folding mechanism at each stage have been described in a step-wise 
manner below:     
1.2.5.1 Client binding 
As discussed previously, the interactions of Group 1 clients with their chaperonin 
subunits are largely suggested to be hydrophobic and mostly non-specific (Fenton et al., 
1994; Chen and Sigler, 1999).  However, the same for Group 2 remains to be confirmed.  
The Group 2 residues homologous to Group 1 client-binding hydrophobics are largely 
polar and charged (Horwich et al., 2007).  Structural data analysis for TRiC complexes 
with actin and tubulin have suggested a patch of positively charged polar residues in the 
apical domain to be involved in client binding in a subunit-specific manner (Llorca et al., 
1999; Pappenberger et al., 2002; Dekker et al., 2011a).  This has been further supported 
by biochemical and phylogenetic analysis (Hynes and Willison, 2000; Ritco-Vonsovici 
and Willison, 2000)   In contrast, using site-directed mutagenesis and cryo-EM 
constructions of VHL-TRiC interactions, hydrophobic residues in helix 10 and 11 were 
proposed for client binding in TRiC (Spiess et al., 2006).  The group further identified 
more clearly a conserved hydrophobic patch at the interface of helix 10 and 11 of 
archaeal chaperonin, MmCCT, by crystallography studies and has suggested it to be the 
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potential client binding site, (Pereira et al., 2010), however the same remains to be 
confirmed by genetic or biochemical studies. 
1.2.5.2 Intra-ring and Inter-ring allostery 
ATP-induced allosteric transitions form the functional basis of all chaperonins.  Each 
ring is in equilibrium between two states: tensed state, with low afﬁnity for ATP and 
high afﬁnity for un/misfolded clients; and a relaxed state, with high afﬁnity for ATP and 
low afﬁnity for un/misfolded protein clients (Yifrach and Horovitz, 1996).  Thus the two 
rings exhibit negative co-operativity i.e. when one ring encapsulates the other ring 
remains free.  This property has been observed for both, Group 1 chaperonin GroEL 
(Yifrach and Horovitz, 1995) and Group 2 chaperonins, TRiC (Kafri et al., 2001) and 
MmCCT (Kusmierczyk and Martin, 2003a).  The inter-ring negative co-operativity is 
thought to enhance the folding efficiency by enabling the chaperonin to function as a 
‘two-stroke’ motor to bind kinetically trapped clients with high affinity in one ring and 
release productively folded substrates from the other (Horwich et al., 2007). 
Nonetheless, studies have shown that single rings are sufficient to mediate productive 
folding of clients (Nielsen and Cowan, 1998).  Moreover, mutants have been also 
reported that allow GroEL to function more effectively as a single ring (Sun et al., 2003). 
While a negative inter-ring co-operativity is seen in all chaperonins, intra-ring allostery 
differs for Group 1 and Group 2 chaperonins.  In GroEL, binding of ATP to subunits 
within a ring is co-operative i.e. the binding of ATP to one subunit increases the affinity 
of the remaining subunits for the nucleotide.  In TRiC however, weak intra-ring positive 
co-operativity is seen and the binding of ATP is sequential rather than concerted 
(Rivenzon-Segal et al., 2005).  A sequential nature of binding can allow domain-to-
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domain interactions of hetereologous subunits of TRiC with multi-domain proteins.  
Such an arrangement can also support co-translational folding consistent with the idea 
that the TRiC client proteins are newly formed polypeptides primarily of multi-domain 
nature (Spiess et al., 2006).  The CCT from T. acidophilum on the other hand, does not 
show positive co-operativity (Bigotti and Clarke, 2005).  However, the homo-oligomeric 
chaperonin complex from M. maripaludis exhibits weak positive co-operativity like TRiC 
(Kusmierczyk and Martin, 2003a).  Hence, co-operativity within a ring does not seem to 
be a generalized feature in thermosomes.  
1.2.5.3 Folding cycle 
Client folding via Group 2 chaperonins is thought to be similar to Group 1 in the context 
that clients bind to the apical domains followed by ATP binding (or ATP binding 
precedes client binding).  However, once the client and ATP have bound to the 
chaperonins, further mechanism of lid closure differ between Group 1 and 2 
chaperonins as schematically shown in Figure 1.10.  As discussed in previous section, in 
GroEL, binding of GroES brings large conformational changes that rearranges apical 
domain and releases client into the cavity.  Lid closure precedes ATP hydrolysis.  
However, for Group 2 chaperonins the closing of the lid is triggered by the transition 
state of ATP hydrolysis.  Single particle cryo-EM analysis of open and closed forms of 
bovine TRiC identified molecular motions that govern lid closure and established that 
unlike GroEL, ATP hydrolysis and not ATP binding is responsible for lid closure (Booth 
et al., 2008).  In view to further expand the theory, the same group have recently 
reported high resolution cryo-EM structures of ATP-free open state, ATP-hydrolysed 
closed state of ∆lid variants (Zhang et al., 2010) and of a D396A variant of MmCCT that 
binds to ATP but does not hydrolyze it (Zhang et al., 2011).  Comparisons of all three 
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structures reveal significant structural differences between the open, pre-hydrolysis and 
the closed state.  The data suggests that like GroEL, a transition from ATP-free to ATP-
bound pre-hydrolysis state does not involve radical changes in the structure.  Instead, 
only a small shrinkage of the folding chamber entrance and a 45⁰ of counter-clockwise 
rotation of the apical domain was observed (Figure 1.11A and B).  At the same time, the 
lower surface of the intermediate domain is shifted towards the nucleotide binding 
pocket to optimise the structure for hydrolysis.  A rocking motion occurs in the structure 
when the ATP bound pre-hydrolysis state traverse to the ATP hydrolysed closed state 
including in the helical protrusions that now cover the lid completely (Figure 1.11C and 
D).  The potential client binding hydrophobic sites (Pereira et al., 2010) are buried in the 
closed state indicating that the client should be released into the cavity.  Thus ATP 
hydrolysis is implicated in dual function of lid closure and client encapsulation in Group 
2 chaperonins (Pereira et al., 2012).  
The release of the folded client from the chaperonin occurs presumably because of the 
ATP binding to the opposite ring that in turn, through intra-ring communication, passes 
a signal for opening of the lid.  The precise nature of such interactions remains to be 
established.  Of note, client folding inside the GroEL cavity occurs during the ATP 
hydrolysis step and the release primarily is mediated by the conformational changes 
occurring due to ATP hydrolysis (Xu and Sigler, 1998).  Certainly ATP hydrolysis is a 
result of ring’s lower affinity for ATP caused due to ATP binding to the opposite ring. 
However, from the above data for Group 2 chaperonins, it is suggested that folding 
occurs only during the transition from already hydrolysed closed conformation to the 
open form.  Such a mechanism can explain the sequential ATP binding in Group 2 
chaperonins that can slow down the process giving more time to the client for folding.  
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Figure 1.10 
 A cartoon representation of different folding mechanisms in Group 1 and Group 2 
chaperonins. 
 For Group 1 chaperonins (upper panel), ATP binding brings a small conformational change 
(blue) that enhances binding to unfolded clients (semi-circle) and co-chaperonin (Green 
triangle). Binding of co-chaperonin induces a large rotational movement closing the cavity. 
The folding occurs while ATP is hydrolysed leading to release of the folded client (circled). 
The two rings work alternatively. 
For Group 2 chaperonins (lower panel), ATP binding brings a small conformational change, 
similar to Group 1, which leads to binding of the unfolded client. In contrast, ATP hydrolysis 
leads to closing of the cavity.  How the cavity opens and releases the client is still under 
question.  
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Figure 1.11 
Structural changes occurring during the ATP binding and hydrolysis cycle of MmCCT  
(A and C) Top-view of apical domains of MmCCT complex in ATP bound and ATP hydrolysis 
stages respectively.  
(B and D) Conformational changes in single subunit of MmCCT complex during ATP bound 
and ATP hydrolysis.  
The dotted blue and red circles touch the innermost part of the apical domains of ATP-free 
and ATP-bound states. The hinge point is marked by a black solid triangle. The black star 
labels the ATP-binding pocket.  
Note: Figure taken from Zhang et al., 2011 
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1.2.5.4 Folding models: 
The passive cage model was initially accepted for Group 2 chaperonins also 
(Thulasiraman et al., 1999).  However, currently both the forced unfolding and active 
cage models have been suggested for Group 2 chaperonins.  Analysis of live folding of 
actin on yeast-CCT and similar other studies have shown that the clients are not released 
in the chamber during folding.  Instead the client remains bound to the apical domains 
and undergo folding in two steps: 1) ATP binding causes the apical domain with their 
bound clients to move and this movement mechanically force client folding 2) ATP 
hydrolysis liberates client and brings back the chaperonin to open state (Gomez-Puertas 
et al., 2004; Stuart et al., 2011).  On the other hand, for archaeal chaperonins, 
encapsulation has been suggested to be an essential step for folding.  For example, 
studies using ∆lid variants of MmCCT show that the lid and hence complete 
encapsulation is indispensible for folding (Meyer et al., 2003; Reissmann et al., 2007).  
Moreover, using D386A variants of MmCCT it has been shown that ATP binding alone is 
ineffective for productive folding of their stringent clients rhodanese or malate 
dehydrogenase (Douglas et al., 2011).  
On the basis of such observations and recent crystal structures of open and closed 
MmCCT (Pereira et al., 2010; Zhang et al., 2011), an active-cage model has been 
proposed for archaeal chaperonins wherein the client is encapsulated upon lid closure 
and the cavity contributes to accelerated folding.  This model is similar to that proposed 
for GroEL where closed confinement and the nature of the residues inside the cavity are 
thought to be the basic reasons for accelerated folding.  Interestingly though, the inside 
of the cavity as seen for closed conformations of GroEL, thermosome and TRiC differ in 
their charge distribution and hydrophobicity (Figure 1.12) (Cong et al., 2010).  As seen 
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in the figure, the charge distribution for thermosome and GroEL is symmetrical while 
asymmetry is observed in TRiC complex; nonetheless, both TRiC and thermosome show 
higher distribution of positively charged residues as compared to the relatively 
negatively charged patches in the GroEL cavity.  Both the inside of TRiC and thermosome 
are highly hydrophilic consistent with the active cage model.  Notably, they display a 
lower proportion of hydrophobic residues as compared to GroEL.  
1.2.5.5 Co-factors for Group 2 chaperonins 
Although the Group 2 chaperonins do not require assistance of a co-chaperonin like 
GroES in Group 1 chaperonins, certain co-factors have been reported to be modulating 
the folding process of Group 2 chaperonins.  One of such co-factors is the 
heterohexameric protein called prefoldin.  Prefoldin also called as GimC is not 
phylogenetically related to GroES and unlike GroES, functions directly by binding to the 
client proteins.  In the cases studied, this hetero-oligomeric protein complex is known to 
interact with the non-native substrates (typically actin and tubulin in eukaryotes) and 
deliver them to the chaperonin system by directly interacting with the chaperonin 
complex (Vainberg et al., 1998).  Prefoldin homologes are found both in eukaryotes and 
in the archaea alongside Group 2 chaperonins though their mechanism of client binding 
has been shown to be different between the two domains (Martin-Benito et al., 2002).  In 
addition to prefoldin, recently, the interactions of conserved phosducin-like proteins 
(Plp1 and Plp2) have been reported to be playing a role in TRiC mediated folding of actin 
and tubulin (Stirling et al., 2007; McCormack et al., 2009).  Such proteins have also been 
reported for productive folding of G-proteins (Willardson and Howlett, 2007). 
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Figure 1.12 
Surface properties of the central cavity for TRiC, thermosome from T. acidophilum and 
GroEL  
 (A-C) Charge distribution of inner cavity of TRiC, thermosome and GroEL: blue represents 
positively charged patches, red negatively charged patches, and white neutral patches. (D-F) 
Degree of hydrophobicity of the cavities: hydrophilic (sky blue), hydrophobic (yellow), and 
main chain (white) 
Note: Figure taken from Cong et al., 2010. 
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1.3 Archaea as models to study Group 2 chaperonins 
1.3.1 Archaea 
Till late 1980s the general accepted classification of life was a five kingdom classification 
placing bacteria and archaea (then known as archaebacteria) in the same kingdom, 
Monera.  The basis of Monera as a different kingdom was rather negative as organisms 
lacking similarities with eukaryotic organisms.  However, the molecular sequencing 
revolution identified unusual and definitely diverging characteristics in archaea discrete 
from bacteria and eukaryotes; one of the characteristic being the distinguishing 
sequence of small subunit rRNA.  On the grounds of dividing the living world on the 
basis of phylogenetic characteristics, at the molecular sequence level rather than at a 
cellular or phenotypic level, Woese introduced a new taxon of ‘domain’ above the 
kingdom level and described a three domain classification that classified archaea as a 
separate domain of life along with the domains Bacteria and Eukarya (Woese et al., 
1990) (Figure 1.13).   
The archaea are divided into two main classes according to rRNA comparisions, the 
Crenarchaeota and Euryarchaeota.  Crenarchaeota mostly consist of hyperthermophiles 
(e.g. Sulfobus) while Euryarchaeota is a more diverse group and includes methanogens 
(e.g. Methanosarcina), halophiles (e.g. Haloferax), thermophilic methanogens (e.g. 
Methanococcus) and hyperthermophiles (e.g. Thermoplasma).  Two more phylums have 
been further added and are referred to as Korararchaeota (Barns et al., 1996) and 
Nanoarchaeota (Huber et al., 2003).  Archaeal species belonging to these classes are 
relatively rare and have peculiar characteristics for example nanoarchaeota equitans has 
a significantly smaller genome size of 490 kb only (Huber et al., 2003) . 
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Figure 1.13 
Universal phylogenetic tree using rRNA as molecular chronometer  
The figure shows the division of living world in three domains and relationship of archaea 
with both Bacteria and Eukarya. The domain Archaea is split into two main kingdoms: The 
most diverse - Euryarchaeota having the euryarchaeal type of rRNA comprise extreme 
halophiles and methanogens, whereas Crenarchaeota consists of thermoacidophiles. 
Nanoarchaeota has one known member (Nanoarchaeum equitans), and so far Korarchaeota 
are indicated only by environmental DNA sequences. The positions of these phyla on the 
rRNAtree are uncertain (indicated by dashed branches).  
Note: (Figure taken from Allers and Mevarech, 2005) 
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It is known that many of the archaeal features are either similar to bacteria or eukarya. 
For example bacteria and archaea have similar cellular framework i.e. similar general 
cell sizes, lack of nuclear membrane and organelles, the presence of a large circular 
chromosome and similar operational machinery of housekeeping genes (Cohen et al., 
2003).  However, the archaeal information-processing systems like DNA replication, 
transcription and translation resemble to those in eukaryotes (Grayling et al., 1996; Bell 
and Jackson, 2001; Hickey et al., 2002).  Because only a subset of the eukaryotic proteins 
is found in archaea, the archaeal system is simpler and more amenable to analysis. 
Archaea have served a streamlined model for understanding complex mechanisms of 
eukaryotes in many fields such as DNA replication (Grabowski and Kelman, 2001). 
 Moreover, thermophilic and halophilic archaeal proteins have been constantly used for 
elucidation of structures for example the first crystal structure for a ribosome was 
obtained using the large ribosomal subunit from Haloarcula marismortui (Ban et al., 
2000).  Thermostable enzymes of archaea are routinely used in laboratories for DNA 
amplification by PCR (for example, Pfu DNA polymerase from Pyrococcus furiosus). Also, 
large number of genetic manipulation techniques for archaea are being developed 
permitting exploration of archaeal models to better understand complex eukaryotic 
systems (Allers and Mevarech, 2005).  
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1.3.2 Why study archaeal chaperonins? 
There are three main reasons to study chaperonins in archaea (Large and Lund, 2009; 
Lund, 2011):  
1. Archaeal chaperonins are excellent models to study general properties of Group 2 
chaperonins.  As discussed in the section 1.2, it becomes apparent that while a lot of 
information has been convincingly established for the working of Group 1 
chaperonins, mechanisms of Group 2 chaperonins are less understood.  Archaeal 
chaperonins contain fewer unique subunits as compared to eight distinct subunits of 
TRiC.  This allows easier recombinant expression in E. coli.  As a result large scale 
purification and further use for biochemical and biophysical methods is enabled.  
Data interpretation is simplified which then can be extended to Group 2 chaperonins 
by targeted experiments.  
2. Although archaeal chaperonins are phylogenetically more related to Group 2 
chaperonins, they resemble to Group 1 chaperonins in a number of aspects.  For e.g. 
archaeal chaperonins are induced by heat shock like GroEL.  Also, they exhibit at least 
some homology between their subunits i.e. not all subunits are encoded by distinct 
genes as for eukaryotic chaperonins.  It can be speculated that archaeal chaperonins 
represent a link between Group 1 and Group 2 chaperonins and hence, may hold a 
key to understanding the divergence between the two groups.  
3. They are of interest in their own right to understand the process of protein folding in 
archaea.  Archaea can thrive under extreme conditions e.g. high temperature and high 
salinity.  It is intriguing to understand how these organisms sustain such conditions 
that otherwise could have profound effects on protein folding.  
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1.3.3 Project flow 
The ultimate aim for this project is to lead to a better understanding of properties of 
archaeal chaperonins and to further comprehend the basis of divergence between the 
Group 1 and Group 2 chaperonins.  This study is a functional analysis of the chaperonin 
from archeaon M. maripaludis (MmCCT) using E. coli as a host organism.  
The first part of the project is targeted at a study where a Group 2 chaperonin, MmCCT, 
was introduced in a Group 1 host, E. coli, when the native Group 1 chaperonins, GroEL 
and GroES, are limited or absent.  This analysis allows an understanding of whether or 
not and if yes to what extent, can an archaeal chaperonin replace the function of GroEL.  
Using mutagenesis approach, further experiments were performed to isolate functional 
variants of MmCCT that can more effectively replace GroEL function (Chapter 3).  
MmCCT along with the functional variants were characterized biochemically for their in 
vitro activity to understand their differential GroEL substituting ability (Chapter 4).   The 
variants of MmCCT with an improved function in GroEL-depleting E. coli cells provided a 
platform to dissect the properties of archaeal chaperonins using E. coli as host.  Thus 
using the generated system, preliminary studies have been initiated to elucidate clients 
that interact with MmCCT in E. coli and to test the validity of potential client binding 
residues of MmCCT (Chapter 5).  To test whether the observed phenomenon holds for 
other archaeal chaperonins also, the study has been extended to chaperonins from 
various archaeal species such as Methanosarcina mazei, Thermoplasma acidophilum and 
Haloferax volcanii (Chapter 6). An initiative has also been described to develop an in vivo 
genetic system in archeaon H. volcanii that can allow direct dissection of the properties 
of archaeal chaperonins (Chapter 7). 
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Materials and Methods 
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2.1 Strains 
2.1.1 E. coli strains 
Table 2.1: List of E. coli strains used in the study 
Strain Genotype/Features Reference(s) 
DH5α F- gyrA96 (Nalr) recA1 relA1 endA1 thi-1 hsdR17(rK- mK+) glnV44 deoR 
Δ(lacZYA-argF) U169 nupG [Φ80d Δ (lacZ) M15] λ– 
Hanahan, 1983, Gibco-BRL 
JM110 F’ traD36 proA+B+ laclq ∆ (lacZ) M15I rpsL (Strr) thr leu thi lacY galK gal 
Tara fhuA dam dcm glnV44∆(lac-proAB) 
Yanisch-Perron et al., 1985 
MGM100 Modified MG1655 kanr-pBAD -groESL  McLennan and Masters, 
1998 
BL21 (DE3) F– ompT hsdSB(rB– mB–) gal dcm (DE3) Novagen 
TAB21 BL21 containing groESL under pBAD promoter Established in the lab  
AI90 Modified TG1 ΔgroEL::kanr Ivic et al., 1997 
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2.1.2 H. volcanii strains 
Table 2.2: List of H. volcanii strains used in the study 
Strain Description Reference(s) 
H. volcanii DS70 Wild-type strain cured from endogeneous pHV2 plasmid. Wendoloski et al., 2001 
H. volcanii H26 ∆pyrE2 deletion in DS70 background Bitan-Banin et al., 2003 
H.  volcanii H26:∆cct2 H26 strain carrying a deletion of cct2 (created by using the pyrE2 
knockout method.)  
Kapatai et al., 2006 
H.  volcanii H26:∆cct3 H26 strain carrying a deletion of cct3 (created by using the pyrE2 
knockout method.) 
Kapatai et al., 2006 
H.  volcanii H26: ∆cct1/∆cct3 Double knockout H26 strain carrying a deletion of cct1 and cct3 genes 
(created by using the pyrE2 knockout method.) 
Kapatai et al., 2006 
H.  volcanii H26:∆cct2/∆cct3 Double knockout H26 strain carrying a deletion of cct2 and cct2 genes  This study 
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2.2 Plasmids 
Table 2.3: List of plasmids used in the study 
Plasmid Features Reference(s) 
pOK12 Low copy number pUC-type vector with a p15A replicon and a lacZ gene 
downstream the multiple cloning site (MCS). 
Vieira and Messing, 
1991 
pET21b A pET expression plasmid containing T7 promoter, lac operator, ampicillin 
resistance marker (AmpR), N-terminal T7 tag and a C-terminal His tag. 
Novagen 
 
pET22b Similar to pET21 except for lacking the N-terminal T7 tag. Novagen 
pET27b Similar to pET21 except for containing a Kanamycin resistance marker (KanR) 
instead of an AmpR 
Novagen 
pTrc99A An expression plasmid driven by the ptrc promoter, IPTG inducible. Amann et al., 1988 
pACYC184 Low copy number expression plasmid containing the p15A origin of replication 
along with chloramphenicol (CamR) and tetracycline (TetR) resistance markers. 
 
pCRPrtneo A pCR2.1TOPO derived vector containing M. maripaludis hpt gene under 
constitutive hmv promoter and a Neomycin resistance marker (NeoR) 
Moore and Leigh, 2005 
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pTA131 pBluescript II with fragment containing H. volcanii pyrE2 gene under ferridoxin 
(fdx) promoter of H. salinarum 
Allers et al., 2004 
p354 E. coli/H. volcanii shuttle vector derived from pTA131 with an additional fragment 
containing pHV1/4 origin of replication 
Norais et al., 2007 
p131-
5’3’flankcct2 
p131 containing upstream and downstream flanking sequences of H. volcanii-cct2- 
gene 
This study 
pOK-PTC2 ptna driven cct2 gene and pyrE2 gene inside the cct1 gene lockers inserted in 
pOK12 
This study 
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2.3 Primers 
Table 2.4: Primers for mutagenesis 
Name of the oligo Sequence (5’ to 3’) Length 
(in bases) 
MmCCT-K216n-F GGTGTTTTAGTTGACnnnGAAAGAGTAAGCGCTCAAATGCC 41 
MmCCT-K216n-R GGCATTTGAGCGCTTACTCTTTCnnnGTCAACTAAAACACC 41 
MmCCT-K216E-F GGCATGATCATTGACGAGGAAAGAGTCCACAC 32 
MmCCT-K216E-R GTGTGGACTCTTTCCTCGTCAATGATCATGCC 32 
MmCCT-D386A-F GCAAGAGCAGTAGACGCTGCTGTTGGTGTAGTTG 34 
MmCCT-D386A-R CAACTACACCAACAGCAGCGTCTACTGCTCTTGC 34 
MmCCT-G61C-F GACGTTGTTGTTACAAACGACTGTGTTACAATCTTAAGAG 40 
MmCCT-G61C-R CTCTTAAGATTGTAACACAGTCGTTTGTAACAACAACGTC 40 
MmCCT-V273n-F AATGTTAAAAGACATGnnnGCTGAAATCAAAGCAAGCGGTGC 42 
MmCCT-V273n-R GCACCGCTTGCTTTGATTTCAGCnnnCATGTCTTTTAACATT 42 
MmCCT-Y297n-F CGATGACTTAGCACAACACnnnTTAGCTAAAGAAGGAATCGTAG 44 
MmCCT-Y297n-R CTACGATTCCTTCTTTAGCTAAnnnGTGTTGTGCTAAGTCATCG 44 
Mma-alphaM226I-For GGAAAGAGTCCACACAAATATCCCTGAGAAAGTAAAGGATGC 42 
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Mma-alphaM226I-Rev GCATCCTTTACTTTCTCAGGGATATTTGTGTGGACTCTTTCC 42 
Mma-gammaM228I-For CGCGTCCACACCGGCATCCCGGAAGTTGTGAAG 33 
Mma-gammaM228I-Rev CTTCACAACTTCCGGGATGCCGGTGTGGACGCG 33 
Xba1_MmCCTinternal_FOR GCCCCGTCTAGAGAAACAGTAAGATCAACACTCGGTCCA 39 
MmCCTinternal_Not1_REV CTAAAAGCGGCCGCAACTTCTGTTGAACCTCCACCAGCTAC 41 
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Table 2.5: Primers for sequencing 
Name of the oligo Sequence (5’ to 3’) Length 
(in bases) 
T7 promoter primer TAATACGACTCACTATAGGG 20 
T7 terminator primer GTAAGCTGCAACCTTGTCATCCATG 25 
MmCCT-seq1 GATACATGGGAAGAGATGCTC 21 
MmCCT-seq2 AGAGTAAGCGCTCAAATGCC 20 
MmCCT-5’-Rev GTTGGGTGTACATTTTGGTCC 21 
MmCCT-Mid-F CAAAGCAAGCGGTGCAAAC 25 
MmCCTgene-F CTTAACGGATTCCTGAAATGAGCTGTTGACAATTAATC 38 
MmCCTgeneSalI-R GGTTAAGTCGACTGAAAATTACATCATTCCTGGCATTC 38 
AI90-GroEL-For CGTAAAATTCGGTAACGACGCTCGTGT 27 
AI90-GroEL-Rev GTAGCCACGGTCGAACTGCATACCTTC 27 
Mma-alpha-mid-For CGGATACAGACTGGCAGCC 19 
Mma-alpha-mid-Rev GTTCTCCCACATGTCAACGACC 22 
cct2gene-For ACAATCAAGGCCTGCATATGAGCCAGCGAA 30 
cct2gene-Rev CCCTCGGACTGTCGGGAATTCGTAGTCGGC 30 
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Table 2.6A: Primers for for inserting CBP tag in Mmcct by overlap extension PCR 
Name of the oligo Sequence (5’ to 3’) Length 
(in bases) 
MmCCTgeneFOR AGA-TAT-ACA-TAT-GGC-ACA-ACC-AGG-AGT-TTT-ACC-TGA-A 37 
MmCCTgeneREV GAA-TTC-GGA-TCC-TGA-AAA-TTA-CAT-CAT-TCC-TGG-CAT-TCC 39 
CBP-A-REV GAT-TCG-CCG-CGC-TCA-CCG-CAA-TAA-AAT-TTT-TTT-TCC-AGC-GGC-GTT-TGC-CGC-
TGC-CTT-TTTCAA-ACT-GCG-GAT-GGC-TCC-AGC-CGC-TGC-CGC-TGC-CAG-GGT-GTT-
TGC-ATT-CTT-CTA-CC  
115 
CBP-B-FOR TGC-GGT-GAG-CGC-GGC-GAA-TCG-CTT-TAA-AAA-AAT-TAG-CAG-CAG-CGG-CGC-GCT-
GGG-CAG-CGGCCA-TCA-TCA-TCA-TCA-TCA-TCA-TCA-TGG-CAG-CGG-CAA-AGC-AGT-
TAC-AAT-GCT-CAT-C 
115 
 
Table 2.6B: Primers for amplifying flanking regions of cct2 gene in H. volcanii  
Name of the oligo Binding site on the gene Sequence (5’ to 3’) Length 
(in bases) 
5’flankingcct2-FOR 474bp upstream of cct2 gene GGAGACGTTCGAATTCGACGTGC 23 
5’flankingcct2-REV 26bp upstream of cct2 gene AGACAGGCCTGGATCCTTTGTGATTC 26 
3’flankingcct2-FOR 25bp downstream of cct2 gene AAATCGGATCCCGCCTTCACACCCC 25 
3’flankingcct2-REV 524bp downstream of cct2 gene CGTTGACCCTCTAGATGCCCGCGG 24 
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2.4 General microbial techniques: E. coli 
2.4.1 Growth media and supplements 
Lysogeny-broth (LB) media: 1% w/v tryptone, 0.5% w/v yeast extract and 1% NaCl 
dissolved in deionised water and sterilized by autoclaving.  For LB agar plates 15 g/L of 
agar was added to the liquid media and then sterilized by autoclaving. 
Supplements: The media supplements are listed in Table 2.7 with their stock and 
working concentrations.  All supplements were supplied from Sigma-Aldrich, UK. The 
stock solutions were prepared in ultrapure MilliQ water (Merck Millipore) unless stated, 
and filtered using 0.2 μm diameter Acrodisc syringe filter (Pall Life Sciences). 
2.4.2 Growth of E. coli strains 
Overnight liquid cultures were grown in LB medium with appropriate supplements in a 
shaking incubator (180-200 rpm) at 37⁰C unless otherwise stated.  Growth of liquid 
cultures was monitored by measuring optical density at a wavelength of 600 nm (OD600) 
using a spectrophotometer.  Plate cultures were grown on LB agar plates containing 
suitable additives with incubation at various temperatures. 
2.4.3 Glycerol Stocks 
Glycerol stocks of E. coli strains were made by mixing 875 μl of a fresh overnight culture 
with 125 μl of 80% sterile glycerol, after which they were stored at -80⁰C. 
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Table 2.7: List of additives used in bacterial culturing with their concentrations 
Supplement Stock concentration  Working concentration 
Ampicillin (Amp) 100 mg/ml 100 µg/ml 
Kanamycin (Kan) 50 mg/ml 50 µg/ml 
Chloramphenicol (Cam) 
(Solvent: Ethanol)    
50 mg/ml 50 µg/ml 
L-Arabinose (Ara) 20% w/v 0.2% (w/v) 
D-Glucose (Glu) 20% w/v 0.2% (w/v) 
IPTG 1 M 1 mM 
Sucrose 50% w/v 5% w/v 
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2.4.4 Plasmid isolation 
Small scale plasmid DNA preparations from E. coli cultures were carried out by using the 
Qiagen Qiaprep spin Plasmid Miniprep kit as per manufacturer’s instructions or by 
alkaline lysis method as described below.  The large scale preparations were carried out 
using Qiagen Plasmid Midiprep kit as per recommended guidelines. 
Alkaline lysis method:  
Single colonies were inoculated into 5 ml of sterile LB broth (with required additives) 
and allowed to grow overnight with shaking at 37⁰C.  Cells from overnight cultures were 
pelleted at 13,000 rpm in a bench top microcentrifuge for 2 minutes.  200 μl of sterile 
GTE (50 mM glucose, 25 mM TRIS pH 8.0, 10mM EDTA) was added and the cells were 
resuspended by vortexing or pipetting.  Next, 400 μl of freshly made lysis solution (1% 
SDS, 0.2 M NaOH) was added and the samples were mixed by inversion and left on ice 
for 5 minutes (lysis is observed by clearing of the turbid solution).  Further, 300 μl of 3 
M sodium acetate pH 5 adjusted by glacial acetic acid was added and the solution, 
inverted several times to mix and incubated at room temperature until a white 
precipitate developed.  The tubes were then spun for 10 minutes at 13,000 rpm.  The 
resulting supernatant free from the protein precipitates was transferred to a clean 
eppendorf tube.   
To precipitate nucleic acids, 600 μl of isopropanol was added and mixed thoroughly by 
inverting tube several times.  The tubes were then spun for 20 minutes at 13,000 rpm to 
get a small white pellet of plasmid DNA.   The pellet was washed first with 500 μl of 70% 
ethanol to remove salts and then with 500 μl of 100% ethanol.  Lastly the pellet was 
dried for 10 minutes in a 370C incubator and resuspended in 50 μl of sterile TE buffer 
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(10 mM TRIS pH 8.0, 1 mM EDTA) to obtain the plamid DNA.  The plasmids were stored 
at -20⁰C freezer. 
2.4.5 Preparation of chemically competent E. coli cells 
Reagents required: 
TfbI 294.5 mg KAc, 121 mg RbCl2, 220 mg CaCl2, 1g MnCl2 and 15 ml of glycerol 
were dissolved in 65 ml of MilliQ water.  The pH was adjusted to 5.8 using 
glacial acetic acid.  The solution was made up to 100 ml with DDW water, filter 
sterilised and stored at -20⁰C. 
TfbII 209 g MOPS, 1.65 g CaCl2, 121mg RbCl2was dissolved in 60 ml DDW water.  To 
this solution 15 ml of glycerol was added and the pH adjusted to 6.5 using 1 M 
KOH.  The solution was made up to 100 ml, filter sterilized and stored at -20⁰C. 
 
Method: 
A flask with 100 ml of pre-warmed LB was inoculated with 1 ml of overnight culture and 
grown in a shaking incubator at 37⁰C.  The growth of the culture was monitored every 
30 minutes until the OD600 reached 0.4.  Care was taken to ensure that the cultures do 
not over-grow.  The flask was then placed on ice for 5 minutes following which the cells 
were harvested by centrifuging at 5000 rpm for 10 minutes at 4⁰C.  The supernatant was 
discarded and the pellet was gently resuspended in 50 ml of TfbI.  This suspension was 
incubated on ice for 10 minutes and then spun down at 6000 rpm for 5 minutes.  The 
resultant pellet of cells was then resuspended in 2 ml of TfbII and incubated on ice for 2 
hours.  Aliquots (100 µl) of the solution were made and frozen at -80⁰C. 
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2.4.6 Transformations  
To 100 µl of competent cells (thawed on ice) approximately 10-100 ng of plasmid DNA 
or appropriate amounts of ligation reactions was added and incubated on ice for 45 
minutes.  The cells were then subjected to heat shock by placing them in a 42⁰C water 
bath for 90 seconds, followed by incubation on ice for 5 minutes.  To this, 900 µl of LB 
media was added and incubated at 37⁰C with shaking for 1 hour.  The cells were then 
plated on LB plates containing appropriate antibiotics. 
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2.5 General microbial techniques: H. volcanii 
2.5.1 Growth media  
Modified Growth Medium (MGM): H. volcanii grows at high salt concentrations.  For 
standard procedures, H. volcanii was cultured on 18% modified growth medium (MGM) 
as described (Table 2.8; Dyall-Smith, Protocols of haloarchaeal genetics).  The 
ingredients were dissolved and pH adjusted to 7.5 using 1 M Tris Base.  The volume was 
adjusted to 1000 ml with pure water and the media was sterilized by autoclaving.  For 
pouring plates, 15 g of Bacto-Difco agar was added to liquid MGM and dissolved by 
boiling to 100⁰C for 15 minutes.  This was then sterilized by autoclaving and poured into 
plates containing appropriate supplements.  
Minimal medium: The pyrE2 cured strain H. volcanii H26 is a uracil auxotroph.  To 
provide a medium for selection, a minimal medium was used (Table 2.9).  For solid 
media 2% of bacto-difco agar was added and dissolved prior to autoclaving.  Uracil and 
5-fluroorotic acid (5-FOA) were added to cultures for pyrE2 based selection. 
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Table 2.8: Modified growth medium for culturing H. volcanii  
Ingredient 18% MGM (per 1 L) 
Salt water (30% stock) 
(240 g NaCl, 30 g MgCl2.6H2O, 35 g of MgCl2.7H2O, 7 g of KCl, in 1 L of 
MilliQ water. After mixing, 5 ml of 1 M CaCl2.2H2O was added and pH 
adjusted to 7.5 with 1 M Tris Base) 
600 ml 
Pure water 367ml 
Peptone (Oxoid) 5g 
Yeast extract 1g 
 
Table 2.9: Minimal media composition for culturing H. volcanii  
 
 
Ingredient Minimal medium 
(per 100 ml) 
Final concentration 
Salt water (30% stock) 67 ml  20% 
Pure water 23 ml - 
500 mM Alanine 5 ml  25 mM 
Mixed and pH set to 7; sterilization by autoclaving 
10% Succinate 4 ml 0.4% 
1 M CaCl2 0.5 ml 0.5g/ml 
0.5 M (KH)PO4 pH 7.4 0.3 ml  
Trace metals 0.1 ml Trace 
*Uracil in DMSO 50 mg/ml 0.1 ml 50 μg/ml 
*5 FOA in DMSO 50 mg/ml 0.1 ml 50 μg/ml 
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2.5.2 Growth of H. volcanii strains 
Liquid cultures were grown in MGM or minimal media inoculated with either a single 
colony or a loop equivalent of glycerol stocks of H. volcanii at 37⁰C or 42⁰C on a shaking 
incubator (180rpm).  It took about 2 days in MGM and 3 days in minimal media for the 
cultures to reach log phase.  The growth of liquid culture was monitored by measuring 
the optical densities of the culture at 650 nm (OD650). For plate cultures, the inoculum 
was spread on MGM or minimal media plates and incubated at 37⁰C or 42⁰C.  The plates 
were kept in a sealed box with wet filters to keep the atmosphere moist.  The colonies 
took about seven days to come up on MGM plates and ten days to come up on minimal 
media plates.  The growth was faster at 42⁰C with 4-5 days on MGM plates and 7-8 days 
on minimal media plates.   
2.5.3 Transformations 
Polyethylene glycol (PEG) mediated transformation procedure was used for H. volcanii 
(Cline et al., 1989).  
Reagents required:  
Buffered 
spheroplasting 
solution (BSS) 
58.5 g NaCl (1 M) , 2.01 g KCl (27 mM), 50 ml of 1 M Tris-HCl pH 8.2 
(50 mM), and 150 g sucrose (15%) were dissolved in 1 L of milliQ 
water and sterilized.  
Unbuffered 
spheroplasting 
solution (USS) 
58.5 g NaCl (1 M), 2.01 g KCl (27 mM) and 150 g sucrose (15%) were 
dissolved, pH adjusted to 7.5 using 1 M NaOH, volume made up to 1 L.  
Spheroplast 
dilution 
solution 
15 g of sucrose (15%) dissolved in 76 ml of 30% saltwater (23%). The 
final volume was made upto 100 ml with milliQ water and the solution 
was autoclaved. After cooling, 0.75 ml of 0.5 M CaCl2 was added.  
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Regeneration 
solution 
60% w/v of 30% Saltwater (18%), 0.5% yeast extract, 0.1% peptone, 
0.1% cas amino acids, 15% sucrose, pH to 7.5 and autoclaved, 3 ml of 
1 M CaCl2 after autoclaving 
60% PEG 
solution 
600 μl of PEG600 in 400 μl of USS 
*All solutions were sterilized by autoclaving except for PEG solution 
 
Method:  
Single colonies were inoculated into 5 ml of MGM (or minimal medium depending upon 
the experiment) and allowed to grow for two days (OD650 between 0.8 and 1).  1 ml of 
the culture was used to set up a 50 ml culture in the same medium and the culture was 
allowed to reach log phase (O.D650 between 0.4 and 0.8) (~24 hours, depends upon the 
strain).  10 ml of the culture was harvested by centrifuging at 5000 rpm for 10 minutes 
at 4⁰C.  The pellet obtained was resuspended in 2 ml of BSS and re-pelleted.  After the 
washing step, the pellet was again resuspended in 600 μl of BSS out of which 150 μl was 
used per transformation.  15 μl of 0.5 M EDTA (pH 8.0) was added from the side of the 
tube and the solution mixed by gentle inversion.  Mixture was allowed to stand at room 
temperature (RT) for 10’ to allow the spheroplast (cells without cell wall) formation.  
Because archaeal cells have a chemically more resistant form of cell wall, conventional 
transformation methods like heat-shock does not allow entry of DNA into the cells.  
EDTA removes the S-layer of cell wall making it susceptible to DNA-intake.  Next, the 
DNA was added (not more that 2 μg in concentration and 7.5 μl in volume) to the 
spheroplast solution and allowed to stand for 5 minutes at RT.  Note that DNA used here 
was prepared from a dam- strain of E. coli, JM110. Non-methylated DNA was important 
to use as the restriction system of Haloferax volcanii degrades methylated DNA, 
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specifically methylated A residues at GATC sites and reduced transformation efficiency 
by 1000 folds (Allers and Mevarech, 2005).  60% PEG solution was then added to the 
mixture (185 μl), the solution mixed gently until homogeneous and incubated for 30 
minutes to 1 hour at RT.  PEG aids in delivering plasmid DNA to the cell surfaces.  
Further, 1 ml of spheroplast dilution solution was added, left at RT for 2 minutes and 
then centrifuged (8000 rpm for 5 minutes) to pellet the spheroplasts.   The supernatant 
was gently removed and 1 ml of regeneration solution was added without disturbing the 
pellet.  Incubation at 37⁰C without disturbing the pellet allows the spheres to grow a 
new cell wall around them.  The pellet was resuspended after 3 to 4 hours and left 
overnight at 37⁰C to regenerate.  Next day the regenerated cultures were plated onto 
appropriate plates containing selectable markers and if necessary, with dilutions.   
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2.6 General molecular techniques 
2.6.1 Restriction digestions 
 For the restriction digest of a plasmid, procedures from New England Biolabs (NEB; MA, 
USA) were followed.  All enzymes used were from NEB, the combinations determined 
using the NEB guidelines.  Approximately 500 ng of plasmid DNA was used for all 
digests.   The buffer and the enzyme concentrations were used according to the manual.  
Incubations were done at 37⁰C unless other temperatures required for specific enzymes.   
2.6.2 Dephosphorylation 
The digested plasmids were dephosphorylated using alkaline phosphatase enzyme 
(NEB) at 37⁰C for one hour.  Enzyme activity was inactivated by incubating the samples 
at 65⁰C for 10 minutes.  The digested and dephosphorylated DNA was then purified 
using DNA clean and concentrator kit (Zymo research, CA, USA) when required for 
downstream analysis like PCR, ligations or transformations. 
2.6.3 Polymerase chain reaction (PCR) 
PCR was used to amplify desired regions of a gene from a plasmid or chromosomal DNA 
for cloning or downstream screening purposes.  All primers were designed using the 
web-based oligoanalyzer primer design programme (Intergrated DNA technologies).  A 
pre-made Reddymix PCR solution was used in general for all PCR reactions (Abgene).  
50 µl reaction mixtures were set up containing 45 µl of reddymix solution, 25 pmol of 
forward and reverse primers (2.5 µl each of 10 pmol stocks) and 50-100 ng of DNA.  The 
reaction cycle was used as shown in Table 2.10.  Reddymix employs an ultra-stable Taq 
polymerase for elongation.  Hence, the pre-denaturation and the denaturation 
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temperatures were set to 95⁰C as per manufacturers’ guide.  The annealing temperature 
was varied from 55⁰C to 70⁰C depending upon the melting temperatures of the primers.  
A temperature-gradient feature of the thermocycler was also employed under certain 
circumstances where in a number of replicates were simultaneously subjected to PCR at 
a specific range of temperature.  The expected band sizes were calculated theoretically.   
The PCR reactions employing reddymix were robust and reproducible however had a 
higher chance of mutation-rate because of the low-fidelity enzyme taq polymerase.  
Thus, in specific cases of cloning, Phusion High-Fidelity PCR Kit was used.  This kit 
employs phusion DNA polymerase, a commercially made high-fidelity enzyme.  
Reactions were performed following the exact protocol by the manufacturer and as 
briefly outlined in Table 2.11. 
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Table 2.10: PCR reaction-cycle details when using PCR-reddymix 
Step Temperature Time Cycles 
Initial denaturation 95⁰C 1 minute 1 
Denaturation 95⁰C 30 seconds  
30 
Annealing x⁰C 30 seconds 
Extension 72⁰C x minutes (1min/kb) 
Final extension 72⁰C 6-10 minutes 1 
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Table 2.11: PCR reaction details when using Phusion High-Fidelity PCR Kit 
For a 50μl reaction mix 
Component Volume Final Concentration 
MilliQ water Add to make 50 μl  
5X Phusion buffer  10 μl  1X 
10mM dNTPs 1 μl  200 uM 
Primer A 2.5 μl (1:10 stock)  0.5 uM  
Primer B 2.5 μl (1:10 stock)  0.5 uM  
Template DNA X μl 1 pg to 10 ng 
DMSO (Optional) (1.5 μl) (1%) 
Phusion DNA pol 0.5 μl 0.02 units/μl 
 
 
Note: 2-step protocol was used when the melting temperature (Tm) for both the 
primers was more than 70⁰C. If the Tm for both the primers was less than 70⁰C, 3-step 
protocol was used (Primer length >20 bp : Annealing temp = Tm+3⁰C of the lower Tm 
primer; Primer length <20bp: Annealing temp = Tm of the lower Tm primer). Tm of the 
primer always calculated from the online Finenzyme calculator 
(http://www.finnzymes.com/tm_determination.html) 
 
Cycle step 2-step protocol 3-step protocol Cycles 
Temp. Time Temp. Time 
Initial denaturation 98⁰C 30 s 98⁰C 30 s 1 
Denaturation 
Annealing 
Extension 
98⁰C 
- 
72⁰C 
5 - 15 s 
- 
15 -30 s/kb 
98⁰C 
X°C 
72⁰C 
5 - 10 s 
10 - 30 s 
15 - 30 s/kb 
25-35 
Final extension 
  
72⁰C 
4⁰C 
5-10 min 
hold 
70⁰C 
4⁰C 
5-10 min 
hold 
1 
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2.6.4 Site-directed mutagenesis  
Site directed mutagenesis was performed using QuikChange Site-Directed Mutagenesis 
Kit (Agilent Technologies, CA, USA) as per manufacturer’s protocol.  Identical primer 
pairs consisting of 25-45 bases were designed such that the desired point mutation is in 
the middle of the fragment.  The length, GC content and the melting temperatures of 
these oligonucleotides were set according to manufacturer’s conditions.  When 
subjected to PCR, the primers hybridize to homologous regions of corresponding 
strands on the plasmid (Figure 2.1).  The high-fidelity enzyme pfu DNA polymerase of 
the kit then extends the complete strand of circular DNA with a nick at the 5’ end of the 
primer.  At the end of the first PCR cycle, two products result, one containing the 
mutation and second that is identical to the parental DNA (Figure 2.1).  The process is 
then repeated for 18 cycles producing both mutated DNA and the parental DNA (Figure 
2.1).  The cycle number is less as compared to normal PCR reactions to reduce the 
amount of wildtype DNA produced.  The methylated and hemi-methylated parental DNA 
is digested by Dpn1 endonuclease enzyme.  The resultant product is transformed into 
XL-Blue competent cells (a part of the kit) and transformants are selected using the 
selectable marker present on the plasmid that is mutagenised.    
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Figure 2.1 
Schematic diagram to explain site-directed mutagenesis using QuikChange Kit 
(Picture adapted from QuikChange mutagenesis protocol from Agilent technologies) 
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2.6.5 Random mutagenesis using XL1-mutator strain 
Random mutagenesis was performed using XL-1 mutator strain (Agilent technologies).  
This E. coli strain is deficient in three genes of error prone mismatch repair system 
(mutD5, mutS and mutT) and hence, according to manufacturer, has a ~5000 fold higher 
mutation rate than the wildtype.  The plasmid to be randomly mutagenised was 
transformed into XL-1 red mutator strain and grown on LB agar with appropriate 
selectable markers.  The colonies obtained were mixed together by resuspending in 500 
µl LB on the plate using a sterilized and bent glass rod and were further cultured in 100 
ml of LB.   After two rounds of further sub-culturing, the plasmids were isolated that 
now should contain random mutations.  Appropriate strains were then transformed 
with these plasmids for selection of mutants. 
2.6.6 Ligations 
For ligations, the vector back-bone and the DNA insert (obtained either by digestion or 
PCR) were usually mixed in a molar ratio of 1:3 and treated with T4 DNA ligase enzyme 
along with appropriate buffer (New England Biolabs) according to manufacturer’s 
instructions.  Ligations were carried out at RT for 2 hours or overnight at 4⁰C. 
2.6.7 Colony PCR 
To screen for colonies containing the desired insert, individual colonies were picked on 
pipette tips streaked onto labelled agar plates and simultaneously swirled into PCR 
tubes containing the PCR reaction mixture.  On heating at 95⁰C in the first step itself in a 
thermocyler, plasmid DNA is released and serves as a template for PCR reactions with 
primers designed to identify the desired region inserted in the vector sequence.  The 
reaction recipe and the cycle were same as described above in section 2.6.3. 
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2.6.8 Agarose gel electrophoresis 
DNA samples including plasmids, digests and PCR fragments were resolved on 1% or 
0.8% agarose gels.  SYBR safe dye (Invitrogen, CA, USA) was added while preparing the 
gels.  Loading buffers and DNA markers employed for the electrophoresis were from 
Bioline (Bioline, MA, USA).  Hyperladder I and lV were generally used.  The gel was run 
in a tank containing 1X TAE (Tris-acetate EDTA buffer) at 100 V until appropriate 
migration of DNA was indicated by the loading dye.  The bands were visualized under 
UV lamp and photographed.   
2.6.9 Sequencing 
DNA samples were sequenced by the Sanger Sequencing method at the Genomics 
laboratory, School of Biosciences, University of Birmingham (Sanger et al., 1977).  
Oligonucleotides were synthesized by Alta Biosciences, University of Birmingham or 
Eurogentec, GBR.  The samples were prepared by mixing 100 to 200 ng of plasmid DNA 
or 1 to 10 ng of PCR fragments with 3.2 pmol of primer in a total volume of 10 μl 
adjusted with water. 
2.7 Complementation analysis (spot test) 
The required strains were grown overnight at 37⁰C.  The cultures were adjusted to an 
OD600 of 1 and serially diluted from neat to a dilution of 10-6 or 10-7.  A maximum of 10 µl 
of each dilution was then spotted onto a labelled square plate and allowed to dry.  Once 
the spots had dried, the plated were sealed with parafilm and placed at various 
temperatures (usually 26⁰C, 30⁰C, and 37⁰C) to test for complementation at those 
temperatures.   
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2.8 Protein Analysis 
2.8.1 SDS gel electrophoresis and staining 
Reagents required: 
Resuspension buffer A 30 mM Tris-HCl pH 7.2, 50 mM NaCl and 5 mM MgCl2  
4X SDS loading dye 0.25 M pH 6.8 TRIS/HCl, 8% SDS, 40% glycerol, 1% Coomassie 
brilliant blue R250 and 3% β-mercaptoethanol added fresh 
1X SDS Running 
buffer 
25 mM Tris pH 8.3, 192 mM glycine and 0.1% SDS 
Coomassie staining 
solution 
0.25g of Coomassie brilliant blue, 45% methanol, 10% glacial 
acetic acid in DDW.  
Destaining solution 30% methanol, 10% glacial acetic acid in DDW 
 
Preparation of samples: 
From E. coli: 
1 ml of log phase or early stationary phase cell culture (in case of induction, cultures 
induced with IPTG for at least 4 hours) was centrifuged at 13,000 rpm for 3 minutes.  
The cell pellet was then resuspended in 150-200 μl of resuspension buffer A.   These cell 
suspensions could be stored in the -20⁰C freezer for 2 to 3 days without having any 
effect on the resultant protein expression analysed by SDS-PAGE.  However if these 
samples were further to be used for isolation of the soluble fractions for Native-PAGE, 
long term storage is not recommended.  For running SDS-PAGE, 10 μl from the 
resuspended mix was drawn into a new eppendorf already containing 2.5 μl of SDS-
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loading dye.  The samples were heat inactivated at 60⁰C for ten minutes on a heat block 
before loading onto the gel.      
From H. volcanii: 
1 ml of log phase culture (0.8 OD) was centrifuged for 5 minutes at 13,000 rpm.  The 
pellet was resuspended in 1 ml of 2 M NaCl containing 50 mM EDTA and incubated for 
15 minutes at RT.  The resuspended cells were sonicated 3 times with 10 seconds bursts 
and again incubated at RT for 10 minutes.  The soluble fraction was harvested by 
spinning the samples at 13,000 rpm for 10 minutes and the proteins were precipitated 
using 30% TCA solution.  Following incubation on ice for 10 minutes, the precipitated 
proteins were then isolated by spinning at 13,000 rpm for 20 minutes at 4⁰C.  The 
proteins were observed as a tiny white pellet.  This pellet was washed thrice with double 
distilled water (DDW) and then SDS-loading dye was added.  The samples were boiled 
for 10 minutes and placed on ice for 2 minutes before loading.   
SDS-PAGE: 
The samples were subjected to sodium dodecylsulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) using 10% Tris-glycine SDS-polyacrylamide gels prepared 
according to the recipe shown in Table 2.12.  The gels were run in a Bio-Rad apparatus 
using SDS running buffer.  Approximately 10-15 μl of protein samples were loaded onto 
separate wells along with protein markers (Figure2.2; PageRuler prestained protein 
ladder, Fermentas).  The gels were run at 120 V for first 10 minutes (for stacking) and 
further at 180 V for about 1 hour (visually seen by the successful run of the protein 
ladder). 
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Detection:  After completion of electrophoresis, gels were stained using the staining 
solution for about 1 hour with shaking (HS250 Basic, IKA, Germany).  The stained gels 
were then destained using the destaining solution for 20-30 minutes, again with 
shaking.  Once satisfactory resolution of proteins was obtained, the gels were kept in 
water until dried.  For storage, the gels were air-dried by sandwiching them between 
two cellophane sheets using the GelAir-Drying accessories from Bio-Rad. 
Silver staining: When higher sensitivity was desired for detection of low concentration 
proteins, silver-staining method was used.  The SilverQuestTM Kit for Mass 
spectrometry-compatible silver staining from Invitrogen was employed for the same.  
The fast-staining protocol was exactly followed as given in the manufacturer’s 
guidelines.  
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Table 2.12: Recipe for preparing SDS-PAGE gel 
(Equivalent for making two gels in a Bio-Rad apparatus) 
10% Resolving gel 
(10 ml) 
Ingredient 5% Stacking gel 
(5 ml) 
4 ml DDW 3.4 ml 
3.3 ml 30% acrylamide mix 830 μl 
2.5 ml (pH 8.8)   1.5M TRIS  (pH 6.8) 630 μl 
100 μl 10% SDS 50 μl 
100 μl 10% Ammonium persulphate 50 μl 
4 μl TEMED 5 μl 
 
 
Figure 2.2 PageRuler prestained protein ladder (Fermentas) 
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2.8.2 Native gel electrophoresis and staining 
To test the assembly of large oligomeric chaperonins either linear or gradient native 
polyacrylamide gel electrophoresis (native-PAGE) techniques were used.   
2.8.2.1 Native-PAGE 
Reagents required: 
Resuspension buffer B  50 mM Tris HCl (pH 7.5), 5 mM EDTA (pH 8.0), 100 mM KCl, 
500 μg/ml lysozyme (Stratagene), 100 μg/ml DNAse 
(Stratagene) and 50 μg/ml of protease inhibitor cocktail 
(Roche) 
4X Native gel loading 
dye 
0.25 M pH 6.8 TRIS/HCl, 80% glycerol, 0.04% bromophenol 
blue  
1X Native gel running 
buffer 
25 mM Tris pH 8.3, 192 mM glycine   
Preparation of samples: 
3 ml of overnight culture was harvested at 13000 rpm for 5 minutes and resuspended in 
350 µl of resuspension buffer B.  The solution was allowed to stand for 10 minutes at RT 
and then sonicated 3 times with 10 second bursts on ice.  After incubation at RT for a 
further 10 minutes, the solution was spun at 13000 rpm and 4⁰C for 10 minutes.  The 
supernatant was transferred into a new eppendorf tube containing 100 µl of native 
loading dye to obtain the sample preparation for Native-PAGE.   
Native-PAGE 
The samples were loaded on native gels prepared using the recipe shown in Table 2.13.  
Electrophoresis was carried out at 220 V for the first hour and then at 250 V for next 6 
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hours (to resolve the ~900kDa archaeal chaperonins) using native gel running buffer.  
The gel tank was placed in ice to avoid heating up due to long gel runs.  Detection was 
done in the same way as described above using the Coomassie blue staining method. 
2.8.2.2 Gradient Native gel electrophoresis 
Gradient Native gel electrophoresis provided a better resolution of high molecular 
weight proteins and was quicker to use.  
Reagents required: 
Freeze thaw buffer 
(FT buffer) 
50 mM Tris-HCl (pH 7.5), 5 mM EDTA (pH 8.0), 5 mg 
lysozyme, 1 mg of DNAse and 50 μg/ml of protease inhibitor 
cocktail 
4X Native gel sample 
buffer 
400 mM MOPS/KOH (pH 7.2), 50% glycerol, 0.05% 
bromophenol blue 
1X Native gel running 
buffer 
100 mM MOPS/KOH (pH 7.2) 
Preparation of samples: 
Cell cultures with OD600 equivalent to 2 were harvested by spinning at 13000 rpm for 5 
minutes.  The pellets were resuspended in 100 μl of FT buffer and incubated on ice for 5 
minutes.  The resulting cell resuspensions were frozen in a -25⁰C freezer (usually takes 
7 – 10 minutes) and thawed at RT.  One cycle of freezing and thawing proved both 
necessary and sufficient to disrupt the cells and at the same time to protect the integrity 
of large protein structures.  The soluble fraction containing proteins was obtained by 
centrifuging the thawed samples at 13000 rpm for 10 minutes at 4⁰C.  10 μl of the 
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soluble fractions were mixed with 4 μl of native gel sample buffer and loaded onto the 
gel.    
Gradient Native-PAGE: 
The gradient native gels were prepared using 3% and 10% acrylamide gel solutions 
using the recipe shown in Table 2.14.  Firstly the 10% gel solution was prepared and 
poured into the gel cassette to make approximately 1 cm layer.  The layer was levelled 
by overlaying with water and was allowed to set.  The remaining 10% gel solution was 
placed on ice to delay polymerization.  Subsequently 3% gel solution was made on ice.  
After the 10% gel had set the excess water was removed by decanting.  To introduce a 
gradient, firstly 2.6 ml of 3% gel solution was drawn in a 5 ml glass pipette followed by 
drawing of 2.6 ml of 10% gel solution.  An air bubble was introduced in the pipette by 
suctioning the pipettor in air.  While traversing towards the top, the air bubble develops 
a 3 to 10% gel gradient in the pipette.  This gel solution was now poured on the top of 
the already set 10% gel.  Combs were introduced and the gel was allowed to set after 
overlaying with excess 3% gel solution (usually took around 30 minutes).  Once the gel 
had set, the gel cassettes were soaked in a wet tissue and covered in silver foil to store 
them for up to two weeks (4⁰C) or the gels were directly used for Native-PAGE.  
Electrophoresis was carried out at a constant of 80 V for four hours at RT.  The resolved 
gels were stained and destained by Coomassie staining method as discussed earlier. 
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Table 2.13: Recipe for preparing a native (non-denaturing) gel 
(Equivalent for making two gels in a BioRad apparatus) 
7.5 % Resolving gel 
(10 ml) 
Ingredient 5 % Stacking gel 
(5 ml) 
2.8 ml DDW 2.5 ml 
2.5 ml 40% acrylamide-bisacrylamide mix 850 μl 
2.5 ml (pH 8.8)   1.5 M TRIS  (pH 6.8) 625 μl 
2.0 ml 80% glycerol 1.25 ml 
100 μl 10% ammonium persulphate 50 μl 
8 μl TEMED 5 μl 
 
Table 2.14: Recipe for preparing a gradient native gel 
(Equivalent for making six gels in a Bio-Rad apparatus) 
10% gel (15 ml) Ingredient 3% gel (15 ml) 
7 ml DDW 10.5 ml 
3.75 ml 40% acrylamide-bisacrylamide mix 1.5 ml 
450 μl 2% bis-acrylamide - 
3 ml 0.5 M MOPS/KOH (pH 7.2) 3 ml 
75 μl 10% ammonium persulphate 75 μl 
7.5 μl TEMED 7.5 μl 
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2.8.3 Western blotting 
For detecting specific proteins in samples, western blotting was employed.  For this 
technique, an SDS PAGE was run as described before.  The gel thus containing the 
resolved proteins was transferred on a membrane for blotting of desired proteins using 
antibodies specific to that proteins in a process as described below. 
Transfer: The gel once obtained after the SDS-PAGE run, was taken out and immersed 
in pre-chilled transfer buffer (10mM CAPS and 10% methanol in DDW, pH adjusted to 
11 using conc.  NaOH).  4 strips of whatmann filter paper and two fiber pads along with a 
PVDF membrane cut to the gel size (Immobilon P-0.45 μm, Sigma) were also immersed 
into transfer buffer for at least 5 minutes.  Soaking the membrane in methanol for ~5 
minutes prior to immersing in the transfer buffer increased the transfer efficiency.  A 
sandwich of these components was assembled in the following order (from anode to 
cathode): Fibre pad, two strips of filter paper, gel, PVDF membrane, two strips of filter 
paper, and a fibre pad.  The sandwich was placed in a Bio-Rad blotting apparatus with an 
ice-pack and immersed in a tank filled with pre-chilled transfer buffer.  The entire 
assembly was placed in a container of ice and run for an hour at a constant current of 
300mA.   
Blocking: The membrane now containing the proteins was washed with 1X TPBS 
(Phosphate Buffer saline; 2g KH2PO4, 14.48g NaH2PO4, 80g NaCl and 2g of KCl in 1000ml 
of DDW to make 10X PBS; 0.1% of Tween20 in 1X PBS to make 1X TPBS) and incubated 
in blocking solution (4% dried milk powder in 1X TPBS) overnight with gentle shaking. 
Blotting: The next day the blocking solution was poured off and the membrane was 
vigorously washed in TPBS (3 times over a period of 15 minutes).  Next, the membrane 
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was incubated in the primary antibody (1:1000 dilution of anti-thermosome antibody in 
blocking solution, with 0.05% sodium azide; provided by Dr G. Bosch, Baumeister lab) 
for an hour with shaking.  Further, the membrane was again washed with TPBS (3 times 
over a period of 15 minutes).  The secondary antibody solution (1:50000 dilution of 
anti-rabbit HRP conjugated IgG in blocking solution; GE healthcare) was then added to 
the membrane and incubated for an hour with gentle shaking.  This was followed by 
washing the membrane twice with TPBS over a period of 15 minutes, the process 
culminating in one last vigorous wash with TBS (Tris buffer saline; 10mM Tris-HCl pH 
7.5 and 0.9% NaCl).  The membrane was dried by pressing gently on a tissue and further 
subjected to detection. 
Detection: The ECL plus kit (Amersham) was used for the detection.  The solutions A 
and B were mixed in 1:1 ratio to make 5 ml of volume and spread over the membrane 
for 1 minute using a Pasteur pipette.  The reagent was removed by again drying the 
membrane on tissue.  Next, the membrane was covered in cling film and placed in a film 
cassette and taken to the dark room.  It was exposed to the photo-sensitive film (Kodak 
Biomax, Sigma) for 1 to 5 minutes and the film was then developed using the XO-Graph 
machine using manufacturer’s instructions.   
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2.8.4 Protein purification 
Reagents required: 
Lysis buffer  30 mM Tris-HCl (pH 7.5), 50 mM NaCl, 5 mM MgCl2, 15% 
ethanol (v/v), 1 mM PMSF, 1 mM protease inhibitor cocktail 
(Roche), small amount of DNAase  
Column buffer A 
(Anion exchange) 
30 mM Tris-HCl (pH 7.5), 5 mM NaCl, 5 mM MgCl2, 1 mM DTT 
Column buffer B 
(Anion exchange) 
30 mM Tris-HCl (pH 7.5), 1 mM NaCl, 5 mM MgCl2, 1 mM DTT 
Column buffer C  
(Gel sizing) 
30 mM Tris-HCl (pH 7.5), 100 mM KCl, 5 mM MgCl2, 1 mM DTT 
Method: 
Cultures of E. coli BL21 cells carrying the pET plasmid-constructs of MmCCT gene or its 
mutants were grown from an overnight culture in LB media at 37⁰C until OD600 of 0.4 
was achieved.  Protein expression was induced by addition of 1 mM IPTG and the 
cultures were further grown for four hours.  Subsequently, the cells were harvested by 
centrifugation for 10 minutes at 4⁰C and 4000 rpm in a Sorvall SLC-4000 rotor.  The 
pellets at this stage could be stored in a -70⁰C freezer.  These pellets were then 
resuspended in lysis buffer and the cells were lysed by three passages through a French 
pressure cell.  The lysates were centrifuged for 20 minutes at 4⁰C and 16000 rpm in 
Sorvall SS-34 rotor and the supernatant was filtered through a 0.2 μ filter. The clear 
supernatant was now applied to a Q high performance (QHP) self packed anion 
exchange column (40 ml bed volume) pre-equilibrated with column buffer A.  Elution 
was achieved with a linear gradient of 0-50% of column buffer B over 200 ml with a flow 
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rate of 2 ml/min and a fraction size of 4 ml.  10 μl of the appropriate fractions as seen 
from the peaks obtained on the resultant chromatogram were resolved by 12% SDS-
PAGE to gradient Native-PAGE.  Running a Native-PAGE gel at this stage was essential to 
differentiate between the fractions that have MmCCT and the ones that have GroEL, as 
MmCCT and GroEL single subunits share similar molecular weights that cannot be 
resolved by SDS-PAGE.  The fractions containing MmCCT were pooled and diluted 4 fold 
into column buffer A and applied to a MonoQ 16/10 anion exchange column (10 ml bed 
volume) (Pharmacia Biotech, Sweden).  Elution was achieved in a similar manner as 
described above and the relevant fractions were identified by running on 12% SDS-
PAGE.  These fractions were pooled and precipitated with 70% ammonium sulphate, 
resuspended in column C buffer and applied to S300 HiPrep 26/60 column (Pharmacia, 
Sweden) pre-equlibrated with buffer C.  The eluates were obtained as a result of gel-
sizing.  The flow rate was adjusted to 1 ml/min and the fraction size to 6 ml.  Again the 
relevant fractions as checked by 12% SDS-PAGE and gradient Native-PAGE were pooled 
and concentrated up to 10 mg/ml using Amicon Ultra-15 Centrifuge devices.  Protein 
concentration was determined with a NanoDrop Spectrophotometer ND-1000 (Peqlab, 
Erlangen, BRD) using the specific extinction co-efficient of MmCCT or MmCCT mutants.  
The pure preparations were supplemented with 10% glycerol and stored at -70⁰C. 
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2.8.5 CBP-tagging and pull downs 
2.8.5.1 CBP-tagging by overlap extension PCR   
A streptavidin-cbp-his tag was used for tagging.  The sequence for the same is 
GSGSGWSHPQFEKGSGKRRWKKNFIAVSAANRFKKISSSGALGSGHHHHHHHHGSG 
(Pappenberger et al., 2006) where red letters represent streptavidin tag, brown letters 
represent cbp tag and green letters represent his tag.  The sequence was reverse 
translated by Sequence Manipulation Suite Copyright © 2000, 2004 Paul Stothard, using 
codon table from E. coli B strain.  The tag was incorporated using overlap extension PCR 
(as described in Figure 5.5, Chapter 5) with primers specifically designed such that they 
contain the entire tag sequence with overlapping ends (Table 2.5A, underlined).  The 
first two PCR steps for this technique were carried as described in Table 2.10 however 
with a lesser time period for denaturation (20 sec).  For the final overlap extension PCR 
step the cycle remained the same, however the primers were added at the end of the 
fifth cycle instead of in the initial mix, to allow the annealing of the tag overlapping 
region (Figure 5.5, Chapter 5).    
2.8.5.2 Pull downs of CBP-tagged MmCCT and its interactors 
The protocol for pull downs of CBP tagged MmCCT was developed with trial 
experiments first and was finalized and described as below.  The reagents and their 
concentrations are noted in Table 2.15. 
 The TAB21 (BL21 strain containing GroEL under pBAD promoter) cells expressing 
cbp-tagged MmCCT-wt and/or mutants under pET21 vector were grown in a 200 ml 
LB culture containing 0.2% arabinose, 50 μg/ml Kan (for TAB21 selection), 100 
μg/ml Amp (for pET21 selection) and 50 μg/ml Chloromphenicol (for pACYC 
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selection).  Protein expression was induced by addition of 1 mM IPTG when the 
cultures reached an OD600 of 0.4.  The cells were further grown for 4 hours at 37⁰C. 
 The cells were harvested by centrifugation (SLC-4000 rotor: 6000 rpm at 4⁰C for 10 
min or Eppendorf 5504R: 5000 rpm at 4⁰C for 10 min). The pellets could be stored at 
least for a week in -70⁰C freezer at this stage. 
 The pellets were resuspended in 6 ml of lysis buffer.  DNAase and PMSF 
(phenylmethanesulfonylfluoride) were added separately after even resuspension.  
Lysis was carried out either by passing the resuspensions through a French pressure 
cell at 1600 psi for three rounds or by sonication with 5 rounds of 30 sec bursts and 
30 second pauses.  Protease inhibitor solution was added at the end of the first of 
round in both the cases.  
 The soluble fractions containing proteins were obtained by centrifugation (SS-34 
rotor: 15000 rpm at 4⁰C for 20 min or Eppendorf 5504R: 11000 rpm at 4⁰C for 20 
min).  The step was repeated to remove additional debris.  
 Calmodulin resin equilibration: The settled calmodulin resin (Agilent Tech. cat no. 
214303) was gently mixed to suspend evenly.  50 µl of the resin was drawn in a 1.5-
ml eppendorf and the pellet containing the beads was obtained by spinning at 1000 
rpm for 2 mins in a microcentrifuge.  The storage buffer was removed carefully.  The 
calmodulin affinity resin was equilibrated in CaCl2-containing equilibration buffer.  
200 µl of equilibration buffer was added to the resin and mixed gently.  This was 
followed by spinning at 1000 rpm for 2 minutes and removal of the buffer with the 
help if a pipette. The step was repeated four times to ensure correct equilibration of 
the resin beads.   
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 Additional CaCl2 to achieve a final concentration of 5 mM was added to 800 μl of 
cleared lysate.  This was now mixed with equilibrated calmodulin resin beads and 
incubated overnight at 4⁰C on a mechanical rotator.  
 The reaction mix was centrifuged (1500 rpm, 3 minutes, 4⁰C) to separate the beads 
with the bound protein from the unbound material.  The unbound supernatant was 
retained for analyzing on SDS-PAGE. 
 The resin beads were washed three times with 300 µl of equilibration buffer and 
three times with 300 µl of wash buffer (Washing with wash buffer containing lower 
amounts of CaCl2 prepares for the next 10mM EDTA step). The bound proteins were 
eluted by 100 µl of elution buffer.  10 µl of all the final protein preparation along with 
wash samples, unbound sample and cleared lysate (diluted ten-fold) were analysed 
by SDS-PAGE and Native-PAGE.  
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Table 2.15: Constituents of CBP tagging and pulldowns 
Constituent Stock  
Concentration 
Working 
concentration 
Volume  
(For 100 ml) 
Lysis buffer 
Hepes pH 7.2 1 M 
(Filter sterilize; 
Fridge) 
300 mM 30 ml 
NaCl 2 M 200 mM 10 ml 
Glycerol 80 % (Autoclaved) 35 % 43 ml 
EDTA pH 8 0.5 M 1 mM 200 μl 
PMSF 0.1 M 
(Solvent: Ethanol;  
Store -20⁰C) 
1mM Directly to lysate 
(For e.g. 100 μl per 
10 ml) 
Protease Inhibitor 
(EDTA-free Roche) 
Tablet 1 tablet/10ml  
Equilibration buffer 
Hepes pH 7.2 1 M 20 mM 2 ml 
NaCl 2 M 1 mM 50 ml 
Glycerol 80 % 20 % 25 ml 
DTT 1 M (Store -20⁰C) 2mM 200 μl 
Triton-X100 100 % 0.01 % 10 μl 
CaCl2 0.1 M (Autoclaved) 2mM 2 ml 
Wash buffer 
Hepes pH 7.2 1 M 20 mM 2 ml 
NaCl 2 M 1 mM 50 ml 
Glycerol 80 % 20 % 25 ml 
DTT 1M 2mM 200 μl 
Triton-X100 100 % 0.01 % 10 μl 
CaCl2 0.1 M 0.2 mM 200 μl 
Elution buffer 
Hepes pH 7.2 1 M 20 mM 2 ml 
NaCl 2 M 1 mM 50 ml 
Glycerol 80 % 20 % 25 ml 
DTT 1 M 2 mM 200 μl 
Triton-X100 100 % 0.01 % 10 μl 
EDTA pH 8 0.5 M 10 mM 2 ml 
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2.8.6 Chaperonin assays 
2.8.6.1 Citrate synthase aggregation assay 
Citrate synthase (CS) is a thermolabile protein that denatures at temperatures above 
42⁰C (Minuth et al., 1998).  The folding intermediates formed after denaturation 
aggregate due to non-specific hydrophobic interactions.  The aggregated particles 
scatter light that allows the process to be followed by spectrophotometric measurement 
at 320 nm.  Chaperonins are able to recognize and bind folding intermediates in turn 
minimizing the local concentration of folding intermediates in solution.  Consequently 
the binding ability of chaperonins can be measured by suppression of light scattering.  
Reagents: 
 CS assay buffer: 30 mM MOPS-KOH (pH 7.5), 300 mM KCl, 5 mM MgCl2  
 CS enzyme (from porcine heart, Sigma Catalogue No. C3260): 1 μM  
Method: 
0.5 μM of MmCCT protein was mixed in 1 ml of CS assay buffer containing 0.5 μM of CS.  
The molecular weight of MmCCT was considered as 931KDa to obtain 0.5 μM 
concentration.  The reaction mixture was incubated in a pre-heated water-bath at 50⁰C.  
The extent of aggregation was followed by measuring the light scattering at 320 nm over 
a period of 30 minutes.  Assay buffer containing only CS and no protein was used as a 
positive control.  
2.8.6.2 Malachite green ATPase assay 
The ATP hydrolysis activity of chaperonins can be determined by measuring the 
liberated Pi by malachite green assay.  The assay is based on the principle that phosphate 
reacts with molybdate and forms a green complex with malachite green that can be 
detected photometrically at 640 nm. 
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Reagents: 
 ATPase assay buffer: 30 mM Tris-HCl (pH 7.5), 300 mM KCl, 5 mM MgCl2, 1 mM DTT 
 Malachite green (MG) solution: 45 gm of MG (Sigma, Catalogue No. 213020) and 
1.09 gm of ammonium molybdate (Sigma, Catalogue No. A7303) were mixed in 100 
ml 1 M HCl by stirring for 1 hr at RT.  Further, 1% Tween-20 was added and stirring 
was continued overnight at 4⁰C.  The solution was centrifuged for 10 minutes at 4000 
rpm and 4⁰C to obtain a cleared MG solution that was stored at 4⁰C. 
 1 mM ATP: 1 ml 100 mM stock solution of ATP (disodium salt, bacterial source, 
Sigma) was prepared in DDW and 100 μl aliquots were stored at -20⁰C.  The ATP 
solution was diluted in a ratio of 1:1 before use.  1 μl of the 1:1 diluted solution was 
added to a 50 μl reaction mixture to obtain a final concentration of 1 mM.  
 10 mM EDTA: 1 μl of 0.5 M EDTA stock solution was added to 50 μl of reaction 
mixture. 
 34% citric acid: 34 gms of citric acid (Fisher, Catalogue No. 624053) was mixed in 
100 ml of water and stored at 4⁰C.  
 1 to 5 nM of KH2PO4: A 100 mM stock solution of KH2PO4 (stored at -20⁰C) was 
freshly diluted 100 fold to obtain 1 mM.  This solution was further diluted to obtain 
nanomolar concentrations. 
Method: 
10-15 μg of protein and 1 mM ATP were mixed in ATPase assay buffer (50 μl reaction 
volume) and incubated at 37⁰C on a heat block for 15 minutes for nucleotide hydrolysis 
reaction.  The reaction was stopped by addition of 10 mM EDTA followed by a short-spin 
in a microcentrifuge.  800 μl of MG solution was then added into the reaction mix and 
the resulting solution was incubated at RT for 10 minutes.  The colour formation was 
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stopped by addition of 100 μl of 34% citric acid.  The intensity of the colour was 
measured photometrically at 640 nm.  The reaction mix without proteins was used as a 
negative control to determine the amount of ATP self-hydrolysis.  The OD640 measured 
for the test sample was correlated with the concentration of released Pi by a calibration 
curve.  For the calibration curve 1 to 5 nmol of KH2PO4 were mixed with 50 μl of ATPase 
assay buffer, 800 ul of MG solution was added followed by addition of 34% citric acid 
after 10 min.  The colour intensities were measured at 640 nm and plotted against Pi 
concentration to obtain the calibration curve. 
2.8.6.3 Rhodanese refolding assay 
Rhodanese is a 33 kDa mitochondrial sulphur-transferase enzyme that catalyzes the 
conversion of toxic cyanide into thiocynate which in turn can conjugate with ferric ions 
to form a red-orange complex.  The amount of active rhodanese can be assayed by 
photometric estimation of this complex.  If rhodanese is subjected to chemical 
denaturation, it loses its ability to refold spontaneously.  Chaperonins can act upon the 
denatured rhodanese and refold it and the extent of refolding can be determined by 
photometric assay described above.  Thus the enzyme is used as a model system to 
measure the refolding ability of chaperonins. 
S2O3- + CN-    SCN- + SO32-   Fe3+(SCN)3 (red-orange complex) 
Reagents: 
 Rhodanese enzyme solution: 25 mM MOPS (pH 7.2), 10 mM KCl, 20 mM Na2S2O3 or 
K2S2O3 and 3% glycerol. 
 Rhodanese enzyme: 10 mg/ml aliquots of Rhodanese enzyme (Sigma Catalogue No. 
R1756) were prepared in rhodanese enzyme solution and stored at -20⁰C. 
102 
 
 Guanidinium HCl (GuHCl): 6 M solution of GuHCl was prepared in 20 mM MOPS (pH 
7.2).  This solution was always prepared fresh. 
 Rhodanese assay buffer: 20 mM MOPS (pH 7.2), 150 mM KCl, 5 mM MgCl2, 5 mM 
DTT, 20 mM Na2S2O3 or K2S2O3. 
 Fe(NO3).9H2O solution: 1 gm of Fe(NO3).9H2O (Sigma) was added to 10 ml of H2O.  2 
ml of 65% HNO3 was further added and mixed.  The final volume was adjusted to 15 
ml and the solution was stored at 4⁰C. 
Method: 
The process was divided into following steps: 
 Rhodanese denaturation: 2 μl of rhodanese was mixed with 14 μl of 6 M GuHCl and 
3 mM DTT and incubated for 30 minutes at RT.  
 Binding of rhodanese to protein: 35 μg of protein (1-10 μl volume) was mixed with 
55 μl of rhodanese assay buffer and 0.8 μl of denatured rhodanese.  The reaction mix 
was incubated at 25⁰C for 15 minutes.  A negative control containing the denatured 
rhodanese and buffer only was also simultaneously added to the experiment to 
determine the amount of spontaneous refolding.   
 Refolding of rhodanese: 1 mM ATP was added and the samples were incubated at 
RT for 30 minutes.  The refolding was stopped by adding 10 mM EDTA and allowing 
the samples to stand at RT for 5 minutes.   
 Rhodanese enzymatic reaction: The samples were diluted by adding 120 μl of 
buffer.  The enzymatic reaction was initiated by addition of 30 μl of 1:1:1 solution of 
KCN, Na2S2O3 or K2S2O3 and KH2PO4 and incubation at 30⁰C for 10 minutes.  This 
reaction was stopped by adding 15% folmaldehyde.  300 μl of Fe(NO3) solution was 
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then added to the reaction mixture followed by an incubation at RT for 20 minutes. 
The intensity of the resultant coloured complex was measured at 420 nm.  
2.8.6.4 Proteinase K sensitivity assay 
Purified MmCCT proteins and its mutants were respectively incubated in 50 μl of assay 
buffer (30 mM MOPS-KOH (pH 7.5), 300 mM KCl, 5 mM MgCl2, 5 mM MgCl2 and 1 mM 
DTT).  The reaction was started by addition of 1 mM ATP or ADP.  In case where metal 
fluoride complexes were to be generated, 5 mM of Al(NO3)3 and 30 mM KF (all dissolved 
in H2O) were added to the mix before the addition of ATP or ADP.  Next, 1 μg/ml 
Proteinase K was added and the samples were incubated for 15 min at 30⁰C.  5 mM 
PMSF (100% v/v in ethanol) was added to inhibit protease activity and the samples 
were immediately mixed with SDS loading dye to be analyzed by 12% SDS PAGE. 
2.9 Mass spectrometry (MS) 
MS analysis was carried out at the Advanced Mass Spectrometry facility at School of 
Biosciences, University of Birmingham.  The samples were prepared by cutting out 
specific bands of proteins resolved on a Coomassie or silver stained Native-PAGE gel.  In 
a case where multiple proteins were to be analyzed, the bands were cut vertically to 
accommodate more proteins as shown in Figure 2.3.  The slicing of gels was carried out 
in a sterile environment and the gel fragments were stored in -20⁰C freezer before 
handing over to the facility for in-gel trypsin digestion and further MS analysis. 
The method employed at the facility has been briefly outlined below: The gel fragments 
are further cut into as small as 2 mm3 cubes and destained using organic solvent 
acetonitrile and buffer salt ammonium bicarbonate.  Gel pieces are then reduced at 60⁰ 
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for 15 min in ammonium bicarbonate solution containing DTT to achieve unfolding of 
tertiary structures.  The unstable –SH groups thus formed are alkylated and converted 
into stable cysteine derivatives by incubating with iodoacetamide in dark.  In-gel trypsin 
digestion (20 μg of trypsin) is then performed using shaking for 30 minutes and a 
further overnight incubation after dilution with ammonium bicarbonate.  The peptides 
are extracted using acetonitrile and formic acid, dried and further resuspended in a 
0.1% formic acid and water solution to concentrate and separate using HPLC (Dionex, 
Sunnyvale, CA, USA) (linear gradient of 0.1% formic acid in acetonitrile solution).  The 
peptides are eluted directly into the LTQ Orbitrap Velos ETD mass spectrometer 
(ThermoFisher Scientific, Germany) via a Triversa Nanomate nanospray device (Advion 
Biosciences, NY).  LTQ-Orbitrap-Velos uses enhanced electrospray ionization for ion 
sourcing, dual pressure cells and quadruple mass filter for linear ion trapping (LTQ) and 
Orbitrap as the mass analyzer (Olsen et al., 2009).  Because protein modifications were 
not to be studied here, collision induced dissociation (CID) was used for product-ion 
dissociation.  The obtained spectra was evaluated using MASCOT software (Perkins et 
al., 1999) with standard MudPIT scoring against BL21 (DE3) database. 
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Figure 2.3 
A schematic diagram to show how band excision for MS analysis was done. 
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CHAPTER 3 
Can an archaeal chaperonin replace 
GroEL function in E. coli? 
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3.1 Background   
The chaperonins function to fold a wide variety of client proteins starting from very 
simple prokaryotic proteins to components of large eukaryotic protein complexes.  As 
discussed in Chapter 1, Group 1 and Group 2 chaperonins share similar structures 
however there are significant structural and functional differences.  These differences 
have been occasionally attributed to the adaptation of chaperonins to their clients in 
respective host organisms.  For example, the transition from homo-oligomeric 
chaperonin rings in Group 1 to a mostly hetero-oligomeric distribution in Group 2 has 
been suggested to have occurred in parallel with the evolution of complex proteins in 
higher organisms (Kubota et al., 1994; Dekker et al., 2011b).  Indeed, Group 2 
chaperonins have been reported to interact with faster-evolving proteins with greater 
structural variety, in contrast to comparatively more-conserved, slower-evolving clients 
for Group 1 chaperonins (Kerner et al., 2005; Hirtreiter et al., 2009).  The intra-ring 
allosteric shift of ATP hydrolysis from concerted in Group 1 chaperonins to sequential in 
Group 2 has been implicated in ordered release of for instance, multi-domain proteins 
bound specifically to selected subunits in contrast to simultaneous release from all 
subunits in Group 1 chaperonins  (Horovitz and Willison, 2005; Horwich et al., 2007).  
The varying surface properties of the chaperonin cage in Group 1 and Group 2 
chaperonins have also been proposed to be associated with differential client specificity 
(Tang et al., 2006; Cong et al., 2010).  
A study has indeed shown that GroEL from E. coli or its mitochondrial homologue, is 
unable to fold eukaryotic TRiC clients, actin and tubulin, in vitro (Tian et al., 1995).  
Conversely it has also been reported that bacterial proteins that require GroEL 
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assistance are unable to fold in the eukaryotic cytosol (Kerner et al., 2005).  Moreover in 
the archaeon Methanosarcina mazei, where both Group 1 and Group 2 chaperonins co-
exist, a non-overlapping set of clients that exclusively interact with either of the groups 
was found in addition to a group of common clients (Hirtreiter et al., 2009).  All of these 
studies propose client-optimization to be one of the drivers of divergence between 
Group 1 and Group 2 chaperonins.  However, substantial biochemical data is still needed 
to support this hypothesis.  Moreover, the precise nature of such deviation between the 
groups at a structural level and its contribution to changes in the mechanisms of action 
is not fully resolved, one of the limitations being the higher degree of structural 
complexity in most Group 2 chaperonins and difficult in vivo analysis in archaeal and 
eukaryal expression systems.   
On the other hand, it may well also be considered that over 80% of the TRiC interactors 
have been shown to be recognized by GroEL (albeit not folded) (Yam et al., 2008), and 
that, GroEL could at least bind and release, if not fold, obligate TRiC-clients, actin and 
tubulin (Tian et al., 1995).  Such results implicate a broader range of specificity probably 
reflecting the common elements for client recognition or binding in Group 1 and Group 2 
chaperonins.  It can be speculated hence that the apparent client specificity of Group 2 
chaperonins is more pronounced at a protein-folding level than client recognition.  
Moreover, while the subunit-specific functionalization is complete in eukaryotic 
chaperonins, archaeal chaperonins do not present absolute sub-functionalization 
(Ruano-Rubio and Fares, 2007).  It is plausible to propose thus, that the Group 1 and 
Group 2 chaperonins may share a certain degree of functional overlap that is more likely 
to be prominent in simple thermosomes than for complex eukaryotic chaperonins.     
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We thought that if a Group 2 archaeal chaperonin in its native form or its improved 
functional mutants can function in a Group 1 host in complete absence of its native 
Group 1 chaperonin, the system hence generated will help the understanding of the 
divergence between the groups and will also allow genetic dissection of properties of 
Group 2 chaperonins using simple Group 1 hosts like E. coli.  
Using archaeal chaperonins as Group 2 representatives and GroEL from E. coli as the 
default Group 1 chaperonin, we proposed a chaperonin swap study to test whether an 
archaeal chaperonin can replace the functioning of GroEL in E. coli.  
Archaeal chaperonin from an obligate mesophile, Methanococcus maripaludis (MmCCT) 
was selected as it has following properties: 1) The MmCCT complex has identical 
subunits and hence is a simpler system to use.  For hetero-oligomeric chaperonins, 
assembly into authentic particles with correct subunit combination remains a concern.  
Also, the homo-oligomeric property of MmCCT facilitates recombinant expression and 
mutagenesis studies in bacterial hosts.  2) The optimum temperature of growth for this 
mesophile is 35⁰C-40⁰C i.e. the chaperonin should exhibit full functionality at bacterial 
growth temperature optima.  3) This chaperonin has already been recombinantly 
expressed in E. coli and characterized for ATPase and in vitro folding properties 
(Kusmierczyk and Martin, 2003b).  The system used for testing the hypothesis is 
outlined below. 
3.1.1 Experimental Design: TAB21 expression system 
If GroEL expression is repressed in a strain of E. coli, growth ceases, as GroEL is essential 
for survival.  When such a strain is complemented by another chaperonin, growth will 
only occur if this chaperonin can functionally replace GroEL.  Thus, a repressible 
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expression system, where the native groESL operon can be switched on and off, was 
established (McLennan and Masters, 1998).   In the BL21 (DE3) strain of E. coli, the 
native groESL operon in E. coli was swapped with externally introduced groESL operon 
under the control of repressible/inducible pBAD promoter along with a Kanamycin 
resistance (KANR) cassette.  This gave rise to BL21 (DE3) strain containing pBAD-
groESL-KANR called as TAB21 (Table 2.1) (Figure 3.1B).  The pBAD promoter is an 
arabinose induced and a glucose repressed promoter.  Hence the cells grow only when 
arabinose is supplemented in the medium, by turning on the groES and groEL genes.  
Alternatively, when glucose is supplied in the medium, the levels of GroES and GroEL 
gradually deplete as the cells grow and divide and eventually reduce to levels that are 
too low to sustain growth.  
The BL21 (DE3) strain is engineered to have λ-prophage that has T7 RNA polymerase 
controlled by lac regulatory construct (lac promoter and a lac operator).  The expression 
of T7 RNA polymerase is hence activated in presence of lactose or its analogue (IPTG in 
this case).   The strain enables the use of pET expression plasmids that contains a T7 
promoter and the lac operator upstream of the polylinker site (Figure 3.1A).  When IPTG 
is present inside the cell, it displaces the lac repressor protein, both from the 
chromosomal genome of BL21 and the pET plasmid.  This activates the expression of T7 
RNA polymerase which in turn transcribes the gene cloned downstream of T7 promoter 
on the plasmid.  The system put together ensures rapid and efficient production of the 
desired protein in the strain (Figure 3.1).   
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Figure 3.1  
Schematic representation of TAB21 expression strain with pET vector 
(A) Components of a pET vector and E. coli BL21 strain 
(B) A schematic diagram representing the TAB21 experimental system for studying the 
effects of introducing archaeal cct genes in E. coli 
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3.1.2 Previous work 
It has been previously found in our lab that archaeal chaperonin MmCCT can express 
and assemble in TAB21 and weakly sustain growth at 26⁰C under groEL repressed 
conditions (Figure 3.2) (Bevan Lin, unpublished results and P. Gowarinathan, PhD 
thesis).  To determine whether mutants can be isolated with improved function in E. coli, 
Mmcct was subjected to random mutagenesis using XL-1 red mutator strain (Section 
2.6.5, Materials and Methods).  It was observed that a single point mutation from 
methionine at the 223 position of the Mmcct gene to a bulky isoleucine residue (M223I) 
enhanced the ability of MmCCT to complement for the (work by former post-doctoral 
fellow, Dr. Andrew Large) (Figure 3.2).  
In this chapter I have built on the observations made by Dr. Andrew Large and Dr. 
Preethy Gowarinathan by first replicating their experiments and then expanding on the 
results.  In line with these findings and our hypothesis, this part of the project had 
following objectives: 
1. To find additional variants of Mmcct with better function in E. coli. 
2. To characterize these mutant proteins in vivo for their expression and assembly.  
3. To determine the complementation ability of these mutants in groEL knock-out 
strain.  
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Figure 3.2 
M. maripaludis chaperonin MmCCT-WT and a point mutant M223I can rescue growth of E. 
coli TAB21 under GroESL limiting conditions 
TAB21 cells containing plasmids pET21, pET21-Mmcct-WT, pET21-Mmcct-M223I grown on 
(A) arabinose (groE induction) at 37⁰C and on (B) 0.2% glucose (groE repression) and 1 mM 
IPTG (Mmcct induction) at 26⁰C.  
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3.2 Results 
3.2.1 Random Mutagenesis of Mmcct using XL1-Red mutator strain 
Before proceeding to the characterization of MmCCT-M223I mutant, random 
mutagenesis was carried out again to determine whether any additional Mmcct mutants 
could be isolated with improved functionality in E. coli.  Previous attempts using 
different methods including error prone PCR and chemical mutagenesis had shown that 
the use of XL-1 mutator strain gave the best results in terms of isolating mutants (Work 
done by Dr. Andrew Large).  Hence XL-1 red strain was used for random mutagenesis.  
This E. coli strain is deficient in three genes of error prone mismatch repair system 
(mutD5, mutS and mutT) and hence according to manufacturer has a ~5000 fold higher 
mutation rate than the wildtype strain.  
The pET21-Mmcct-wt plasmid was transformed into XL-1 red strain and grown on LB 
agar containing Amp.  All the colonies obtained were mixed together by resuspending in 
500 µl LB on the plate and were cultured overnight at 37⁰C in 100 ml of LB containing 
Amp.  For a higher mutation rate, these cultures were sub-cultured and grown overnight 
for two cycles, after which the plasmids were isolated that now should contain 
mutations at random positions.  The plasmids (confirmed to contain Mmcct gene using 
restriction digestions) were transformed into TAB21 and grown on plates containing LB 
agar with Kan, Amp, 0.2% glucose and 1 mM IPTG (referred to as KAGI plates) at 26⁰C, 
30⁰C and 37⁰C.  It was already known that cells where the Mmcct-wt gene was expressed 
and groEL gene was repressed, took up to five days to come up as colonies on the plates, 
however in this case a few faster growing colonies were observed at 26⁰C and 30⁰C.  
These colonies were distinctly bigger than the rest of the colonies. No growth was 
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observed on the plates at 37⁰C. The faster growing colonies obtained on 26⁰C and 30⁰C 
plates could be a result of either of the following: 
1. A mutation in pBAD promoter or AraC gene (responsible for regulation of pBAD 
promoter by AraC protein) on the chromosome, arising due to random events 
occurring in the cells.  In either case, repression could be lifted allowing faster 
growth due to groEL expression.  
2. A mutation in the T7 promoter on the pET plasmid that increases the expression of 
MmCCT or a mutation on the plasmid that increases its copy number and hence the 
amount of MmCCT protein in the cell.  Higher amounts of MmCCT protein might help 
in better complementation. 
3. A mutation in Mmcct gene itself that allows the protein to efficiently replace GroEL 
function.  
To exclude the first possibility, it was necessary to confirm that the phenotype of such 
colonies segregated with the plasmid.  The fast growing colonies from the plates grown 
at both 26⁰C and 30⁰C were selected by eye and cultured overnight on LB containing 
arabinose.  The plasmids were isolated from these cultures and retransformed into 
TAB21.  Individual colonies from the resultant plates were cultured in LB containing 
arabinose for ~ 3 hours (until OD600 =1) and serially diluted from 10-1 to 10-7 dilutions.  
10 μl of each dilution were spotted on KAGI plates along with dilutions of cells carrying 
pET21 empty vector, pET-Mmcct-wt and pET-Mmcct-M223I as controls at appropriate 
temperatures.   
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Two representative plates each for 26⁰C and 30⁰C are shown in Figure 3.3.  Some of the 
colonies grew as fast as those containing pET-Mmcct-M223I (b, c and f in the figure), 
while some grew a little faster than those carrying pET-Mmcct-WT (a, d and e), both 
suggesting that the improved phenotype was carried with the plasmid.  The plasmids of 
the six potential candidates were sequenced using four different Mmcct gene primers 
with overlapping ends (Table 2.4, Materials and Methods).  The sequence of whole gene 
was constructed from the best read regions of all four primers.  The final gene sequences 
obtained for all candidates were aligned with the Mmcct-wt sequence (Xbase ID: 
MMP1515) using ClustalW multiple alignment software. The gene sequences were 
translated into corresponding protein sequences using ExPASy translate tool and 
aligned against the MmCCT-WT protein sequence (GenBank ID: NP_988635.1).  
In accordance with the previous finding Methionine to Isoleucine substitution at 
position 223 was obtained for two out of six candidates (b and c in Figure 3.3A). 
Additionally for one candidate, a substitution from Lysine at position 216 to Glutamic 
acid (K216E) was found (f in Figure 3.3A).  No mutations were detected for the rest of 
the candidates (a, d, and e).  The improved phenotype in such candidates could be due to 
mutations in T7 promoter or rest of the plasmid as mentioned in the second point above.  
To exclude the possibility of such a process also happening in the obtained mutants, the 
T7 promoter region was sequenced using an internal Mmcct gene reverse primer.  No 
mutations were found here.  The aspect of increase in copy number of the plasmid and 
hence an increase in the amount of total MmCCT protein in the cell was checked by 
comparing the protein expression profiles of the mutants and the wildtype.  No 
significant increase in protein levels was observed making the possibility of higher 
amounts of protein to have an effect on the phenotype, less likely.  To completely ensure 
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that the improved phenotype was a result of the point mutations, the M223I and K216E 
mutations were independently incorporated in the Mmcct-wt gene by site-directed 
mutagenesis.  Growth for both the mutants was indeed observed to be faster than the 
wildtype in GroEL limiting conditions.  This part of experiment will be explained in more 
detail in section 3.2.2.3.  
Both K216 and M223 reside in the apical domain of the MmCCT complex and attain 
different positions in open and closed conformations (Figure 3.4 and 3.5).  The M223 
residue lies in a loop beneath helix 11 near to the helical protrusion and is seen to be 
embedded on the outer surface of the chaperonin in a surface representation of closed 
MmCCT complex (Figure 3.6).  The K216 residue faces towards the inner of the cavity 
and contributes to the hydrophilic nature of the cavity as described recently (Pereira et 
al., 2010) (Figure 3.7).  Both K216 and M223 are highly conserved in all archaeal species.  
When tested among the archaeal chaperonins of 20 different species, K216 and M223 
were found to be 100% and 95% conserved respectively (Figure 3.8).  Because mutant 
M223I was found earlier than K216E, this order will be maintained throughout the 
document.  
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Figure 3.3 
Random mutagenesis of Mmcct yielded mutants MmCCT-M223I and MmCCT-K216E with 
improved phenotype in E. coli under GroEL and GroES depleting conditions. 
(A) Six fast growing clones of TAB21 (a-f) obtained as a result of random mutagenesis along 
with controls TAB21/pET21b (1), TAB21/pET21-Mmcct-wt (2) and TAB21/pET21-Mmcct-
M223I (3) were cultured on arabinose, serially diluted and spotted on LB agar plates 
containing 0.2% glucose and 1mM IPTG at 26⁰C (left) and 30⁰C (right).  
(B) Alignment of the protein sequences derived from the Mmcct gene sequences of the 
potential mutant candidates against the wildtype protein by ClustalW software. 
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Figure 3.4 
Location of M223 and K216 residues on MmCCT subunit 
MmCCT subunit showing M223 and K216 residues highlighted as blue and green 
respectively.  The subunits were visualized in PyMOL from structures submitted to Protein 
Data Bank (PDB ID: 3KFK) by Pereira et al., 2010. Red: Apical domain, Blue: Intermediate 
domain, green: Equatorial domain and Orange: Helical protrusion. 
 
120 
 
 
Figure 3.5 
Location of M223 and K216 residues on open and closed subunits of MmCCT 
MmCCT subunit showing M223 (blue) and K216 (green) residues on lidless-closed (left) and 
lidless-open (right) conformations.  The images were derived from PDB codes 3KFB and 3KFE 
respectively (Pereira et al., 2010) and visualized in PyMOL. 
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Figure 3.6 
Location of M223 residues on a surface representation of MmCCT closed complex 
Side view of closed conformation of MmCCT complex highlighting M223 residues (blue).  The 
images were drawn in PyMOL using structures derived from PDB (ID: 3KFK) (Pereira et al., 
2010). 
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Figure 3.7 
Location of K216 residues on a surface representation of MmCCT complex 
The figure shows the cis cavity as viewed from bottom of the cross-sections of closed 
(above) and open (below) conformations of lidless MmCCT complex, highlighting K216 
residues (green).  The images were drawn in PyMOL using structures derived from PDB (ID: 
3KFB and 3KFE) (Pereira et al., 2010). 
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Figure 3.8 Conservation of K216 and M223 in 20 different archaeal species  
Sequences obtained from Xbase aligned by ClustalW software (A) and distribution observed 
using sequence logos (B) created by WebLogo. 
A 
B 
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3.2.2 Analysis of MmCCT-M223I and MmCCT-K216E mutants in E. coli 
This section describes the experiments conducted to test the expression and assembly of 
the MmCCT-M223I and MmCCT-K216E proteins in E. coli and further to confirm the 
ability to support its growth when GroEL is limiting.  As discussed in the experimental 
design, TAB21 expression system using pET21 vector was used for all experiments.  
3.2.2.1 Expression of MmCCT-M223I and K216E in TAB21 
The first step towards characterization of MmCCT-M223I and K216E mutants was to 
test their expression in E. coli.  Competent TAB21 cells were transformed with pET21b 
empty plasmid, or pET21 carrying either the Mmcct-wt gene, Mmcct-M223I, or Mmcct-
K216E and plated on LB agar plates containing Kan, Amp and arabinose (referred to as 
KAA plates).  Individual colonies were cultured at 37⁰C in arabinose in duplicate sets.  As 
the cultures reached an OD600 of 0.4, 1 mM IPTG was added to one set and the cells were 
grown further for four hours.   All the cultures were diluted to the same starting OD 
(OD600 = 1) to have comparable densities.  The protein samples were collected from 
these cultures and subjected to SDS gel electrophoresis.    
The pET empty vector served as a negative control and pET-Mmcct-WT served as a 
positive control.  Both MmCCT-M223I and K216E expressed profusely as ~60KDa 
monomeric subunits on SDS gel in IPTG induced conditions as seen in Figure 3.9.  It 
should be noted however that the expression shown here is at 37⁰C.  The wildtype and 
the mutants when tested at 26⁰C and 30⁰C showed poorer expression (results not 
shown). 
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Figure 3.9 
Expression of MmCCT-M223I and MmCCT-K216E in TAB21 
Crude extracts from E. coli TAB21 cells overexpressing pET21-MmCCT-WT, pET21-MmCCT-
M223I and pET21-MmCCT-K216E in IPTG induced and non-induced conditions, as analyzed 
by 10% SDS-PAGE and Coomassie staining. 
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3.2.2.2 Assembly of MmCCT-M223I and K216E in TAB21 
Next, the mutants were subjected to native gel electrophoresis for testing the correct 
assembly into chaperonin oligomers.  At every stage i.e. initial densities at sub-culturing, 
point of IPTG induction, cell densities for harvesting and cell lysis for protein extraction, 
equivalent conditions were ensured to allow comparison of soluble proteins from 
different samples.  Initially, assembly was tested using 7.5% native-PAGE.  While the 
MmCCT-WT and K216E mutant proteins assembled quite well at similar levels (Figure 
3.10A), MmCCT-M223I showed a more variable behaviour often resulting into apparent 
non-assembly (Figure 3.10A, buffer with KCl).  Numerous trials with varying buffer 
compositions and methods of cell lysis were employed to test the validity of the result. 
When KCl, a component added in the cell-lysis buffer for stabilization of complexes was 
eliminated, M223I assembled into its functional complex (Figure 3.10A, buffer without 
KCl), albeit in lesser proportion as compared to MmCCT-WT or K216E.  However, it 
should be noted that assembly was observed in buffers with KCl, sometimes in equal 
proportions as the WT.   
The assembly of the mutants was also checked by a 3-10% native gradient PAGE where 
both MmCCT-M223I and K216E showed assembly into their oligomers (Figure 3.10B).  
Consistent with the previous result, the yield for M223I protein was less than that of the 
WT while the levels for K216E and WT were similar.  The GroEL and MmCCT-WT 
purified protein (provided by Dr. Andew Large) were run in parallel with the samples to 
determine the positions of the bands.  A GroEL band can also be seen in all samples on 
native gels because the cultures were grown in arabinose that allows expression of 
groEL gene. 
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Figure 3.10 
Assembly of MmCCT-M223I and MmCCT-K216E in TAB21 
Soluble fractions of equal densities of E. coli TAB21 cells expressing pET21 empty vector, 
pET21-MmCCT-WT, pET21-MmCCT-M223I and pET21-MmCCT-K216E in IPTG induced 
conditions, prepared in non-denaturing conditions using buffer with or without KCl and 
analyzed by A) 7.5% Native PAGE.  The latter were also analyzed by B) 3-10% Native gradient 
PAGE. Purified MmCCT-WT and GroEL proteins were ran as controls.  Both the gels were 
stained with Coomassie.  
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3.2.2.3 Complementing ability of the mutants when groESL operon is switched off 
To test the ability of the mutants to compensate for the loss of GroEL and GroES in vivo, 
both MmCCT-M223I and K216E were subjected to growth analysis in liquid and solid 
media under GroEL depleting conditions.  
Liquid media analysis: Overnight grown TAB21 cultures expressing pET21-Mmcct-
M223I or pET21-Mmcct-K216E along with the empty vector and wildtype controls were 
sub-cultured into fresh media containing glucose and the degree of growth was 
measured over a period of time at 37⁰C.  The cells were expected to grow while GroEL 
depletion occurs to finally reach a point where growth was no longer possible due to 
absence of GroEL.  However, all the cultures including the TAB21 cells on their own 
continued to grow at normal rates (Figure 3.11A).  Such an observation suggested either 
a carry-forward of residual GroEL or a leaky repression of T7 promoter.  Indeed, when 
these cultures were further sub-cultured in glucose containing medium for a second 
cycle, absolutely no growth was observed.  It was assumed hence, that the TAB21 cells 
grown on arabinose when sub-cultured in glucose containing medium, exhibited a 
normal growth pattern owing to the residual GroEL supposedly sufficient for survival.  
To see what changes occur in the growth pattern of TAB21 cells that express MmCCT-
WT, MmCCT-M223I and MmCCT-K216E,  IPTG was added in the medium once cells 
reached OD600=0.4 and the growth was followed by measurement of optical densities.  It 
should be noted that addition of IPTG leads to a general growth-slowing of TAB21 cells 
at 37⁰C.  This is because of the presence of T7 RNA polymerase that competes with 
bacterial RNA polymerases for cell resources such as ribosomal capacity and also due to 
expression of Lac proteins that are known to exhibit a burden to growth on E. coli cells 
129 
 
(Malakar and Venkatesh, 2012).  However this being a general phenomenon should not 
affect the particular differences observed between the samples.  It was observed that 
under IPTG induced conditions, the cultures containing vector only ceased to grow after 
reaching an OD600 of approximately 0.8.  While the wildtype showed a better phenotype, 
the M223I and K216E mutants were able to rescue growth of the cells more effectively 
than the wildtype (Figure 3.11B) as predicted from the phenotype of these mutants on 
plates.  
Solid media analysis: 1 ml of the non-induced cultures were diluted to the same 
starting OD and harvested.  The pellets were washed thrice with LB containing glucose 
to remove any traces of arabinose and resuspended in 1 ml of LB.  Cultures were serially 
diluted from 10-1 to 10-7 and 10 μl of each dilution was spotted onto KAA and KAGI 
plates.  The plates were incubated at 26⁰C, 30⁰C and 37⁰C. 
Consistent with the random mutagenesis results and liquid media results, both MmCCT-
M223I and K216E exhibited a fairly better GroEL-complementing ability than the WT at 
26⁰C and 30⁰C (Figure 3.12 for 30⁰C).  No growth was observed at 37⁰C. 
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Figure 3.11 
Liquid medium growth analysis of MmCCT mutants under GroEL depleting conditions  
TAB21 cultures expressing pET21, pET21-Mmcct-WT, pET21-Mmcct-M223I and pET21-
Mmcct-K216E grown in LB containing glucose with or without IPTG at 37⁰C followed by 
measurement of optical densities over the indicated interval of time . The error bars are not 
included because the ODs obtained varied being dependent on the initial OD of induction. 
However the given pattern represents at least three independent experiments. 
131 
 
 
Figure 3.12 
Solid medium growth analysis of mutants under GroEL depleting conditions at 30⁰C 
TAB21 cells containing plasmids pET21, pET21-Mmcct-WT, pET21-Mmcct-M223I and pET21-
Mmcct-K216E grown on 0.2% glucose and 1mM IPTG at 30⁰C for five days.  
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3.2.3 Substitution of M223 and K216 with other amino acids 
It was found that almost all amino acid substitutions at the M223 position were able to 
better complement for the loss of GroEL than the wild type (work carried out by Dr. 
Andrew Large).  Similar experiment was carried out for the K216E mutant.  The primers 
were designed such that random base pairs are inserted at K216 position generating a 
mixture containing different amino-acid combinations.  This mixture of primers 
(MmCCT-K216n-F and MmCCT-K216n-R) was used to perform site directed 
mutagenesis in pET21-Mmcct-wt (Section 2.5.3, Materials and Methods).  Approximately 
50 colonies obtained were individually cultured, plasmid isolated and sequenced to 
generate a library of K216 point mutants.  A total of 14 out of 19 substitutions (K216 to 
A,C,D,F,G,L,N,P,Q,R,S,T,W and Y) were obtained.  All the mutants being in pET21 
plasmids were directly subjected to complementation analysis in TAB21.  Also, they 
were tested for their expression and assembly in TAB21 using SDS and native gel 
electrophoresis.  
Similar to results obtained for M223I, almost all amino-acid substitutions at K216 
displayed K216E-like complementation in TAB21 under groEL repressed conditions at 
30⁰C (Figure 3.13).  The only exceptions were the K216R and K216W mutants that 
showed weaker phenotype.  Accordingly, all point mutant proteins expressed and 
assembled in a correct manner except for K216W that showed degradation (Figure 3.14 
and 3.15).  These results are summarized in Table 3.1.  Such results indicated that 
mutations at these residues imparted some sort of functional flexibility leading to 
improved complementation in E. coli.  
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Figure 3.13 
Growth of K216n mutants at 30⁰C under GroEL depleting conditions 
TAB21 cells expressing 14 different K216 mutants as indicated under pET21 vector grown on 
0.2% glucose and 1 mM IPTG at 30⁰C for five days. 
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Figure 3.14 
Expression of  MmCCT-K216n mutants in TAB21 
Crude extracts of TAB21 cells expressing 14 different MmCCT-K216n mutants i.e. K216A (1), 
K216C (2), K216D (3), K216F (4), K216G (5), K216L (6), K216P (7), K216Q (8), K216R (9), K216S 
(10), K216T (11), K216V (12), K216W (13) and K216Y (14) along with controls pET21 empty 
vector (C1) and pET21-MmCCT-K216E (C2) as analyzed by 12% SDS PAGE and stained by 
Coomassie staining.  The arrows indicate the position of MmCCT bands. 
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Figure 3.15 
Assembly of  MmCCT-K216n mutants in TAB21 
Soluble fractions of induced (+) and non induced (-) TAB21 cells expressing 14 different K216 
mutants i.e. K216A (1), K216C (2), K216D (3), K216F (4), K216G (5), K216L (6), K216P (7), 
K216Q (8), K216R (9), K216S (10), K216T (11), K216V (12), K216W (13) and K216Y (14) along 
with controls pET21 empty vector (C1) and pET21-Mmcct-K216E (C2) as analyzed by 7.5% 
Native PAGE and stained by Coomassie staining.  The arrows indicate the position of the 
MmCCT bands. 
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Table 3.1: Summary of the functional analysis of MmCCT-M223n and K216n mutants in vivo 
 
 
Substitutions at M223 (Work by Dr. Andrew Large) Substitutions at K216 (This work) 
Mutation 
in MmCCT 
Expression Assembly Complementation 
(30⁰C) 
Mutation 
in MmCCT 
Expression Assembly Complementation 
(30⁰C)  
M223I Y Y +++ K216A Y Y ++ 
M223F Y Y +++ K216C Y Y +++ 
M223G Y Y +++ K216D Y Y +++ 
M223E Y Y +++ K216F Y Y ++ 
M223L Y Y +++ K216G Y Y +++ 
M223R Y Y +++ K216L Y Y ++ 
M223S Y Y +++ K216P Y Y ++ 
M223V Y Y +++ K216Q Y Y +++ 
M223W Y Y +++ K216R Y Y + 
M223Y Y Y +++ K216S Y Y +++ 
    K216T Y Y ++ 
    K216V Y Y +++ 
    K216W N N - 
    K216Y Y Y ++ 
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3.2.4 Effect of an additional mutation (D386A) in MmCCT-M223I and 
MmCCT-K216E on the phenotype 
To understand the reasoning underlying the better phenotype of the mutants MmCCT-
M223I and K216E, one possibility we considered was that these mutations could cause a 
loss of chaperonin function, but nonetheless allow partial function that could still part 
replace GroEL.  For example, this could be by locking the chaperonins in the open state, 
thereby providing more hydrophobic surface on which nascent unfolded proteins could 
bind, thus reducing somewhat the need for GroEL.  If this is the case, we would predict 
that the ATPase activity of chaperonins would no longer be necessary.  To test this 
hypothesis, a second mutation D386A that blocks the ATPase activity of the chaperonin 
was introduced.  The D386A mutant on its own can bind to ATP but is unable to 
hydrolyze it (Reissmann et al., 2007), hence stopping the chaperonin from undergoing a 
folding cycle.  In other words the protein is locked in its ATP-bound open conformation.  
If MmCCT-M223I and K216E are functioning better by just binding to the clients in an 
open conformation, the additional D386A mutation should not affect the phenotype of 
the mutants.  If, on the other hand, the mutants are still acting as chaperonins requiring 
a full ATPase cycle, the additional D386A mutation should not support growth of the 
cells. 
The D386A mutation was introduced into the cct gene in pET-Mmcct-wt, pET-Mmcct-
M223I and pET-MmCCT-K216E using site-directed mutagenesis.  The resultant 
constructs i.e. Mmcct-D386A, Mmcct-M223I-D386A and Mmcct-K216E-D386A were 
transformed into TAB21 and first checked for correct protein expression and assembly 
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(Figure 3.16A and B, C respectively).  Subsequently the mutants were subjected to 
complementation analysis in TAB21.  As shown in Figure 3.17C, the D386A mutant on its 
own only weakly supported growth as expected.  However, the MmCCT-M223I-D386A 
and MmCCT-K216E-D386A double mutants also displayed a similar phenotype i.e. poor 
growth of the cells in groEL repressed conditions.  The results suggest that blocking the 
ATPase activity severely affects the complementing ability of the mutants in GroEL 
limiting conditions.  The observations strongly support the idea that the MmCCT-M223I 
and K216E mutants act as genuine chaperonins and undergo an ATP dependent 
chaperonin cycle to function.  
139 
 
 
Figure 3.16 
Expression and assembly of D386A mutants in TAB21 
A) Crude extracts of TAB21 cells expressing pET21 empty vector (1), pET21-Mmcct-D386A 
(2), pET21- Mmcct -M223I-D386A (3) and pET21- Mmcct -K216E-D386A as analysed by 10% 
SDS PAGE B and C) Soluble fractions of the above samples as analyzed by 7.5% Native PAGE 
(B) and 3-10% Native gradient PAGE (C). All gels stained by Coomassie staining. The arrows 
indicate the position of the MmCCT bands. 
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Figure 3.17 
Growth of D386A mutants at 30⁰C under GroEL depleting conditions 
TAB21 cells expressing MmCCT-D386A mutants as indicated under pET21 vector grown on 
0.2% glucose and 1 mM IPTG at 30⁰C for five days. 
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3.2.5 Analysis of MmCCT-M223I and MmCCT-K216E in groEL knockout 
strain AI90 
As noted in section 3.2.2.3, TAB21 cells could grow even after 48 hours of glucose 
repression.  Western blotting of the proteins extracted from these cultures using anti-
GroEL antibodies showed presence of residual GroEL (Dr. Andrew Large, personal 
communication).  This suggested that glucose mediated groEL repression was not 
completely effective.  It was possible hence that the growth of TAB21 cells expressing 
MmCCT proteins on glucose containing plates was due to residual GroEL (and not 
MmCCT).  However the empty vector control not containing Mmcct gene was unable to 
survive under glucose repressed conditions suggesting that the residual GroEL was not 
sufficient for full functionality of cells and that assistance of MmCCT proteins was a 
requirement.  The findings however did not establish as to whether or not MmCCT or its 
point mutants can exclusively fold all the essential client proteins of GroEL. 
Therefore, to test whether MmCCT is acting as a helper-chaperonin or can completely 
replace GroEL function, complementation experiments were carried out in a ∆groEL 
strain of E. coli called as AI90 (Ivic et al, 1996).  The chromosomal copy of groEL in this 
strain is replaced by a kanamycin resistance marker cassette and the strain sustains on 
an external copy of pTrc promoter-regulated groEL on an expression plasmid.  This 
expression plasmid also contains a sacB gene and a chloramphenicol resistance marker 
(Cam).  The Bacillus subtilis sacB gene encodes an exoenzyme levansucrase (sucrose: 
2,6-b-D-fructan 6-b-D-fructosyltransferasegene) that catalyzes hydrolysis of sucrose and 
synthesis of levans, and its expression is proved to be lethal for E. coli growth when 
sucrose is present in the medium (Gay et al., 1985; Stibitz, 1994).  It can therefore be 
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used as a marker to select for cells that have lost the plasmid.  When a plasmid 
expressing Mmcct (Amp) is introduced in AI90, a population of cells will now possess 
both – original plasmid containing groEL-sacB-CamR and the new plasmid containing 
Mmcct-AmpR.  Upon plating these cells on sucrose, the groEL containing plasmid is 
driven out and only the cells with plasmid expressing Mmcct are able to grow (Figure 
3.18).  Selection takes place against the sacB gene and hence the groEL-sacB-camR 
plasmid is exited making the cells sucrose resistant and chloramphenicol sensitive.  In 
such conditions, growth will occur only if MmCCT can completely replace GroEL (Figure 
3.18).   
Because pET expression vectors require a BL21 strain or its derivative for expression, 
pET21 plasmids bearing MmCCT genes could not be used in AI90 strain.  Hence, Mmcct 
gene fragments (WT, M223I and K216E) from pET plasmids were cloned into HindIII 
and XbaI sites of pTrc99A vector under the regulation of IPTG inducible ptrc promoter.  
Competent AI90 cells were transformed with pTrc99A, pTrc-groESL, pTrc-Mmcct-wt, 
pTrc-Mmcct-M223I and pTrc-Mmcct-K216E and were plated at 26⁰C, 30⁰C and 37⁰C on 
a set of plates with different components as shown in Table 3.2.  The pTrc-groEL plasmid 
was used as a positive control for the experiment.  
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Figure 3.18 
Schematic diagram explaining plasmid shuffling in AI90 strain  
(Diagram adapted from Chapman et al., 2006) 
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Table 3.2:  Expected results in plasmid shuffling experiments 
Components in LB agar plate Expected observations  
Kan-Cam-Amp Growth expected for all as the two plasmids co-exist 
Kan-Sucrose-Cam-Amp In presence of sucrose, plasmid shuffling occurs. 
Hence, if pTrc-sacB-camr-groesl plasmid is 
displaced by the new plasmid, no colonies should 
appear because of chloramphenicol sensitivity. 
Kan-Sucrose-Amp (KSA) Growth should not occur because there is no 
replacement for GroEL. 
Kan-Sucrose-Amp-IPTG (KSAI) Only if MmCCT-WT or the mutants can replace the 
functioning of GroEL completely, growth can occur. 
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The positive control pTrc-groEL behaved as expected giving colonies on plates 
containing sucrose only (KSA) and sucrose + IPTG (KSAI).  The pTrc99A empty vector 
did not give any colonies.  Also, no colonies were observed for MmCCT-WT and MmCCT-
M223I at any temperature suggesting that they are incapable of supporting growth in 
complete absence of GroEL.  However, AI90 cells with MmCCT-K216E mutant showed 
distinct colonies after 3 days on KSAI plates at 26⁰C and 30⁰C.  Also approximately after 
5 days a few colonies were observed at 37⁰C (Table 3.3).  
The same experiment was carried out with selected mutants from K216n library and 
results were recorded as shown in Table 3.4.  AI90 cells expressing MmCCT-K216D, 
K216Q and K216S gave similar number of colonies as K216E.  MmCCT-K216A and 
K216L showed poorer growth however MmCCT-K216R showed no growth consistent 
with the results obtained for TAB21 analysis. 
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Table 3.3:  Analysis of MmCCT functionality in GroEL-knockout strain AI90 
 
Table 3.4:  Analysis of MmCCT-K216n functionality in GroEL-knockout strain AI90 
 
Note: The results are indicative of average number of colonies obtained for each sample 
from three independent experiments. The number of cells transformed, amounts of DNA 
used and the dilutions plated were uniformly maintained to be of equal number. 
(Number of colonies between 0 and 50 (+), 50 and 100 (++), 100 and more (+++)) 
 
 
 GroEL MmCCT 
WT 
MmCCT 
M223I 
MmCCT 
K216E 
 
Sucrose ++ - - - 26⁰C 
Sucrose and IPTG +++ - - ++ 
Sucrose ++ - - - 30⁰C 
Sucrose and IPTG +++ - - ++ 
Sucrose ++ - - - 37⁰C 
Sucrose and IPTG +++ - - + 
 MmCCT 
K216E 
MmCCT 
K216A 
MmCCT 
K216D 
MmCCT 
K216L 
MmCCT 
K216Q 
MmCCT 
K216R 
MmCCT 
K216S 
 
Sucrose - - - - - - - 30⁰C 
Sucrose and 
IPTG 
++ + ++ + ++ - ++ 
Sucrose - - - - - - - 37⁰C 
Sucrose and 
IPTG 
+ - - + - - + 
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The colonies obtained were subjected to three confirmatory experiments to ensure loss 
of groEL and expression of MmCCT-K216E: 
1. Checking chloramphenicol sensitivity 
 To eliminate any chances of background colonies appearing (arising due to a mutation 
in sacB gene making the cells sucrose resistant), the colonies were patch plated on 
chloramphenicol plates.  No growth was observed on chloramphenicol containing plates 
confirming loss of groEL-sacB-camR containing plasmid. 
2. Colony PCR using GroEL internal primers 
Six representative colonies supposedly expressing only MmCCT-K216E from plates 
grown at temperatures 26⁰C, 30⁰C and 37⁰C were subjected to colony PCR using GroEL 
internal primers.  DH5alpha and AI90 strains were used as positive controls.  Also 
colonies obtained from using the pTrc-groESL plasmid in the above experiments served 
as a positive control.  As shown in Figure 3.19A, the groEL gene band was not detected in 
any of the test colonies.  
3. Western blotting of the protein extract from cultures of the test colonies: 
The colonies were cultured in LB containing sucrose and 1 mM IPTG at respective 
temperatures.  While the cultures at 26⁰C and 30⁰C reached saturated levels in 
approximately 36 hours, the cultures at 37⁰C ceased to grow after reaching an OD600 of 
0.3.  Even when left in the incubator for seven days the cultures did not go beyond an 
OD600 of more than 0.5.  Protein samples were extracted from cultures grown at 26⁰C 
and 30⁰C and were subjected to western blotting using anti-GroEL and anti-thermosome 
antibodies.  Protein extracts from DH5α cells that produce GroEL in normal quantities 
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served as a positive control for anti-GroEL selection (Figure 3.19B, Upper panel, Lane 1). 
Purified MmCCT-WT protein (obtained from Dr. Andrew Large) served as a positive 
control for anti-thermosome antibodies (Lower panel, Lane 4).  The cultures containing 
MmCCT-K216E showed complete absence of GroEL protein (Figure 3.19B, Upper panel, 
Lane 2 and 3).  At the same time the cultures showed presence of MmCCT protein 
(Lower panel, Lane 2 and 3) confirming that K216E mutant can support growth of cells 
lacking GroEL at 26⁰C and 30⁰C.   
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Figure 3.19 
Confirmation of loss of groEL gene and GroEL protein from AI90 cells with MmCCT-K216E 
(A) Colony PCR of AI90 cells containing MmCCT-K216E using groEL-gene internal primers. ‘C’ 
denotes positive control (AI90 colonies transformed with ptrc-groEL). #1 to #6 denotes six 
test colonies from plates grown at 25⁰C, 30⁰C and 37⁰C.  (B) Western blots of soluble protein 
extracts from cultures using anti-GroEL (upper panel) and anti-thermosome (lower panel) 
antibodies. Lane 1: DH5α; Lane 2: AI90/ptrc-MmCCT-K216E (26⁰C); Lane 3: AI90/ptrc-
MmCCT-K216E (30⁰C); Lane 4: MmCCT-WT purified protein (low concentration) 
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3.3 Discussion 
Using MmCCT from archaeon M. maripaludis and GroEL from E. coli as examples, we 
have shown here that a Group 2 chaperonin can weakly replace the functioning of a 
Group 1 chaperonin at reduced temperatures.  Further using random mutagenesis we 
established that point mutants M223I and K216E significantly improve the 
complementing ability by several fold and that the K216E mutant, but not M223I is able 
to completely replace GroEL function.   
Both M223 and K216 reside in apical domain of the chaperonin where most sequence 
divergence is observed between Group 1 and Group 2 chaperonins (Kim et al., 1994; 
Archibald et al., 2001; Dekker et al., 2011b).  Because the apical domain harbours the 
client binding site, the simplest explanation for better functionality of MmCCT-M223I 
and K216E mutants could be improved client specificity.  However, this is difficult to 
confirm as the client binding regions for Group 2 chaperonins are not explicitly defined. 
Previously, both hydrophobic residues in helix 10 and 11 (Feldman et al., 2003; Spiess et 
al., 2006) and hydrophilic residues lining the inner cavity (Pappenberger et al., 2002; 
Gomez-Puertas et al., 2004) have been implicated in client binding.  It is interesting that 
M223I structurally corresponds to the F204 on GroEL, a residue involved in client 
binding for Group 1 chaperonins (Horwich et al., 2007).  In contrast, based on the solved 
crystal structure of MmCCT chaperonin, Pereira et al. put forward a hydrophobic pocket 
(consisting of L269, V273, A274, I276, L293, A294, Y297, L298 and I303) between helix 
10 and helix 11 as the client binding region (Pereira et al., 2010).  Neither M223 nor 
K216 are in this region making the hypothesis that mutations of these residues 
improves client binding, less likely. 
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Further, we recognized that almost all amino-acid substitutions at M223 and K216 
resulted in improved growth of TAB21 strain in groEL repressed conditions as 
compared to MmCCT-WT.  This observation suggested a more general change in 
function of the mutants.  One possibility we considered was that the mutants simply 
cause a loss of function that in turn produces a positive effect.  If the loss of function is at 
the level of the chaperonin complex, the mutants should cease to function in an ATP 
dependent open-closed conformational cycle.  We hypothesized that the M223I and 
K216E mutants locked in open conformations would bind to a large number of 
unfolded/misfolded proteins in the cell thus decreasing their amounts and increasing 
the viability of the cells (or delaying their death).  However, the additional D386A 
mutation, that blocks the ATPase activity of MmCCT, severely affected the growth of the 
cells in groEL repressed conditions.  The transition from the open to the closed 
conformation occurs due to ATP binding and hydrolysis.  The results clearly suggest that 
the mutants M223I and K216E undergo a folding cycle to function.  However the 
mechanism that enables the mutants to function in a better way than the wildtype 
remained unresolved. 
It was observed that the TAB21 strain where the groEL expression should completely be 
repressed in presence of glucose still showed GroEL presence after 48 hours of growth 
in glucose containing medium.  However, the amounts of GroEL present did not suffice 
for growth of the cells on solid medium (the strain itself does not grow on glucose 
containing plates; also the strain containing a pET empty vector ceases to grow on 
glucose containing plates).  Supplementing MmCCT to such cells allows slow growth 
which further is improved by point mutants MmCCT-M223I and K216E.  The data 
demonstrates that MmCCT can function as a chaperonin in E. coli, however it does not 
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prove that MmCCT can completely replace GroEL functioning.  Indeed, when tested in a 
groEL knock out strain AI90, MmCCT-K216E was the only candidate to be able to 
support growth at 26⁰C/30⁰C and partially at 37⁰C.  While it can be concluded that 
MmCCT-WT and MmCCT-M223I cannot completely replace GroELS-function, the result 
with MmCCT-K216E is striking as it establishes that a Group 2 chaperonin, despite 
substantial structural differences, can replace the functioning of GroES and GroEL. 
It should be noted, however, that the growth of AI90/pTrc-Mmcct-K216E was slower 
than AI90/pTrc-groEL (positive control).  Moreover, despite the knowledge that the ptrc 
promoter is leaky and allows gene expression in absence of IPTG induction, MmCCT-
K216E containing cells did not grow in absence of IPTG as against the positive control 
that showed growth in non-induced conditions.  This indicates that large amounts of 
MmCCT-mutant protein are required for sustenance as compared to low quantities of 
GroEL that are generally sufficient (McLennan et al., 1994; Ivic et al., 1997).  
Furthermore, MmCCT-K216E is inefficient in replacing GroEL at 37⁰C.  The liquid 
cultures reach an OD600 of 0.5 in 10 days.  Although, it has been shown that GroEL and 
GroES are essential at temperatures as low as 17⁰C (Fayet et al., 1989).  Such an 
observation reaffirms that the mutant MmCCT-K216E completely replaces the function 
of GroES and GroEL in E. coli.  Nonetheless a number of possibilities could be considered 
for inefficient growth at 37⁰C: 1) The recombinant protein production of MmCCT could 
be more efficient at 30⁰C as compared to at 37⁰C.  However such an explanation is less 
likely as MmCCT expresses at considerable levels at 37⁰C in various strains tested (this 
work and past work in Lund group).  2) The slower growth kinetics at 30⁰C or lower can 
give the cells more time for MmCCT production and folding into its functional form 
(Assuming that MmCCT itself would be required to fold other MmCCT molecules).  In 
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turn, the functional forms now can bring about the folding of the client proteins 
efficiently.  At 37⁰C, however, the equilibrium between the MmCCT functional molecules 
and the unfolded client proteins might be disturbed owing to faster and increased 
requirement of MmCCT protein.  This could result in an increase of unfolded/misfolded 
molecules that cease the growth of the cells.  3) The mechanism by which MmCCT 
operates could be different from GroEL.  It has been hypothesized that Group 1 
chaperonins are more involved in folding of clients that are aggregation-prone while 
Group 2 chaperonins are mainly operative on nascent chains and multi-domain proteins 
(Yam et al., 2008; Hartl and Hayer-Hartl, 2009).  It could be possible that the mechanism 
by which MmCCT operates is unable to efficiently rescue the aggregation prone proteins 
that, presumably, are higher in number at 37⁰C.  
A selection of K216n mutants (K216A, D, L, Q, R, and S) was also tested for their ability 
to sustain growth in complete absence of GroEL.   Although there was not a major 
systematic bias observed in the biochemical properties of substituted amino acids 
consistent with previous analysis in TAB21, one notable result was for the mutant 
K216R which was unable to support growth in complete absence of GroEL.  Even during 
TAB21 analysis the mutant K216R despite assembling into functional complexes could 
not improve the phenotype of the cells as compared to MmCCT-WT (Figure 3.13).  Note 
that K216 faces inside of the chaperonin cage (Figure 3.7) and hence such a result points 
towards the possibility that loss of surface positive charge could facilitate folding of 
bacterial clients.  Indeed, the wall of GroEL cavity is enriched with negatively charged 
residues (net surface charge is -42) in contrast to comparatively neutral distribution of 
MmCCT cavity (Cong et al., 2010).  Based on extensive mutational and biochemical 
analysis, the negatively charged clusters of the cage wall are strongly implicated to 
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facilitate folding of GroEL clients (Tang et al., 2006; Chakraborty et al., 2010).  Moreover 
it has been shown that changing three negatively charged residues facing the inner 
cavity of GroEL to positive, resulted in strong reduction of cell growth (Tang et al., 
2008).  This suggests the possibility of negatively charged residues having a role in 
efficient folding by GroEL, potentially by providing local repulsion to acidic proteins, 
predominantly found in E. coli (Horwich et al., 2009).  Although the validity of these 
results has been challenged recently (Motojima et al., 2012), it would be interesting to 
change the more positively charged residues facing the inner cavity of MmCCT to 
negative, ideally corresponding to the ones tested by Tang et al., 2008 and analyze the 
effects on E. coli growth in absence of GroEL. 
Nonetheless, the data clearly suggests that an archaeal chaperonin MmCCT can fold 
bacterial clients in vivo and the mutants MmCCT-M223I and K216E are more efficient in 
doing so.  Moreover, the K216E mutant completely replaces GroEL functionality in vivo 
at 30⁰C, suggesting that all of the bacterial essential clients can utilize MmCCT-K216E.  
However, the underlying reason for the improved function remained unclear.  To 
answer this, the next step hence was to analyze the properties of mutants chaperonin in 
vitro the results of which are described in the next chapter.   
In summary, we hereby establish a system that allows a Group 2 chaperonin to function 
in Group 1 host in absence of native Group 1 chaperonin.  Such a system puts forward a 
medium for biochemical, mutational and interactome analysis of chaperonins with one-
to-one comparison between the two groups that in turn could provide useful insights in 
understanding the divergence between the two groups.  One of such applications has 
been studied and further described in Chapter 5.  
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CHAPTER 4 
Biochemical characterization of MmCCT-
M223I and MmCCT-K216E mutants 
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Note: This part of the project was carried out in collaboration with Dr. Jӧrg Martin’s 
group, Max Planck Institute of Developmental biology, Tübingen, Germany.  The work on 
mutant M223I was done by Dr. Astrid Ursinus and for the mutant K216E was done by 
me either during or after my visit to Max Planck Institute in Oct-Nov, 2011.  The 
following table provides information regarding the same. 
 
 Experiment Responsible personnel  Figure No. 
1 Protein Purification M223I Dr. Astrid Ursinus 4.7C 
2 Protein Purification K216E Riddhi Shah 4.7B 
3 Protein Purification K216E, again Dr. Astrid Ursinus 4.7C 
4 Assays  
1. Protease protection assay 
Dr. Astrid Ursinus  
4.11 
5 Assays  
1. Citrate synthase binding assay 
2. ATPase assay 
3. Rhodanese refolding assay 
4. Protease protection assay 
Riddhi Shah  
 
 
4.8 
4.9 
4.10 
4.11B 
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4.1 Background 
In Chapter 3, chaperonin mutants MmCCT-M223I and MmCCT-K216E were described 
that partially or completely replace the function of GroEL in E. coli respectively at 30⁰C.  
While the in vivo assays indicated that both MmCCT-M223I and MmCCT-K216E are 
functional chaperonins, in vitro data was essential to support the results and to attempt 
to understand the improved GroEL-complementing ability of the mutants as compared 
to the wildtype.  In this chapter we analyse the biochemical properties of the mutants 
and compare it with those of the wildtype in order to understand the differences if any, 
that may in turn explain the better functionality of these mutants.  
The additional properties gained due to the point mutations M223I and K216E could 
change the biochemical behaviour of chaperonin oligomers at one or more of the 
following stages: 1. Ability to bind and encapsulate bacterial client proteins, 2. Change in 
ATP turn over i.e. rate of hydrolysis of ATP, 3. Change in the ability to refold clients for 
various reasons for example change in the charge distribution of inner cavity, 4. 
Nucleotide-dependent conformational changes.  All these stages are testable in vitro as 
has been described previously for wildtype MmCCT protein (Kusmierczyk and Martin, 
2003b).  Thus the aim of this part of the project was to purify MmCCT-M223I and 
MmCCT-K216E proteins and test their ability to bind and fold clients, examine the rates 
of ATP hydrolysis, and to check the nucleotide-dependent conformational cycle as 
compared to the wildtype-MmCCT.  Each stage has been described in detail while 
discussing the results in the next section. 
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4.2 Results 
4.2.1 Purification of MmCCT-K216E mutant 
The purification of the MmCCT-K216E mutant was carried out in three steps, first two 
steps of anion exchange chromatography followed by a gel filtration step (Section 2.8.4, 
Materials and Methods).  The BL21 (Gold) cells containing pET21-Mmcct-K216E were 
induced with 1 mM IPTG for 4 hours and correct expression checked using SDS-PAGE.  
After cell-lysis, the supernatant was loaded onto pre-equilibrated self-packed QHP anion 
exchange column.  The elution was carried out with a linear gradient of 0-50% buffer B 
(30 mM Tris pH 7.5, 1 M NaCl, 5 mM MgCl2).  Based on the obtained chromatogram 
(Figure 4.1), the selected fractions were run on SDS-PAGE gel and Native-PAGE gel 
(Figure 4.2A and 4.2B respectively).  The signal of absorbance (dark blue) and 
conductivity (light blue) can be seen in Figure 4.1, where the initial peak is indicative of 
non-specific proteins and the small peak just after that of MmCCT-K216E being eluted at 
approximately 30% of salt concentration. 
The fractions (22-32) were pooled, concentrated and its salt concentration adjusted by 
equalizing conductivity to buffer A (30 mM Tris pH 7.5, 100 mM NaCl, 5 mM MgCl2) 
using conductivity-meter.  The resultant solution was subjected to the next round of 
anion exchange chromatography using self-packed MonoQ olumn.  The elution was 
carried out in a similar manner as above.  Because of a manual error in inserting the 
total volume to be used over the gradient of buffer B, the absorbance peak was observed 
very quickly owing to 40 – 50% of buffer B concentration in just first few fractions 
(Figure 4.3).  Nonetheless, these fractions were run on an SDS-PAGE gel (Figure 4.4) and 
fraction 2 containing MmCCT was used for gel-filtration chromatography.  
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Figure 4.1 
Chromatogram of QHP anion-exchange chromatography for purification of MmCCT-K216E 
UV absorbance signal is seen in dark blue and the salt concentration is seen in light blue.  
The arrow shows the peak where MmCCT-K216E was eluted. 
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Figure 4.2 
SDS-PAGE and Native-PAGE analysis of eluted fractions of MmCCT-K216E after QHP anion-
exchange chromatography 
(A) Alternative fractions (number 10-30) corresponding to the first two peaks in Figure 4.1 as 
analysed by 12% SDS-PAGE and (B) The fractions containing MmCCT-K216E (14, 16, 24-32) 
selected from SDS-PAGE gel and analysed by 3-10% gradient Native-PAGE with purified 
GroEL (C1) and purified MmCCT-WT (C2) as controls. ‘I’indicates the initial fraction that was 
introduced into the column and ‘FT’ indicates flow-through after elution. Arrows indicate the 
position of MmCCT-K216E on the gels. 
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Figure 4.3 
Chromatogram for MonoQ anion-exchange chromatography  
UV absorbance signal is seen in dark blue and the salt concentration is seen in light orange. 
The arrow shows the peak where MmCCT-K216E was eluted. 
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Figure 4.4  
SDS-PAGE analysis of eluted fractions of MmCCT-K216E after MonoQ anion-exchange 
chromatography 
Fractions (number 1-6) corresponding to the peak observed in Figure 4.3 as analysed by 12% 
SDS-PAGE and Coomassie staining.  Red bracket indicates the MmCCT protein. 
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Gel filtration chromatography was carried out using S-300 column (320 ml bed volume) 
and samples were eluted with buffer C (30 mM Tris-HCl pH 7.5, 100 mM KCl, 5 mM 
MgCl2, and 1 mM DTT).  The fractions corresponding to the two peaks observed on the 
chromatogram (Figure 4.5) were run on SDS-PAGE gel (Figure 4.6A and B) and native-
PAGE gel (Figure 4.7A).  The appropriate fractions corresponding to a single peak (12 
and 13) were pooled and concentrated.  However when higher concentration of the 
purified protein was run on native-PAGE gel (Figure 4.7B), it was observed that the 
preparation was not satisfactorily pure especially with the presence of endogenous 
GroEL.  Although the biochemical assays were conducted in Germany using this protein 
preparation, it was essential to ensure that any chaperonin activity that was observed 
subsequently in the assays was because of MmCCT itself and not due to contaminating 
GroEL.  As a result the purifications were carried out again for MmCCT-K216E along 
with MmCCT-M223I by Dr. Astrid Ursinus following the same protocol and the samples, 
now satisfactorily pure (Figure 4.7C), were sent to Birmingham where the assays were 
developed and conducted.  
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Figure 4.5 
Chromatogram of S300 gel filtration analysis for the purification of MmCCT-K216E  
UV absorbance signal is seen in red. The arrow shows the peak where MmCCT-K216E was 
eluted. 
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Figure 4.6 
SDS-PAGE analysis of eluted fractions of MmCCT-K216E after gel filtration chromatography 
Fractions (number 11-27) corresponding to the peaks observed in Figure 4.5 as analysed by 
12% SDS-PAGE.  ‘I’indicates the initial fraction that was introduced into the column and the 
arrow indicates the position of MmCCT-K216E on the gel. 
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Figure 4.7 
Native-PAGE analysis of eluted fractions after gel filtration chromatography and of purified 
protein MmCCT-K216E 
(A) The fractions containing MmCCT-K216E (number 12-17) selected from SDS-PAGE gel 
were analysed by 3-10% gradient Native-PAGE. ‘I’indicates the initial fraction that was 
introduced into the column. 
(B) The purified protein MmCCT-K216E as analysed by Native-PAGE.  
(C) Purified proteins MmCCT-M223I and MmCCT-K216E as analysed by Native-PAGE. The gel 
was obtained from Dr. Astrid Ursinus.  
Purified GroEL (C1) and purified MmCCT-WT (C2) were used as controls to determine the 
position of bands on the gels.  The red and black arrows indicate the position of MmCCT-
K216E and GroEL respectively.  
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4.2.2 Client-binding ability of MmCCT-M223I and MmCCT-K216E 
We first tested the ability of MmCCT mutants to bind to porcine heart citrate synthase as 
a non-native model substrate in an aggregation prevention assay as described 
previously (Kusmierczyk and Martin, 2003b).  The mutants MmCCT-M223I and MmCCT-
K216E were incubated with a buffer containing citrate synthase at 50⁰C.  Protection 
against aggregation of the enzyme was measured spectrophotometrically at 320 nm 
(Section 2.6.8.1, Materials and Methods).   
Incubation of citrate synthase at 50⁰C resulted in rapid increase in OD320 of the solution 
over a period of 30 minutes (Figure 4.8A).  However presence of equimolar 
concentrations of MmCCT-WT, MmCCT-M223I or MmCCT-K216E was sufficient to 
suppress the aggregation (Figure 4.8A for MmCCT-K216E).  The molar concentrations 
were calculated with respect to the 931 KDa MmCCT complex.  The experiments were 
first carried out in a time dependent manner and then the measurements were taken 
after 30 minutes as an end point for the assay (Figure 4.8B).  MmCCT-mutants along 
with controls GroEL and MmCCT-WT suppressed light scattering of citrate synthase at 
50⁰C indicating effective binding to the enzyme.  The results indicated no obvious 
difference between the proteins for their client binding efficiencies by this assay. 
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Figure 4.8 
Binding ability of MmCCT mutants as assessed by citrate synthase aggregation assay 
Citrate synthase (CS) in absence or presence of the various proteins as mentioned was 
incubated at 50⁰C and the increase in aggregation was measured at 320 nm over a time 
course of 30 minutes (A) or at 30 minutes as an end point for the assay (B). The proteins and 
CS were used in equimolar concentrations. The data represent averages of three 
independent experiments.  
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4.2.3 ATPase activity of MmCCT-M223I and MmCCT-K216E mutants 
A defining characteristic of all chaperonins is their ATP hydrolysis activity.  The GroEL- 
complementing ability of MmCCT-M223I and K216E mutants was hindered when an   
additional D386A mutation was incorporated (Chapter 3) suggesting that the mutants 
were functional ATPases.  The same was assessed in vitro using the malachite-green 
molybdate ATPase assay (Section 2.8.6.2, Materials and Methods).  The protein and the 
appropriate controls were incubated at 37⁰C with 1 mM ATP for 15 minutes in 
applicable buffer and the release of phosphate was measured calorimetrically at 640 nm.   
The amount of liberated inorganic phosphate for MmCCT increases linearly with time 
and an incubation for 15 minutes has been established as a standard for the assay 
(Kusmierczyk and Martin, 2003a and J. Martin, personal comm.).  The readings obtained 
for spontaneous hydrolysis of ATP were deducted from the readings obtained for 
samples containing MmCCT proteins.  The readings obtained for MmCCT-WT were set as 
100% and the observations for MmCCT-M223I and MmCCT-K216E were plotted as a 
percentage of MmCCT as shown in Figure 4.9.   
It was observed that the mutants can effectively hydrolyze ATP.  The mutant MmCCT-
K216E exhibited a fairly similar rate of ATP hydrolysis as compared to the wildtype 
whereas, comparatively, a significant drop in activity was observed for the mutant 
MmCCT-M223I.  Similar results were consistently obtained for three independent 
experiments. 
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Figure 4.9 
ATP hydrolysis activity of MmCCT mutants 
The MmCCT proteins were incubated in appropriate buffer at 37⁰C and the ATPase activity 
was initiated by adding 1 mM ATP and continued for 15 minutes.  The release of phosphate 
was assayed by malachite green-molybdate method and the absorbance at 640 nm was 
recorded.  The observations for MmCCT mutants are plotted as percentage of the wildtype.  
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4.2.4 Client refolding capacity of MmCCT-M223I and MmCCT-K216E 
The enzyme rhodanese has been widely used as a model-client to test the in vitro 
refolding ability of both GroEL (Mendoza et al., 1991; Martin et al., 1993) and MmCCT 
(Kusmierczyk and Martin, 2003b).  When rhodanese is chemically denatured, it 
aggregates and becomes inactive.  However, presence of chaperonins under appropriate 
conditions leads to recovery of native Rhodanese that can be assayed.   
Rhodanese was denatured using 6 M guanidinium chloride (GuHCl) and incubated with 
the MmCCT wildtype and mutant proteins in presence of ATP as described in section 
2.8.6.3 of Materials and Methods.  The reaction was followed for 30 minutes and activity 
of refolded rhodanese was assayed by conversion of cyanide into thiocynate followed at 
480 nm.  As seen in Figure 4.10, approximately 60% to 70% recovery of native 
rhodanese was observed for MmCCT-M223I and K216E.  There was not a significant 
difference in the values obtained for the mutants as compared to those obtained for the 
wildtype as observed here or reported previously (Kusmierczyk and Martin, 2003b).  
However MmCCT-M223I consistently showed a relatively lower refolding activity when 
compared to MmCCT-K216E which in turn showed activity that was almost similar to 
the wildtype. 
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Figure 4.10 
Rhodanese refolding ability of MmCCT mutants 
GuHCl-denatured rhodanese was incubated in absence or presence of various proteins as 
mentioned in appropriate buffer containing 1 mM ATP at room temperature for 30 minutes. 
The observations for MmCCT proteins are plotted as a percentage activity of native 
rhodanese.  
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4.2.5 Protease sensitivity test for M223I and K216E mutants 
Chaperonins exhibit different conformations at different stages of the folding cycle.  To 
determine the asymmetric conformations of chaperonin complexes in presence of 
different nucleotides a simple assay based on susceptibility of digestion by a protease 
has been described (Langer et al., 1992; Martin, 2000) and extensively used for both 
Group 1 and Group 2 chaperonins.  In its open conformation, MmCCT-WT is susceptible 
to protease digestion because of the accessibility to the highly dynamic lid region 
(Reissmann et al., 2007).  However in the presence of ATP, the oligomer undergoes the 
conformational cycle and transiently attains a closed conformation.  The closed state 
buries the sites that are susceptible to protease cleavage and hence leads to protection 
against protease digestion.  Two considerations were made here in order to observe 
protease digestions effectively.  Firstly, higher ATP concentration (1 mM) was used for 
the experiment.  Higher concentration of ATP (more than 0.4 mM) has been shown to 
overcome the negative cooperativity between the rings resulting into a symmetrically 
closed complex that theoretically should be fully protected against protease treatment 
(Kusmierczyk and Martin, 2003b; Meyer et al., 2003).  Secondly, the gamma phosphate 
mimic AlFx was also used along with ATP.  AlFx has been shown to stabilize the closed 
conformations leading to more efficient protease protection (Meyer et al., 2003; Iizuka 
et al., 2005).  (Figure 4.11A, number 3).   
If the point mutations M223I and K216E led to conformational changes of the complex 
or an alteration of time spent in the different conformations, the pattern of proteolytic 
digestion would be different than the wildtype.  Both the mutants were subjected to 
Proteinase K sensitivity assay (section 2.8.6.4, Materials and Methods).  Briefly, the 
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purified proteins were incubated with proteinase K at room temperature for 10 minutes 
in absence or presence of nucleotides ADP, ATP, AMP-PNP and ATP-AlFx and analysed 
by SDS-PAGE to check the extent of digestion.  
The results showed that the mutant MmCCT-M223I was rather weakly protected against 
protease digestion (Figure 4.11A) suggesting that the mutant spends more time in open 
conformation rather than closed, consistent with its lower ATPase activity.  The mutant 
MmCCT-K216E on the other hand was partially protected against proteolytic cleavage in 
presence of ATP and to a greater extent in presence of ATP-AlFx similar to the 
observations for wildtype protein (Figure 4.11B).  Note that when the non-hydrolysable 
ATP analogue, AMP-PNP, was used, effective protease protection was not achieved 
suggesting that ATP hydrolysis is important to attain the closed conformation consistent 
with previously reported results (Reissmann et al., 2007) (Figure 4.11B, number 4).  
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Figure 4.11 
Protease sensitivity test for MmCCT-M223I and MmCCT-K216E 
Protection against Proteinase K (PK) for MmCCT-WT, MmCCT-M223I and MmCCT-K216E as 
observed by SDS-PAGE: (A) Analysis of MmCCT-WT and MmCCT-M223I without (-) or with (+) 
PK in absence of nucleotide (1) or presence of ATP (2) and ATP-AlFx (3). (B) Analysis of 
MmCCT-WT and MmCCT-K216E without (-) or with (+) PK in absence (1) or presence of ATP 
(2), ADP (3), AMP-PNP (4) and ATP-AlFx (5).  All gels stained by Coomassie staining.  
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4.3 Discussion 
Group 2 chaperonin MmCCT from Methanococcus maripaludis and its mutants MmCCT-
M223I and MmCCT-K216E rescue growth of E. coli when GroES and GroEL are depleting 
at 30⁰C.  Moreover mutant MmCCT-K216E sustains E. coli growth in the complete 
absence of GroES and GroEL.  The additional properties acquired by the chaperonin 
complexes as a result of single point mutations M223I and K216E could be traced by 
investigating the biochemical properties of the mutant.  Thus experiments were 
conducted to purify the proteins and analyze them biochemically to understand their 
behaviour in vitro.  
The purification of MmCCT was carried out with a method similar to described 
previously (Kusmierczyk and Martin, 2003b), which has been followed with minor 
modifications for purification of MmCCT in general (Reissmann et al., 2007).  Two 
rounds of anionic exchange chromatography and a step of gel filtration, both at pH 7.5, 
were employed to purify MmCCT.  Because the pI of MmCCT (4.97) and GroEL (4.85) are 
quite close to each other, anion exchange using strong anionic exchanger (quaternary 
resin MonoQ, in this case) has been found to be an essential step in separation of 
MmCCT and GroEL (Kusmierczyk and Martin, 2003b).  Because of the use of a very steep 
salt gradient during this step, contaminating GroEL was found in the protein 
preparations.  However subsequent purifications resulted in almost 95% pure proteins 
as determined by SDS-PAGE gels and Native-PAGE gels.  These purified proteins were 
then subjected to biochemical assays. 
The biochemical profile for MmCCT-M223I differed from that of wildtype and MmCCT-
K216E.  While the mutant was able to bind the client citrate synthase efficiently, the 
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rates of ATP hydrolysis and rhodanese-refolding were lower than corresponding rates 
of MmCCT-WT and MmCCT-K216E.  Moreover MmCCT-M223I was not efficiently 
protected against protease digestion in presence of ATP or ATP-AlFx.  Using D386A 
mutants of MmCCT, it has been shown that ATP hydrolysis is absolutely required for 
attaining the protease-resistant closed conformation (Reissmann et al., 2007).  In this 
regard, it can be considered that the mutation M223I has a negative effect on ATP 
hydrolysis and hence the cavity-closure, particularly when lower ATPase activity was 
consistently observed for the mutant.  Alternatively, it has also been reported that 
susceptibility to protease digestion is in general due to the lid region and that ∆lid-
MmCCT variants are protected even in absence of any nucleotides (Reissmann et al., 
2007).  Because M223 does not lie in this region, it can be speculated that protease 
sensitivity results due to some secondary conformational changes or steric hindrances   
that in turn blocks the movement of lid region.  The close proximity of M223 residue to 
the lid region (Figure 3.4) might be instrumental for such changes.  Indeed structural 
studies like electron microscopy or crystallography are required to understand in detail 
the implications of this mutation on the oligomeric rearrangement and assembly.   
 In either case, it can be proposed that the mutant MmCCT-M223I resists the formation 
of closed conformation and tends to lock the chaperonin complex in its open state that is 
able bind to clients but not fold them.  Such an action however is not fully achieved and 
the chaperonin does undergo albeit a slow ATPase cycle to bring about a certain degree 
of productive folding as demonstrated for rhodanese.  This model is consistent with the 
initially described hypothesis (Chapter 3) that suggests that the improved GroEL-
complementing ability of the MmCCT-M223I could be partly because of a loss of 
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chaperonin function and that the better phenotype results due to slower aggregation of 
the misfolded proteins that are transiently stabilized by binding to the mutants.  In 
addition, folding of at least some clients (even with slow ATP turn-over) depend on 
MmCCT-M223I as completely obstructing the ATPase activity by an additional D386A 
mutation leads to cessation of growth (Chapter 3).  The results thus suggest that both 
active folding of clients and slow aggregation kinetics of the misfolded proteins could 
probably contribute together, for improved GroEL-complementing ability of MmCCT-
M223I.  Future experiments should elucidate the findings better, for example by 
examining the growth effects when a non-native toxic protein known to aggregate in E. 
coli is over-expressed along with the mutant M223I.   
The biochemical properties of MmCCT-K216E on the other hand were almost identical 
to that of wildtype.  The mutant was able to bind the client, effectively hydrolyze ATP 
and refold rhodanese with efficiency comparable to that of the wildtype MmCCT.  Also 
the mutant showed nucleotide dependent open and closed conformation cycle based on 
protease sensitivity assay.  Because MmCCT-K216E was able to completely replace 
GroEL functionality, it was expected to behave differently in fact in a better way than the 
wildtype during in vitro analysis.  However no significant differences were observed 
suggesting a similar reaction cycle and mechanism of folding clients.  
Such results point towards the possibility that the improved functioning of MmCCT-
K216E could be client-specific instead of better functioning of the chaperonin complex 
itself.  The additional properties acquired by point mutant MmCCT-K216E could be a 
structural adjustment for either accommodating more bacterial clients than the 
wildtype or to increase the efficacy of folding of particular bacterial clients.  Such a 
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proposition is in line with the previous results where mutation of K216 to any amino 
acid but a positively charged residue leads to better rescue of E. coli in GroEL and GroES 
limiting conditions.  Elimination of positive charge at this residue thus perhaps allows 
more efficient interaction or folding of bacterial clients.  The validity of these 
conclusions indeed requires further experimentation, an attempt for which has been 
made in the next chapter by elucidating interacting clients.   
Of note, we also considered certain broader issues such as stability of the MmCCT 
mutant proteins and their total amount in the cell to be contributing towards their 
improved function.  Careful experiments were done to compare the protein levels of the 
mutants to the wildtype with appropriate controls.  The results showed no significant 
difference in their expression (Chapter 3 and results not shown).  Also the melting 
temperatures (Tm) of both the mutants (63⁰C) were found to be similar to that of the 
wildtype (65⁰C) as deduced from circular dichroism melting curves (J. Martin, pers. 
comm.).  This suggests that the mutants are as thermally stable as the wildtype protein 
and rules out the issues described above for better function in E. coli.  The results 
however do not exclude more general effects arising due to mutations like cross-talks 
with other chaperone systems and/or other regulatory events which although are 
unlikely to play a role, would require a more elaborate scheme of experiments in a case 
where a direct answer to reason the better function of the mutants is not derived. 
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Chapter 5 
Towards investigation of MmCCT clients 
and client binding site in E. coli. 
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Note: The results discussed in sections 5.3.2.1, 5.3.2.2 and 5.3.3.3 were done by 
undergraduate students Kate Wilkinson, Wing Chun, Kiren Baines, and Lynette Jude 
supervised by myself.  The following table provides information regarding the same. 
 
 Experiment Responsible personnel  Figure No. 
1 Generating V273n mutants library Kate Wilkinson - 
2 Generating Y297n mutants library Wing Chun - 
3 Expression and assembly of V273n 
mutants 
Kiran Bains 5.16 
4 Complementation of V273n mutants Kiran Bains 5.17 
5 Complementation of Y297n mutants Lynette Jude 5.18 
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5.1 Background 
In chapter 3, an in vivo system was described wherein MmCCT was shown to be active as 
a chaperonin in E. coli under GroEL depletion conditions.  Such a system generated a 
platform for investigating properties of Group 2 chaperonin, MmCCT, in a Group 1 host.  
Using this system, in this chapter, we describe our preliminary attempts to elucidate the 
MmCCT dependent clients in E. coli (Section 5.2) and dissect its client binding site 
(Section 5.3) by means of proteomic and mutational analysis. 
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5.2 Elucidation of MmCCT-clients in E. coli 
5.2.1 Introduction 
An important aspect in the field of chaperonins is identification of the proteins that 
partially or stringently require a particular chaperonin to fold, re-fold or maintain its 
native structures.  Several genome and proteome-wide studies have been conducted to 
identify GroEL-interactors (Houry et al., 1999; Kerner et al., 2005; Fujiwara et al., 2010), 
yeast and mammalian TRiC-interactors (Thulasiraman et al., 1999; Dekker et al., 2008; 
Yam et al., 2008) and interactors of archaeal chaperonins from M. mazei (Hirtreiter et al., 
2009).  
Our finding that the chaperonin MmCCT has GroEL-like function in E. coli offered a 
unique opportunity to identify bacterial proteins that interact with and are potentially 
folded by an archaeal chaperonin.  We initiated this study on account of two reasons:  
Firstly, as discussed in Chapter 4, we hypothesized that the better GroEL-
complementing ability of the point mutants MmCCT-M223I and MmCCT-K216E was 
because of their ability to interact with and perhaps fold more clients than the wildtype.  
This hypothesis could be tested by comparing the interactors of MmCCT with those of 
the mutants.  The differences if obtained might provide reasons for the enhanced GroEL-
complementing ability of the mutants as compared to the wildtype.  Secondly, the study 
is interesting on its own right as it will enable isolation of proteins from a Group 1 host, 
E. coli, that are possibly recognized and folded by a Group 2 chaperonin, MmCCT.  
Comparison of such proteins with the already known GroEL-interactors can identify 
overlapping and novel sets of potential MmCCT-interactors.  We suggest that this 
initiative provides a platform for comparative analysis that can help understand the 
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differences between interactors and in turn can reflect on evolutionary co-relation 
between chaperonins and clients.   
A combination of diverse techniques have been reported in the literature to isolate the 
chaperonin interactors for example pulse chase assays followed by two dimensional 
chromatography of the immunoprecipitated chaperonins (Houry et al., 1999; Yam et al., 
2008), immunoprecipitation technique using specific antibodies (Kerner et al., 2005; 
Hirtreiter et al., 2009) or usage of internal tagging  methods and subsequent pull-downs 
(Dekker et al., 2008) among others.  The details of these studies are outlined in Table 
5.1.  Initially we had undertaken two different approaches to identify potential MmCCT 
interactors in E. coli.  Firstly, we tried utilizing an additional point mutant of MmCCT that 
contains a G to C substitution at the highly conserved glycine 61 residue.  The equivalent 
mutation (G65C) in the archaeal chaperonin from the Thermococcus strain KS-1 has been 
shown to yield a ‘trap variant’ of this chaperonin.  The variant binds to and supposedly 
encapsulates the clients - citrate synthase and green fluorescent protein (GFP) with 
significantly higher affinity than that of the wildtype, but restricts their release and 
hence productive folding, even in the presence of ATP.  This refolding arrest activity has 
been proposed to occur due to inhibition of the ATP dependent conformational changes 
possibly by steric hindrance of side-chain of the residue position (Iizuka et al., 2001).  
We speculated that if the soluble fractions of cells expressing MmCCT proteins 
containing the G61C mutation are run on a Native-PAGE gel, the ‘trapped’ interactors 
should remain associated with the chaperonin proteins and become identifiable by MS 
analysis.  While a significant number of proteins were isolated with this method, a high 
background possibly due to slower migration of certain protein on native-PAGE gels was 
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consistently observed, questioning the obtained results.  It was concluded that a more 
pure protein preparation was essential.   
Hence we further attempted to isolate MmCCT proteins by C- or N- terminal His-tagging 
method.  However, these experiments were again not successful and resulted in 
conformational inconsistencies of the chaperonin complexes.  Such observations were 
attributed to the poor accessibility of cavity-buried termini and subsequent falling apart 
of the complexes during metal affinity chromatography as had been previously observed 
(Dr. Andrew Large, former post-doc).  We speculated that using an internal tag could 
overcome these difficulties and allow identification of potential MmCCT interactors.  
Thus, we here describe a comprehensive internal-tagging approach undertaken for our 
analysis as previously described by Dekker et al., 2008.  The method utilizes calmodulin 
binding protein (cbp) affinity tag incorporated at a specific solvent exposed site of one of 
the subunits yeast CCT (cct3).  The tag enables isolation of CCT complexes using a 
calmodulin resin along with the bound proteins that can be further analysed by mass 
spectrometry (Pappenberger et al., 2006).   
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Table 5.1: A summary of client identification studies for various chaperonins.  
Chaperonin Study by Description of the approach 
GroEL Houry et al., 1999 1. Pulse chase analysis of live E. coli cells followed by immunoprecipitation, 2D PAGE and MS 
analysis 
Kerner et al., 2005 
1. Biochemical assay analysis of individual proteins detected by Houry et. al. 
2. MS analysis of isolated client containing GroEL-GroES complexes by immobilized metal-
affinity chromatography using a C-terminal His-tagged GroES  
Chapman et al., 
2006 
1. Identification of clients from inclusion bodies after depletion of cellular GroEL levels 
Fujiwara et al., 
2010 
1. Proteome wide MS analysis of GroE depleted cells and identification by comparing 
abundance ratios. 
2. Individual characterization based on solubility in GroE depleted cells of proteins detected 
by above method and by Kerner et al.   
3. Identifying metabolites by direct assays in GroE depleted E. coli cells  
Mammalian 
TRiC 
Thulasiraman et 
al., 1999 
1. Pulse chase analysis of cells with newly translated proteins followed by 
immunoprecipitation and 2D gel analysis. 
Yam et al., 2008 
1. Pulse chase assays of newly translated proteins, immunoprecipitation, 2D PAGE, MS 
analysis 
2. Genomic screens in a cell free mammalian translation system 
Yeast CCT Dekker et. al., 
2008 
1. Pull-downs of yeast-CCT and the bound interactors using internal tagging method 
2. Testing genetic interaction spectrum of yeast-CCT using a temperature sensitive allele by 
synthetic gene array screen. 
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5.2.2 Results 
To comprehensively identify MmCCT-interactors we employed a recently described 
approach used for identification of yeast CCT clients by Dekker et al. 2008.  They have 
utilized an internal tagging method where Histidine (His), streptavidin (strep) and 
calmodulin binding protein (cbp) affinity tags were incorporated in tandem at a specific 
solvent exposed site of one of the subunits yeast CCT (cct3).  The CCT complexes were 
then isolated using a calmodulin resin along with the bound proteins.  These bound 
proteins were further purified by sucrose gradients and analysed by mass spectrometry 
to identify yeast CCT clients.  They showed that addition of ATP in the final wash step 
removed these proteins and hence suggested that the isolated proteins were bona fide 
CCT clients.  The site for tag insertion (between proline 374 and lysine 375 on yeast cct3 
subunit) was finalized after several attempts of terminal or internal tagging at different 
positions on yeast cct gene using different tags (Pappenberger et al., 2006).  Because of 
successful results obtained with the chosen tags and the tag insertion site for yeast CCT 
(Dekker et al., 2008), the same combination of tags and equivalent site on MmCCT was 
employed for this study as described below. 
5.2.2.1 Insertion of CBP-tag in MmCCT 
In the case of yeast CCT the tag was inserted internally between the residues P374 and 
K375 of yeast cct gene.  These residues reside on the outer surface of the chaperonin 
complex and hence are more accessible in comparison to the N and C termini that lie 
inside of the complex.  The corresponding residues for MmCCT, P362 and K363 were 
found to be positioned in a similar manner (Figure 5.1).  A 56 amino-acid long tag 
containing his- strep-cbp sequences in tandem was inserted in Mmcct gene by overlap 
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extension PCR (Figure 5.2 and section 2.8.5.1, Materials and Methods).  Although only 
cbp tag was required for downstream calmodulin based pull-down analysis, the 
combination of tags described by Pappenberger et al. was retained for this analysis.  This 
is because, as stated before, such a combination was finalized after several trials taking 
into account the stability and in vivo/in vitro function of the differentially tagged yeast 
CCT proteins (Pappenberger et al., 2006).  It should be noted however that MmCCT is a 
homooligomeric chaperonin and hence tagging would occur in all 16 subunits of the 
complex as against on a single subunit for yeast CCT.  Thus, the tagged MmCCT protein 
was first checked for its expression and solubility in E. coli as described in next section. 
For the ease of understanding in the document, a protein that is not tagged will be 
referred to as untagged and not as the wildtype protein.  
5.2.2.2 Expression and solubility of cbp-tagged MmCCT protein 
The construct Mmcct-wt-tag was cloned into pET21 vector and tested for its expression 
and solubility in E. coli TAB21 strain in a similar manner as described in chapter 3.  
MmCCT-WT-tag protein migrated as a 64KDa monomer on SDS-PAGE gels (Figure 5.3A) 
however the expression levels were lower than that of the wildtype.  When tested for its 
solubility, the tagged protein was not detected in soluble fractions of cells as analysed by 
SDS-PAGE and western blotting (Figure 5.3B and C).  In addition the tagged protein was 
not able to restore the GroEL complementing ability of the wildtype MmCCT protein in 
TAB21 (Figure 5.3D).  
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Figure 5.1 
Choice and location of tag insertion site for MmCCT 
(A) Alignments of selected sequences of Group 2 chaperonins from organisms as mentioned. 
(B) MmCCT subunit showing P362 and K363 residues highlighted as yellow and red 
respectively. The subunits were coloured in PYMOL from structures obtained from Protein 
Data Bank (PDB ID: 3KFK) submitted by Pereira et al. 2010. 
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Figure 5.2 
Schematic illustrating the overlap extension PCR method used to generate MmCCT-tag. 
(A) The diagram shows the sites of the four primers required for overlap extension PCR. The 
calmodulin binding protein (cbp) tag is contained within primers 3 and 4.  Both these primers 
have a tag overlapping region (coloured red), in addition to the 5’ and 3’ regions respectively 
(coloured orange and green) that are complementary to 21 bp upstream and downstream of 
the tag insertion site P363|K363 in Mmcct gene.  Primers 1 and 2 contain NdeI and BamHI 
restriction sites respectively.  
(B) In the first PCR step, primers 1 and 3 are used to amplify the first part of the Mmcct 
gene.  The product now has an adjoining tag region with a 3’ patch that can overlap with the 
product of second PCR step that is similarly obtained by amplifying Mmcct gene with primers 
2 and 4.  In the final PCR step, the two products are mixed together, denatured, annealed, 
and the 3’ tails are extended by DNA polymerase.  This generates a small amount of chimeric 
product containing the whole tag sequence. The full length product was amplified using 
primers 1 and 4.  This product was then cloned into the NdeI/BamHI site of the pET21b 
expression vector.  
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Figure 5.3 
Expression, solubility and complementation analysis of MmCCT-WT-tag protein in E. coli 
(A) Crude extracts of E. coli TAB21 cells expressing pET21-MmCCT-WT and pET21-MmCCT-
WT-tag as analyzed by 12% SDS PAGE and Coomassie staining.  
(B) and (C) Non-induced crude extracts (1), IPTG-induced crude extracts (2) and IPTG 
induced soluble extracts (3) of E. coli TAB21 cells expressing pET21-MmCCT-WT and 
pET21-MmCCT-WT-tag as analyzed by 12% SDS PAGE (B) and western blotting using anti-
thermosome antibody (C). Black and red arrows show tagged and untagged MmCCT 
proteins respectively. 
(D) TAB21 cells expressing MmCCT proteins as indicated grown on 0.2% glucose and 1 mM 
IPTG at 30⁰C for five days.  
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5.2.2.3 Co-expression of tagged and untagged MmCCT proteins 
The insolubility of tagged MmCCT protein was thought either be to be due to lack of 
formation of functional complexes or instability of already assembled complexes 
because of the presence of the tag on all 16 subunits.  Thus an attempt was made to co-
express the tagged and untagged MmCCT wildtype proteins together such that 
heterooligomers with lesser number of tagged subunits per complex would result.  Such 
heteroligomers could therefore be more stable and hence functional in E. coli.  
Because both tagged and untagged Mmcct constructs were in the same vector pET21, it 
was first necessary to subclone one of the genes into a compatible vector for co-
expression.  We chose a lower copy number plasmid, pACYC184, to express the tagged 
MmCCT protein so that complexes with fewer tagged subunits could be obtained owing 
to its relatively lower expression.  The Mmcct-tag fragment was cloned into pACYC184 
by disrupting its tetracycline marker cassette (Figure 5.4).  The resulting construct 
pACYC-Mmcct-tag was transformed together with pET21-Mmcct-wt into E. coli TAB21 
cells and tested for its expression and solubility.  While IPTG was added to the medium 
for pET21 based expression of the untagged wildtype protein, the expression of Mmcct-
tag relied on the tetracycline promoter upstream of the gene on the pACYC plasmid.  
Selection was based on chloramphenicol marker for pACYC184 and the standard 
ampicillin marker for pET guided expression of the untagged wildtype.   
As shown in Figure 5.5A, both tagged and untagged MmCCT proteins were resolved as 
monomeric subunits on SDS-PAGE gels when expressed together.  However, only the 
untagged monomers were detected in the soluble fractions of the cells (Figure 5.5B and 
C).  This could either mean that the complexes containing only the wildtype untagged 
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monomers are soluble or that complexes containing relatively lower numbers of tagged 
monomers per complex are soluble but undetectable because of their smaller number.  
It should be noted that the proportion of the tagged subunits was lower than that of the 
untagged in whole cell lysates (Figure 5.5A lane 5).  The ratio of tagged:untagged 
monomeric subunits was reproducibly obtained between 1:3 to 1:4 when analysed by 
densitometry.  If it is assumed that the assembly of the chaperonin complexes is random 
inside the cells, the approximate relative distribution of complexes containing 1 to 16 
tagged subunits could be calculated using the formula  ((p)^k)((1-p)^(n-k))(n!/(k!(n-
k)!)) where k are untagged subunits and n-k represent tagged subunits, and where the 
relative probabilities of k and n-k are p and 1-p respectively.  With the stoichiometry 1:3 
the distribution obtained can be represented as shown in Figure 5.6.  Indeed these 
figures are based on the approximation that the binary distribution assumes an infinite 
pool of both sorts of subunits, but as subunits assemble, the number of remaining 
subunits goes down.  Nonetheless, the data suggested that at a given time ~ 80% of the 
total chaperonin population contained less than 5 tagged subunits.  If this was the case it 
could have been possible that the complexes containing fewer tags were stable and 
soluble however because of their lower numbers were not detected during gel analysis.  
Based on this assumption, the analysis was carried forward and pull-downs were 
performed.  
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Figure 5.4 
Schematic diagram to explain construction of pACYC-MmCCT-tag. 
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Figure 5.5 
Expression and solubility of coexpressed MmCCT-WT and MmCCT-WT-tag proteins in E.coli 
Whole cell crude lysates (A) and soluble extracts (B) of E. coli TAB21 cells expressing MmCCT 
proteins as analyzed by 12% SDS PAGE and Coomassie staining.  Soluble extracts also 
analysed by western blotting using anti-thermosome antibodies (C). 
(1) TAB21/pET21 empty vector 
(2) TAB21/pET21-Mmcct-WT 
(3) TAB21/ pET21-Mmcct -tag 
(4) TAB21/ pACYC184-Mmcct-tag 
(5) TAB21/pET21-Mmcct -WT+ pACYC184-Mmcct -tag 
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Figure 5.6 
Frequency distribution of MmCCT complexes containing tagged and untagged subunits.  
The numbers are based on the approximation that the binary distribution assumes an 
infinite pool of both sorts of subunits.  
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5.2.2.4 Pull-downs using calmodulin-affinity resin 
The TAB21 cells co-expressing MmCCT wildtype tagged and untagged subunits were 
subjected to pull-down analysis using calmodulin resin beads as described in section 
2.8.5.2, Materials and Methods.  Briefly, the cells were lysed and soluble fraction was 
incubated with the resin for binding of tagged complexes.  The unbound and non-
specific material was removed by several washes with wash buffer and protein was 
eluted using EDTA.  Any proteins bound to MmCCT should also be eluted along with it 
and become detectable in downstream analysis.  
The eluted fractions showed the presence of both tagged and untagged subunits of 
MmCCT when resolved by SDS-PAGE gel (Figure 5.7) suggesting that the method had 
worked and that at least some tagged complexes were soluble.  When analysed using 
densitometry, the ratio of tagged to untagged subunits was reproducibly obtained 
between 1:4 and 1:5.  A lower co-expression ratio was consistent with our earlier 
estimates and therefore indicated a lower number of tagged subunits per complex as 
hypothesized earlier.  The reason for detection of soluble tagged MmCCT monomers in 
the eluate but not in the soluble fractions during the previous experiments could be due 
to a smaller population of tagged monomers.  To test whether the same was happening 
for complexes with all tagged subunits, the above experiment was repeated with TAB21 
cells expressing only pACYC184-Mmcct-WT-tag.  However the complexes with all tagged 
subunits failed to isolate during the analysis (Figure 5.8, Lane 4b), verifying the previous 
results and confirming that heteromers with lesser number of tagged subunits per 
complex were required to form the oligomeric complexes.  The proteins isolated with 
MmCCT tagged protein were visually observed on the gels stained with silver staining 
(Figure 5.9, Lane 3).  
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Figure 5.7 
Calmodulin-based pull-downs of cbp tagged MmCCT hetero-oligomers analysed by SDS-
PAGE and Coomassie staining. 
SDS-PAGE analysis of fractions obtained at different stages (1 – 8) during the calmodulin 
based pull-down analysis of TAB21 cells expressing both pET21-Mmcct-WT and pACYC184-
Mmcct-WT-tag.  The gel was stained by Coomassie staining. Black and red arrows indicate 
the tagged and untagged MmCCT monomers respectively. 
(1) Crude extracts (OD600=1), 4 hours after IPTG induction 
(2) Soluble fraction after lysis  
(3) Insoluble fraction after lysis 
(4) Unbound material 
(5) Wash 1 
(6) Wash 2 
(7) Wash 3 
(8) Elution  
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Figure 5.8 
Calmodulin-based pull-downs of cbp tagged MmCCT homo- and hetero-oligomers analysed 
by SDS-PAGE and Coomassie staining. 
SDS-PAGE analysis of fractions obtained at different stages (1 – 4) during the calmodulin 
based pull-down analysis of TAB21 cells expressing MmCCT proteins as indicated below (a-c).  
The gel was stained by Coomassie staining. Black and red arrows indicate the tagged and 
untagged MmCCT monomers respectively. (1) Soluble fractions after lysis; (2) Wash 2; (3) 
Wash 2; (4) Eluates. 
(a) TAB21/pET21b + pACYC184 empty vectors 
(b) TAB21/pACYC184-Mmcct-WT-tag 
(c) TAB21/pET21-Mmcct-WT+ pACYC184-Mmcct-WT-tag 
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Figure 5.9 
Potential MmCCT- interactors detected by SDS-PAGE and silver staining 
Protein eluates of pull-down analysis resolved by SDS-PAGE and silver staining.  
(1) TAB21 + pET21b + pACYC184 empty vectors 
(2) TAB21 + pET21-Mmcct-WT  
(3) TAB21 + pET21- Mmcct-WT + pACYC184- Mmcct-WT-tag 
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5.2.2.5 MS analysis of MmCCT-interactors 
The next step was to identify the potential MmCCT-interactors using MS analysis.  Due to 
a limited amount of time this analysis was only done once and currently the work is 
ongoing in the laboratory to test reproducibility of the results described below.  
The gel-lane expressing the potential bound interactors (Figure 5.9, Lane 3) was sliced 
into three vertical pieces as shown in Figure 2.4, Materials and Methods.  Care was taken 
to avoid the gel-area expressing the MmCCT tag and untagged proteins because it has 
been noted that presence of higher amounts of a particular protein during the MS 
analysis reduces the chances of picking up the proteins that are relatively present in 
lower concentrations.  As a control, three slices at similar positions to the sample were 
cut out from the gel-lane that resolved pull-downs of cells expressing untagged MmCCT-
WT protein (Figure 5.9, Lane 2).  Such a control served for two purposes: first to test if 
untagged MmCCT protein has any affinity for the resin and second to determine whether 
there are any other calmodulin binding proteins, that if present would give rise to false 
positives.  All the gel slices were individually subjected to in-gel trypsination and LTQ-
Orbitrap MS analysis and the peptides were identified by MASCOT search engine using 
the BL21 (DE3) database.  
The protein hits obtained from all three gel samples of tagged MmCCT protein as a result 
of the analysis were combined and arranged score-wise.  The overall analysis revealed a 
total of 96 potential MmCCT-interacting proteins (Table 5.2).  As seen, MmCCT-tag and 
MmCCT-untagged subunits were the first scorers of the list.  Even though the samples 
were made particularly leaving the bands for MmCCT, the high scores of these proteins 
suggested a potential carry forward in the sample gel-slices possibly due to a certain 
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extent of degradation.  Out of these 96 proteins, 16 proteins overlapped with the 
proteins obtained from analysis of untagged MmCCT control (Table 5.2, 81-96).  
Additionally 60 other proteins were detected in the control sample and again MmCCT-
WT protein was one of the top scoring candidates.  These signals possibly represent 
proteins with an affinity for calmodulin resin.  However also note that ~50% of the 77 
control protein signals consisted of ribosomal proteins.  Because ribosomal proteins are 
among the highly abundant proteins, the results also suggest that the proteins present in 
higher amounts (and hence MmCCT) are not completely removed during the washes and 
can be eluted as background contamination.  For simplicity of this analysis the non-
overlapping control proteins have not been considered.  
Out of the obtained protein signals, 30 proteins were found to be previously reported as 
GroEL-interactors (Table 5.3) (Kerner et al., 2005; Fujiwara et al., 2010).  Using the data 
by Kerner et. al., the probability for a protein to be a GroEL client out of total 2400 
soluble proteins of E. coli can be calculated as 0.103 (247 GroEL-interactors).  Taking 
this value into consideration and assuming that the selection is totally random, the 
cumulative probability for selection of 30 or more GroEL-interactors out of 96 was 
solved as 1.68E-08.  This suggested that the obtained data was statistically significant.   
GroEL-interactors have been divided into four groups (Azia et al., 2012): Class I that can 
fold independently of GroEL but still are found to be associated with GroEL, Class II that 
partially depend on GroEL for folding, and the obligate GroEL clients belonging to either 
Class III- described by Kerner et. al. (Kerner et al., 2005) or Class IV described by 
Fujiwara et. al., 2010.  Out of the 30 GroEL clients obtained in this analysis, 7 belonged to 
Class I (highlighted as blue), 10 belonged to Class II (highlighted as red), 3 to Class III- 
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(highlighted as green) and 10 to Class IV (highlighted as purple).  Almost all proteins 
were well below the 60kDa cut-off.   
The remaining signals (approximately 70 proteins) could represent a novel set of 
proteins that probably interact with MmCCT but not GroEL.  However note that  67% of 
these proteins belong to the group of 1100 most abundant proteins in E. coli (Ishihama 
et al., 2008) (Table 5.2, A1-A5 where A1 represents first 20%, A2 next 20% and so on).  
It is possible thus that several low abundant GroEL-interactors that are recognized by 
MmCCT have escaped this analysis.  Moreover, the study does not establish whether the 
potential MmCCT-interacting proteins are bona fide clients.  Testing the ATP dependent 
release of the obtained interactors would hence be the next immediate step for a clearer 
analysis.  Nonetheless the results described here demonstrate that the internal tagging 
method has been successful and can be utilized for identification of MmCCT interactors.  
Once the reproducibility of the results is tested, future experiments will be targeted at 
identifying potential interactors of different MmCCT mutants.    
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Table 5.2: MmCCT-interactors in E. coli determined using tagging approach 
Note1 : Highlighted cells represent four groups of GroEL clients as described by Kerner et al. and Fujiwara et al. Blue – Group I ; 
Red – Group II; Green – Group III- and Purple – Group IV.   
Note2: Abundance by the emPAI scores for 1100 E. coli proteins by Ishihama et. al. 2008 (A1 belongs to first 20% of abundant 
proteins, A2 belongs to next 20% and so on).  
 No Accession 
No. 
Description Gene 
name 
Score Coverage # 
AAs 
MW 
[kDa] 
calc. 
pI 
Essen
tiality 
Abund
ance 
1 MmCCT_tag Mmcct_tag  345.3 67.11 599 64.2 5.97   
2 MmCCT WILDTYPE_Mmcct  341.9 73.85 543 58.2 5.06   
3 253775633 F0F1 ATP synthase subunit beta   atpB 35.23 21.74 460 50.3 5.01  A2 
4 253775592 Transcription termination factor Rho   rho 34.04 22.91 419 47.0 7.25   
5 253774547 Efflux transporter RND family, MFP subunit  (Multidrug 
efflux transporter) 
acrA 16.73 12.59 397 42.2 7.99   
6 253774856 Dihydrolipoamide dehydrogenase   lpD 16.61 11.81 474 50.7 6.15   
7 253772597 Exodeoxyribonuclease VII large subunit   xseA 15.46 11.84 456 51.8 9.98   
8 253775631 F0F1 ATP synthase subunit alpha   atpA 15.02 12.67 513 55.2 6.13  A2 
9 253772127 Outer membrane channel protein   tolC 13.96 6.69 493 53.7 5.66   
10 253774875 Cell division protein ftsz   ftsZ 12.51 13.58 383 40.3 4.78 E A3 
11 253774876 Cell division protein ftsa   ftsA 11.9 8.33 420 45.3 6.24 E  
12 253772794 NADH dehydrogenase I subunit F   nuof 10.52 10.56 445 49.3 6.86  A4 
13 253774042 Outer membrane protein F   ompF 9.64 6.63 362 39.3 4.96  A3 
14 253774355 (dimethylallyl)adenosine trna methylthiotransferase   miaB 8.68 5.91 474 53.6 5.34   
15 253775430 ATP-dependent protease ATP-binding subunit hslu   hslU 7.63 8.35 443 49.6 5.35  A3 
16 253775201 Ftsh protease regulator hflk   hflK 6.16 6.44 419 45.5 6.43  A5 
17 253773284 Glutamate dehydrogenase   gdhA 6.08 8.05 447 48.6 6.4  A5 
18 253774310 Type II citrate synthase   gltA 6 5.15 427 48.0 6.68  A2 
19 253771741 Glucose-1-phosphate adenylyltransferase   glgC 5.75 4.64 431 48.7 6.14   
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20 253773266 Glyceraldehyde-3-phosphate dehydrogenase   gapA 5.33 7.85 331 35.5 7.11 E A1 
21 253772553 Serine hydroxymethyltransferase   glyA 5.05 4.32 417 45.3 6.48 E A1 
22 253774981 DNA repair protein rada   radA 5.01 6.96 460 49.4 7.24   
23 253775140 Peptidase pmba   pmbA 4.7 4.89 450 48.3 5.6  A5 
24 
25 
26 
253775449 
253773798 
253774289 
Two-component sensor protein   
Gtp-dependent nucleic acid-binding protein engd   
Translocation protein tolb   
cpxA 
ychF 
tolB 
4.49 
3.96 
3.95 
3.94 
6.61 
3.26 
457 
363 
430 
51.6 
39.6 
45.9 
  
27 253773411 Electron transport complex protein rnfg   rnxG 3.93 5.83 206 21.9 7.53   
28 253773420 Adenosine deaminase   add 3.73 3.3 333 36.4 5.6  A5 
29 253774575 Trigger factor   tig 3.72 5.09 432 48.2 4.88  A1 
30 253773263 Mlta-interacting mipa family protein   mipA 3.68 5.24 248 27.8 5.85  A4 
31 253774279 Lac repressor   lacI 3.48 5.51 363 38.9 6.89   
32 253775352 Aspartate kinase III   lysC 3.47 2.67 449 48.5 5.11  A5 
33 253773868 FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase   
ndh 3.24 3.23 434 47.3 8.85   
34 253772448 Alanyl-trna synthetase   alaS 3.23 1.37 876 96.0 5.92 E A2 
35 253772354 Hypothetical protein ECBD_0934   ygdH 3.15 2.42 454 50.9 6.48  A5 
36 253772574 Cysteine desulfurase   iscS 3.06 2.97 404 45.1 6.37 E A2 
37 253774964 Threonine synthase   thrC 3.04 3.04 428 47.1 5.4  A3 
38 253771552 L-lactate dehydrogenase   lldD 2.98 2.78 396 42.7 6.81   
39 253774804 30S ribosomal protein S2   rpsB 2.88 6.64 241 26.7 7.14  A1 
40 253775469 Formate dehydrogenase subunit beta   fdnH 2.87 4.33 300 33.1 5.33  A5 
41 253772392 Sulfate adenylyltransferase subunit 2   cysD 2.83 3.64 302 35.2 8.02   
42 253773044 Lipopolysaccharide biosynthesis protein   wzzE 2.81 3.37 326 36.3 5.34   
43 253773768 Hypothetical protein ECBD_2388   rssA 2.78 3.5 314 34.3 6.73   
44 253771825 FKBP-type peptidyl-prolyl cis-trans isomerase   slyD 2.76 4.59 196 20.8 5.05 E A1 
45 253772976 D-tagatose-bisphosphate aldolase, class II, non-
catalytic subunit   
gatZ 2.72 2.62 420 47.0 5.78  A3 
46 253774769 Hypothetical protein ECBD_3415   yafD 2.67 5.02 259 29.1 9.41   
47 253775630 F0F1 ATP synthase subunit delta   atpH 2.66 6.21 177 19.3 5.02  A2 
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48 253773850 Putrescine/spermidine ABC transporter atpase protein   potA 2.65 3.17 378 43.0 5.3  A5 
49 
50 
51 
253772462 
253774993 
253775034 
Glycine betaine transporter ATP-binding subunit   
Patatin (predicted esterase) 
5-methylcytosine-specific restriction enzyme subunit 
mcrb   
proV 
yjjU 
mcrB 
2.6 
2.52 
2.51 
2.75 
3.08 
2.15 
400 
357 
465 
44.1 
39.8 
53.7 
5.57 
8.48 
5.86 
 A3 
52 253772387 Phosphoadenosine phosphosulfate reductase   cysH 2.48 4.1 244 28.0 5.91   
53 253773947 Outer membrane N-deacetylase   pgaB 2.46 1.19 672 77.4 6.19   
54 253775242 Lysyl-trna synthetase   lysS 2.45 2.18 505 57.8 5.24  A5 
55 253774573 ATP-dependent protease ATP-binding subunit clpx   clpX 2.43 2.12 424 46.3 5.35  A4 
56 253774088 ATP-dependent Clp protease ATP-binding subunit   clpA 2.43 1.32 758 84.2 6.32  A5 
57 253772822 Undecaprenyl phosphate 4-deoxy-4-formamido-L-
arabinose transferase   
arnC 2.38 3.73 322 36.3 7.3   
58 253772446 Recombinase A   recA 2.32 3.12 353 37.9 5.19  A4 
59 253772053 Hypothetical protein ECBD_0630  
 (Predicted role as  L-cysteine desulfidase ) 
yhaM 2.3 2.06 436 45.3 5.53   
60 253774829 Poly(A) polymerase I   pcnB 2.29 4.03 472 54.6 9.66  A5 
61 253774775 DL-methionine transporter substrate-binding subunit   metQ 2.24 4.06 271 29.4 5.29  A3 
62 253773882 3-oxoacyl-(acyl carrier protein) synthase II   fabF 2.19 3.39 413 43.0 6.09  A2 
63 253775603 Branched-chain amino acid aminotransferase   ilvE 2.19 3.56 309 34.1 5.82  A4 
64 253775229 Chaperonin GroEL   groL 2.17 1.82 548 57.3 4.94 E A1 
65 253772304 Sugar transporter   araE 2.08 1.91 472 51.7 9.26  A3 
66 253772112 Bifunctional heptose 7-phosphate kinase/heptose 1-
phosphate adenyltransferase   
rfaE 2.07 2.52 477 51.0 5.41  A5 
67 253772329 N-acetylmuramoyl-L-alanine amidase   amiA 2.06 2.64 417 45.6 9.58   
68 253772791 NADH dehydrogenase subunit B   nuoB 1.98 3.18 220 25.0 5.74  A3 
69 253775399 Soluble pyridine nucleotide transhydrogenase   sthA 1.91 1.72 466 51.5 6.57  A5 
70 253772496 Signal recognition particle protein   ffh 1.89 2.21 453 49.8 9.51 E A5 
71 253773042 6-phosphogluconate dehydrogenase   gnd 1.89 1.92 468 51.5 5.07  A1 
72 253773003 Deoxycytidine triphosphate deaminase   dcd 1.89 4.66 193 21.2 5.91  A5 
73 253775198 Adenylosuccinate synthetase   purA 1.8 1.85 432 47.3 5.49  A1 
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74 253773813 D-amino acid dehydrogenase small subunit   dadA 0 3.01 432 47.6 6.62 E  
75 
76 
253774382 
253774880 
D-alanyl-D-alanine carboxypeptidase fraction A   
N- acetylglucosaminyltransferase  murg 
dacA 
murG 
0 
0 
2.73 
2.25 
403 
355 
44.4 
37.8 
8.28 
9.73 
E A4 
A5 
77 253771935 Malate dehydrogenase   mdh 0 2.24 312 32.3 5.77  A2 
78 253773756 Oligopeptide transporter ATP-binding component   oppD 0 4.45 337 37.1 6.1 E  
79 253771537 ADP-heptose:LPS heptosyl transferase I   rfaC 0 3.68 326 36.2 8.79 E  
80 253771835 Elongation factor Tu   tuf 31.38 32.49 394 43.3 5.45  A1 
81 253772760 Acetyl-coa carboxylase subunit beta   accD 11.01 12.5 304 33.3 7.68  A3 
82 253774014 Outer membrane protein A   ompA 10.76 13.58 346 37.2 6.42  A1 
83 253773728 Transcriptional regulator cysb   cysB 10.01 12.35 324 36.1 7.42  A5 
84 253772660 Ethanolamine ammonia-lyase   eutB 9.95 9.27 453 49.4 4.93  A5 
85 253771881 DNA-directed RNA polymerase subunit alpha   rpoA 8.41 10.33 329 36.5 5.06  A1 
86 253774788 Acetyl-coa carboxylase carboxyltransferase subunit 
alpha   
accA 6.09 8.46 319 35.3 6.04 E A3 
87 253771920 Rod shape-determining protein mreb   mreB 5.48 7.2 347 36.9 5.26 E A2 
88 253774954 Chaperone protein dnaj   dnaJ 3.09 3.19 376 41.0 7.66  A3 
89 253771856 50S ribosomal protein L3   rplC 2.82 4.78 209 22.2 9.91 E A1 
90 253774102 NAD-dependent epimerase/dehydratase   ybjS 2.72 2.87 349 39.6 8.63 E  
91 253771862 30S ribosomal protein S3   rpsC 2.72 5.15 233 26.0 10.2  A1 
92 253771859 50S ribosomal protein L2   rplB 2.59 4.03 273 29.8 10.9 E A1 
93 253772512 Protein disaggregation chaperone   clpB 2.52 1.4 857 95.5 5.52  A2 
94 253771880 30S ribosomal protein S4   rpsE 2.5 5.34 206 23.5 10 E A1 
95 253775387 50S ribosomal protein L1   rplA 2.26 5.56 234 24.7 9.64  A1 
96 253774410 Alkyl hydroperoxide reductase subunit C   ahpC 2.04 7.49 187 20.7 5.17  A1 
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Table 5.3: Distribution of GroEL-clients among the potential MmCCT interactors 
Total MmCCT clients 
detected 
120 
Total GroEL client 
proteins out of 120 
30 Abundant? 
(Ishihama et. al.) 
Essential? Overlap with 
control? 
Group 1 7 First 25% 1 -  1 ompA 
25%-50% 3 2 gapA 
glyA 
-  
50%-75% 0 -  1 ahpC 
75%-end 3 -  -  
Group 2 10 First 25% 5 -  1 rpoA 
25%-50% 4 2 accA, 
mreB 
2 accA, 
mreB 
50%-75% 1 -  -  
75%-end 0 -  -  
Group 3 3 First 25% 0 -  -  
25%-50% 1 -  1 dnaJ 
50%-75% 2 -  -  
75%-end 0 -  -  
Group 4 10 First 25% 1 -  1 eutB 
25%-50% 5 -  -  
50%-75% 2 2 ybjS, 
fabF 
1 ybjS 
75%-end 2 1 dadA -  
Essential proteins 23/120 
Total essential proteins 
amongst 30 GroEL 
clients 
7/30 
Note: ybjS, FabF, dadA not described essential by Fujiwara et al. but by Kerner et al. 
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5.3 Preliminary investigation of MmCCT client-binding site 
5.3.1 Background 
Notable structural, biophysical and mutagenic studies have converged to identify the 
patch of hydrophobic residues in helices H and I of the GroEL apical domain as the client 
binding region in Group 1 chaperonins (Fenton et al., 1994; Buckle et al., 1997; Chen and 
Sigler, 1999; Tanaka and Fersht, 1999).  And accordingly, a number of studies have 
recognized GroEL-client interactions to be primarily hydrophobic in nature (Hayer-Hartl 
et al., 1994; Lin et al., 1995; Wang and Boisvert, 2003; Chaudhuri and Gupta, 2005; Li et 
al., 2009).   
For Group 2 chaperonins however, the client binding site has not been explicitly defined 
and has remained a point of debate.  Electron microscopic studies of actin and tubulin 
bound to TRiC chaperonin have identified subunit-specific binding of these clients that 
occur mainly via polar and electrostatic interactions (Llorca et al., 1999; Llorca et al., 
2000; Llorca et al., 2001).  These observations were supported by biochemical and 
mutagenic studies that recognized polar surface regions on actin and tubulin to be 
involved in binding to CCT (Hynes and Willison, 2000; Ritco-Vonsovici and Willison, 
2000; McCormack et al., 2001).  Indeed the solved crystal structure of mouse CCTγ 
apical domain and corresponding phylogenetic analysis confirmed these results and the 
study further proposed a conserved patch of polar and charged residues facing the 
inside of the cavity, as the potential site for client recognition and interaction for TRiC 
(Pappenberger et al., 2002; Gomez-Puertas et al., 2004).  The recently solved crystal 
structure of yeast CCT have further suggested these ‘signature’ residues that are 
distributed differently in all eight subunits to be potentially involved in client-binding 
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(Dekker et al., 2011a).  However, mutational analysis of these potential client binding 
residues was shown to have no effect on binding of TRiC to its obligate client, von 
Hippel-Lindau (VHL) tumor suppressor protein (Feldman et al., 2003; Spiess et al., 
2006).  Instead, based on further mutational and cryo-EM reconstruction studies, 
hydrophobic residues in helices 10 and 11 were proposed to be involved in VHL-binding 
to TRiC (Spiess et al., 2006).  These observations are consistent with several other 
findings such as genetic screens where deletion of hydrophobic sequences in actin was 
shown to disturb its interaction with CCT (Rommelaere et al., 1999), proteolytic analysis 
that recognized hydrophobic-rich interdomain segment in tubulin as the TRiC-
interaction site (Dobrzynski et al., 1996) and stability studies where for example TRiC 
has been shown to preferentially recognize hydrophobic β-strands and stabilize 
reconstituted WD-40 proteins (Kubota et al., 2006).  While a clear consensus remains to 
be established, all these studies suggest a non-generalized and subunit-specific 
mechanism of client interaction for eukaryotic chaperonins.   
For archaeal chaperonins on the other hand, previously, solved X-ray structures of 
archaeal chaperonins combined with the electron microscopy and NMR studies 
suggested two patches of hydrophobic residues, one occluding the cleft of the helical 
protrusion region and other at the base of the apical domain in a region corresponding 
to Group 1 client binding site, to be involved in client binding (Klumpp et al., 1997; 
Schoehn et al., 2000b; Heller et al., 2004).  However, the helical protrusion region was 
found to be dispensable for client binding (Iizuka et al., 2004; Reissmann et al., 2007).  
Albeit, detailed client binding studies to determine the nature of interactions have not 
been done for archaeal chaperonins so far, it has been shown that the ability of S. 
solfataricus chaperonin to prevent aggregation of clients, lysozyme and yeast α-
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glucosidase, is largely governed by hydrophobic interactions (Guagliardi et al., 1995).  
Evidently, on the basis of the recently solved crystal structure of M. maripaludis 
chaperonin (MmCCT) in an open conformation, an interface between helices 10 and 11 
consisting of 9 hydrophobic residues has been put forward as the potential client 
binding site (Pereira et al., 2010) (Figure 5.13).  However precise genetic or mutational 
studies to complement these structural propositions have not yet been done.  
The experimental system described in Chapter 3 provided an in vivo platform to 
examine properties of archaeal chaperonins such as analysis of client binding region in 
this case.  The system allows genetic dissection of the archaeal chaperonin MmCCT and 
the resulting changes can be studied on the basis of growth of bacterial cells.  Also of 
interesting note is that the results would be produced from the totality of the cell 
including at least all possible essential clients rather than a specific case.    
Thus an attempt has been made to provide a genetic basis to the proposed client binding 
site for MmCCT (Pereira et al., 2010) by mutating the residues and studying the effects 
of the resultant mutants on the growth of E. coli in absence of GroEL and GroES.  To 
further substantiate the results, a preliminary experiment has been initiated where the 
mutants with limited ability to restore GroEL function, presumably because of restricted 
client binding function are further subjected to calmodulin-pull down analysis to test 
whether or not (and if yes, to what extent) proteins isolate with the potential client-site 
mutants.  
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Figure 5.10 
Proposed client binding region by Pereira et al., 2010 
The potential client binding site for MmCCT is shown as a red patch in the apical domain of 
MmCCT monomer on the left diagram. On the right are shown the nine hydrophobic 
residues proposed to be involved in client binding.  
Note: Picture taken from Pereira et al., 2010. 
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5.3.2 Results 
5.3.2.1 Selection of residues for mutagenesis 
The 9 hydrophobic residues i.e. L269, V273, A274, I276, L293, A294, Y297, L298, I303 
encompassing the potential client binding site for MmCCT (Pereira et al., 2010) are 
highly conserved across all archaeal chaperonins (Figure 5.11A and B).  Out of these, 
V273, A274, L293 and Y297 residues are solvent-exposed and have been proposed to 
support direct interactions with the clients (Pereira et al., 2010).  Thus for this analysis 
two residues, V273 from helix 10 and Y297 from helix 11, on the basis of their 
particularly high conservation among the archaeal chaperonins were selected for 
mutagenesis (Figure 5.11 and 5.12).   
5.3.2.2 Mutagenesis of residues V273 and Y297 
Site-directed mutagenesis using two sets of primers that contain randomised bases at 
the positions corresponding to V273 and Y297 respectively was employed to generate a 
series of point mutants with different substitutions at V273 and Y297 (method as 
described in section 3.2.3, Chapter 3).  The pET21 plasmid containing Mmcct gene that 
already bears the K216E mutation was used as a template for these experiments.  
Because MmCCT-K216E, as compared to the wildtype, is more efficient in rescuing the 
growth of the strain TAB21 in GroEL and GroES depleting conditions, it was speculated 
that a clearer comparative phenotypic analysis of the mutants would result with the 
additional K216E background mutation.  As a consequence a more robust system is 
generated that allows better resolution of growth-based results of the potential client-
site mutants.  The mutagenesis experiments yielded a library of following mutants: 
MmCCT-V273A, D, E, G, I, N, S, T, W, Y and MmCCT-Y297A, C, E, F, G, N, R, S, T and W.  
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. . . . . . . . 265 . . . . . . . . . 275 . . . . . . . . . 285 . . . . . . . . . 295 . . . . . . . . . 305 
A.fulgidus.b K L Q K F I E Q E E A M L K E M V D K I V N A G A N V V F C Q K G I D D L A Q Y Y L A K A G V L A V 
T.acidophilum.b M I Q K F L A Q E E N M L R E M V D K I K S V G A N V V I T Q K G I D D M A Q H Y L S R A G I Y A V 
T.volcanium2 M I Q K F L A Q E E N M L R E M V E K I K S V G A N V V I T Q K G I D D M A Q H Y L S K E G I Y A V 
A.profundus1 M L Q K F I E Q E E K M I K E M V D R I V Q A G A N V V F C Q K G I D D L A Q Y Y L A K A G I L A V 
T.gammatolerans Q L Q A F L E Q E E R M L K E M V D K I K E V G A N V V F V Q K G I D D L A Q H Y L A K Y G I M A V 
T.gammatolerans Q L F D F I E Q E E K M L K E M V E A I A K T G A N V V F V Q K G I D D L A Q H Y L A K Y G I M A V 
P.abyssi Q L Q A F L E Q E E K M L K E M V D K I K E V G A N V V F V Q K G I D D L A Q H Y L A K Y G I L A V 
M.mazei.gamma Q M Q L F L D Q E E A M L R E I V D K V I D T G A N V V F C Q K G I D D L A Q Y Y L T K A G I F A M 
D.kamchatkensi. L I K A F L D K E A E M L K E M V D K I A S V G A N V V V C Q K G I D E V A Q H F L A K K G I L A V 
A.pernix.alpha K L E S F L E E E T R M L R D M V E K I A A T G A N V V I T Q K G I D E V A Q H F L A K K G I L A V 
A.fulgidus.a Q L M K F I E Q E E K M L K E M V D R L A E A G A N V V F C Q K G I D D L A Q Y Y L A K A G I L A V 
A.profundus2 M L Q K F I E Q E E K M I K E M V D R I V Q A G A K V V F C Q K G I D D L A Q Y Y L A K A G V L A V 
M.burtonii Q L Q S F L D Q E E S M L K S L V T S I T K T G A N V V F C Q K G I D D M A Q H Y L A K E G I F A V 
T.acidophilum.a K I Q D F L N Q E T N T F K Q M V E K I K K S G A N V V L C Q K G I D D V A Q H Y L A K E G I Y A V 
T.volcanium1 K I Q D F L N Q E T S T F K E M V E K I K K S G A N V V L C Q K G I D D V A Q H Y L A K E G I Y A V 
M.hungatei Q L Q A F L D E E E R M I K S I T D K I I K S G A K V L F C Q K G I D D I A Q H Y L A K A G I L A V 
M.palustris Q L Q S F L D E E E R M I R T I V E K I I A S G A N V L F C Q K G I D D I A Q H Y L A K A K I F G V 
M.mazei.alpha Q L Q S F L D Q E E Q M L K K I V Q K V I N S G A N V V F C Q K G V E D L A Q H Y L A K A G I F A V 
N.pharaonis.bet Q L Q E F I D K E E E Q L R E K V D A I A A T G A D V V F C Q R G I D D L A E H F L A K E G I I A A 
H.lacusprofundi Q L Q R F L D Q E E E Q L R D K V D K I V E S G A D V V F C Q K G I D D L A Q H Y L A K E G I L A V 
N.pharaonis.alp Q L E Q F L E Q E E K Q L R E M V D Q L A D A G A D V V F C Q K G I D D M A Q H Y L A Q E G I L A V 
H.lacusprofundi Q L Q Q F L D Q E E E Q L R E M V D H L V D I G A D V V F V G D G I D D M A Q H Y L A Q E G I L A V 
H.utahensis K L Q E F L D Q E E A Q L Q E M V D Q L A D V G A D A V F C Q K G I D D M A Q H Y L A Q E G I L A V 
S.solfataricus. Q I K A F L D E E S K Y L K D M V D K L A S I G A N V V I C Q K G I D D I A Q H F L A K K G I L A V 
S.acidocaldariu Q I K S F L D E E A R Y L K E M V D K L A S I G A N V V I C Q K G I D D V A Q H F L A K K G I L A V 
S.tokodaii.alph Q I K A F L D E E A K Y L K D M V D K L A S I G A N V V I C Q K G I D D V A Q H F L A K K G I L A V 
M.jannaschii K L M E F I E Q E E K M I K D M V E K I A A T G A N V V F C Q K G I D D L A Q H Y L A K K G I L A V 
M.vulcanius K L M E F I E Q E E K M I K D M V E K I A S T G A N V V F C Q K G I D D L A Q H Y L A K K G I L A V 
M.fervens K L M E F I E Q E E K M I K D M V E K I A A T G A N V V F C Q K G I D D L A Q H Y L A K K G I L A V 
M.vannielii K L M E F I E Q E E K M L K D M V N E I K A S G A N V V F C Q K G I D D L A Q H F L A K E G I V A A 
M.thermautotrop Q M Q A F I E Q E E Q M I R D M V N S I V D T G A N V L F C Q K G I D D L A Q H Y L A K A G V L A V 
A.pernix.beta Q I K A L Y E K Q E R I L Q E K I E K I A A T G A N V V I T Q K G I D D V A Q H F L A K K G I L A V 
D.kamchatkensi. Q L E K F L Q Q E E D I L V K M V D K I A S V G A N V V V C Q K G I D E V A Q H F L A K K G I L A V 
S.solfataricus. Q M H K F L E E E E N I L K E K V D K I A A T G A N V V I C Q K G I D E V A Q H Y L A K K G I L A V 
S.acidocaldariu Q M K K F L D E E E N I L K E K V D K I A Q T G A N V V I C Q K G I D E V A Q H Y L A K K G I L A V 
S.tokodaii.beta Q M K K F L E E E E N L L K E K V D K I A A T G A N V V I C Q K G I D E V A Q H Y L A K K G I L A V 
M.thermautotrop Q M Q A F I E Q E E Q M I R D M V E K I K S S G A N V V F C Q K G I D D L A L H Y L S R E G I M A L 
M.barkeri D L E D F V K Q E E E A L F E M A D Y I I R A G A N A V F C S K G M D D K I A A Y L Q N R G I Y A T 
M.mazei.beta. D I E N F V K Q E D A A L F E M A D Y I I R A G A N A V F C S K G M D D K V A A Y L Q N R G I Y A T 
M.aeolicus K M M E F I E Q E E K M L K D M V E E I K A S G A N V L V C Q K G I D D L A Q H Y L A K A G I L A I 
M.maripaludis K L M E F I E Q E E K M L K D M V A E I K A S G A N V L F C Q K G I D D L A Q H Y L A K E G I V A A 
S.solfataricus. Q I K G Y L D E Q T A Y V K Q M V D K I K A M G V K L F I T Q K D I D E I A S Y L M G K N G I M A L 
S.acidocaldariu Q I K L A L E E Q A K Y I R S M I D T L E K I G A K V V I T Q K G M D D I A L H F L A K K G I M G I 
Consistency 6 8 6 4 9 8 6 8 9 7 5 6 8 7 7 7 9 7 6 9 5 5 5 * 9 8 9 8 7 7 9 9 9 9 9 8 7 9 8 8 8 9 8 8 5 9 9 6 9 8 
 
Figure 5.11A 
Conservation of proposed client binding residues across 20 archaeal species 
The arrows indicate the residues of the potential client binding region as suggested by 
Pereira et al., 2010.  Conservation scoring is performed by PRALINE (Simossis and Heringa, 
2005).  The scoring scheme works from 0 for the least conserved alignment position, up to 
10 for the most conserved alignment position. The colour assignments are:  
Unconserved  Conserved 
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Figure 5.14B 
Conservation of proposed client binding residues across 20 archaeal species 
The arrows indicate the residues of the potential client binding region as suggested by 
Pereira et al., 2010.  The sequence logos were generated by WebLogo server.  The size of the 
amino acid letter in the sequence logo indicates the degree of conservation on a logarithmic 
scale.  The colour assignements are: blue - hydrophilic amino acids (RKDENQ), green - 
neutral aminoacids (SGHTAP) and black - hydrophobic amino acids (YVMCLFIW). 
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Figure 5.12 
Location of residues V273 and Y297 on MmCCT 
The figure shows MmCCT subunit highlighting residues V273 and Y297 in yellow and red 
respectively.  The subunits were coloured in PYMOL from structures obtained from Protein 
Data Bank (PDB ID: 3KFK) submitted by Pereira et al., 2010.  K216 residue is highlighted in 
green. 
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5.3.2.3 GroEL-complementing ability of the potential client-site mutants 
The obtained mutants were first checked for their correct expression and assembly in E. 
coli TAB21 strain by SDS-PAGE and native-PAGE analysis respectively.  Figure 5.13 
shows the expression and assembly of five of these mutants (MmCCT-K216E-V273A, D, 
L, S and W), and essentially represents the results obtained for rest of the tested 
mutants, the observations for which are recorded in Table 5.4.  
All the mutants were then subjected to complementation analysis in TAB21.  Out of the 
ten MmCCT-K216E-V273n point mutants, the proteins with mutations - V273A and 
V273I preserved the improved GroEL-complementing ability of MmCCT-K216E (Figure 
5.14 and Table 5.4).  Indeed, from a function-conservation point of view these are among 
the most preferred amino acid substitutions mostly due to the similarity in their amino 
acid properties (Betts and Russell, 2003).  Along the same lines thus, MmCCT-K216E-
Y297F and MmCCT-K216E-Y297W out of the ten Y297 point mutants were found to be 
able to restore the characteristic improved phenotype (Figure 5.15 and Table 5.4).  The 
amino acids phenylalanine and tryptophan share similar properties with tyrosine such 
as having aromatic side-chains, partial hydrophobicity etc., and hence the corresponding 
substitutions are less likely to alter the chaperonin function.  Indeed, a constitutive 
replacement of tyrosine to phenylalanine at the position equivalent to Y297 is observed 
in several archaeal species (Figure 5.11).   
On the other hand, substituting V273 or Y297 to relatively distinct hydrophilic residues 
(D, E, N or R) or neutral residues (S and G) resulted in a significantly weaker phenotype 
of the cells (Figure 5.14 and 5.15, Table 5.4).  This combined with the earlier 
observations indicated a requirement of hydrophobic residues at the positions V273 and 
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Y297 in MmCCT.  Intriguingly however, substitutions of V273 to hydrophobic but 
aromatic residues like tryptophan and tyrosine severely affected the phenotype of the 
cells and conversely, the same effect was observed when Y297 was replaced by aliphatic 
residues like alanine and cysteine (Figure 5.14 and 5.15, Table 5.4).  Such results 
probably suggest that in addition to a certain degree of hydrophobicity, other factors 
such as presence or absence of an aromatic ring, reactivity and conformational flexibility 
of side-chains among others, may also contribute to the functional significance of V273 
and Y297 residues.  Such an implication is further supported by the threonine mutants 
of V273 and Y297 that in contrast to other polar or neutral substitutions (like to serine 
or glycine) improved the phenotype (Figure 5.14 and 5.15).  This observation 
particularly holds for the V273T mutants as the cells expressing MmCCT-K216E-V273T 
showed no apparent difference in growth pattern when compared to corresponding 
MmCCT-K216E control (Figure 5.14).   
In sum, the results established that substituting V273 and Y297 to dissimilar residues 
has a rather negative effect on MmCCT function in E. coli.  The next obvious question 
hence was to ask whether V273 or Y297-mutants actually impede client recognition or 
binding.  We hypothesized that if the reduced function of such mutants was because of a 
perturbed client-binding ability, there should be a decline (or absence) in the number of 
proteins that interact with them.  As a preliminary experiment thus, two of the potential 
client-site mutants were subjected to calmodulin based pull down assays to test the 
effects on the interacting proteins that in absence of the client-site mutations should 
isolate with MmCCT.  
220 
 
 
 
Figure 5.13 
Expression and assembly of potential client-site mutants in TAB21 
A) Crude extracts of TAB21 cells expressing 5 different MmCCT-K216E-V273n mutants 
namely V273A (1), V273D (2), V273L (3), V273S (4) and V273W (5) under pET21 vector along 
with controls pET21 empty vector (C1) and pET21-Mmcct-K216E (C2) as analysed by 10% 
SDS-PAGE. 
B) Soluble fractions of the above samples as analyzed by 3-10% gradient native-PAGE. 
The control C3 represents purified GroEL protein.   
Both the gels are stained by Coomassie staining. The arrows indicate the position of the 
MmCCT bands. 
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Figure 5.14 
Solid medium growth analysis of MmCCT-K216E-V273n mutants in TAB21 at 30⁰C under 
GroEL depleting conditions 
Dilutions (10-1 to 10-7) of TAB21 cells expressing the MmCCT mutant proteins as indicated, 
grown on agar plates containing 0.2% glucose and 1 mM IPTG at 30⁰C for five days. 
Work done by undergraduate students: Kiren Bains, Wingyun Cheung, Kate Wilkinson 
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Figure 5.15 
Solid medium growth analysis of MmCCT-K216E-Y297n mutants in TAB21 at 30⁰C under 
GroEL depleting conditions 
Dilutions (10-1 to 10-7) of TAB21 cells expressing the MmCCT mutant proteins as indicated, 
grown on agar plates containing 0.2% glucose and 1 mM IPTG at 30⁰C for five days. 
Work done by undergraduate students: Lynette Jude, Wingyun Cheung, Kate Wilkinson 
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Table 5.4: In vivo functional analysis of V273 and Y297 mutants in E. coli 
 
Note: 
1. All mutants have a background K216E mutation. 
2. Colour assignments are based the increasing hydrophobicity index of the substituted amino acids (Monera et al., 1995):  
Blue – hydrophilic substitutions, green – neutral substitutions, black – hydrophobic substitutions 
3. Symbol assignments:  
+++ Growth similar to MmCCT-K216E mutant    
++ Growth similar to MmCCT-WT  
+  Growth poorer than MmCCT-WT    
Substitutions at V273 Substitutions at Y297 
Mutation in 
MmCCT 
Expression Assembly 
Complementation 
(30⁰C) 
Mutation in 
MmCCT 
Expression Assembly 
Complementation 
(30⁰C)  
V273D Yes Yes + Y297E Yes Yes ++ 
V273E Yes Yes + Y297N Yes Yes ++ 
V273N Yes Yes + Y297R Yes Not checked + 
V273S Yes Yes ++ Y296S Yes Yes + 
V273G Yes Not checked + Y297G Yes Not checked + 
V273T Yes Yes +++ Y297T Yes Yes ++ 
V273A Yes Yes +++ Y297A Yes Yes + 
V273I Yes Yes +++ Y297C Yes Not checked + 
V273W Yes Yes + Y297F Yes Yes +++ 
V273Y Yes Not checked + Y297W Yes Yes +++ 
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5.3.2.4 Pull-down assays of potential client site mutants  
The mutants MmCCT-K216E-V273W and MmCCT-K216E-Y296A were selected for the 
calmodulin based pull down analysis on account of two reasons: 1) The cells expressing 
these mutants showed a severely impaired phenotype and 2) The results obtained from 
these substitutions could highlight the importance of properties such as aliphaticity or 
aromaticity at V273 and Y297 respectively, in addition to their hydrophobic character.  
As the mutant proteins were not tagged, the experiments were conducted by co-
transforming the TAB21 cells with pET21 vector containing the mutated Mmcct genes 
and pACYC184 containing tagged Mmcct-wt.  Because the number of tagged subunits per 
a stable oligomeric complex was calculated to be less than five at any given time (Figure 
5.9), it was anticipated that any resultant effect on bound proteins would be because of 
the client binding mutations.    
Figure 5.16 shows the eluates from these pull-down experiments as analysed by SDS-
PAGE and silver staining.  Differences in the profiles of the proteins which co-elute with 
MmCCT can be seen between the wildtype and K216E controls (lanes 3, 5) and the 
potential client site mutants (lanes 4, 5).  However the resolution of the gel is not 
sufficiently clear to determine whether this difference is significant and it is clear that 
many proteins still co-elute with the versions of MmCCT which carry the potential client 
binding site mutants.  Additional experiments are needed to determine whether or not 
the apparent difference is significant, which if so would support the identification of the 
client binding site.  It should be noted that the complexes in this experiment will be a 
mix of wild-type and mutated sub-units, so an obvious early experiment would be to 
introduce the V273W and V297A mutations into the tagged sub-units.  
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Figure 5.16 
Calmodulin based pull down analysis of potential MmCCT client-site mutants  
The figure shows protein eluates from the pull-down analysis as analysed by 10% SDS-PAGE 
and silver staining.  
(1) TAB21/ pET21b + pACYC184 empty vectors  
(2) TAB21/ pET21-Mmcct-WT 
(3) TAB21/ pET21-Mmcct-WT+ pACYC184-Mmcct-WT-tag 
(4) TAB21/ pET21-Mmcct-M223I + pACYC184-Mmcct-WT-tag 
(5) TAB21/ pET21-Mmcct-K216E + pACYC184-Mmcct-WT-tag 
(6) TAB21/ pET21-Mmcct-K216E-V273W + pACYC184-Mmcct-WT-tag 
(7) TAB21/ pET21-Mmcct-K216E-Y297A + pACYC184-Mmcct-WT-tag 
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5.3.3 Discussion 
The client binding sites for Group 2 chaperonins have not been clearly defined despite 
the various structural propositions for both eukaryotic and archaeal chaperonins.  
However based on recently solved crystal structure of MmCCT in its open conformation, 
a pocket like structure formed by nine highly conserved hydrophobic residues at the 
interface of helices 10 and 11, which structurally correspond to client binding region 
between helices H and I of GroEL, has been put forward as the potential client binding 
site for MmCCT (Pereira et al., 2010).  Using the experimental system described in 
Chapter 3, we initiated a mutagenic analysis of two of these residues, V273 and Y297, 
and tested the effects of the resultant MmCCT-mutants on growth of E. coli TAB21 cells 
in GroEL depleting conditions. 
Our findings suggest that mutating residues V273 and Y297 indeed affects the 
chaperonin function of MmCCT as seen by altered GroEL-complementing capacity of 
most of the mutants.  The impaired cell growth due to hydrophilic and certain neutral 
substitutions probably highlights the importance of hydrophobicity at V273 and Y297 
positions.  However, severe growth reduction due to aromatic-hydrophobic 
substitutions at V273 and in contrast, the enhanced growth effects due to a polar 
threonine-substitution indicates that the functional contribution of the residue V273 
might not be restricted solely to its hydrophobic property.  Similarly, the growth 
impairment observed due to hydrophobic-aliphatic amino acid substitutions at Y297 
more obviously suggests that in addition to hydrophobicity, the aromatic nature of this 
residue is possibly critical.  The equivalent Y301 residue in T. acidophilum has been 
shown to undergo severe positional changes with the movement of highly dyanamic 
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helical protrusion, suggesting that this residue probably due to its aromatic stacking 
interactions might also be playing a stabilizing role by causing compensatory changes in 
conformations of surrounding residues (Klumpp et al., 1997).  Moreover, improved 
growth because of polar theronine substitutions at both V273 and Y297 suggest that a 
certain degree of functional redundancy is allowed at these residues.  While it is possible 
that other hydrophobic residues might still permit the supposed hydrophobic client 
interactions, the overall results question to a certain extent the hypothesis that these 
residues govern client recognition and binding solely on the basis of their hydrophobic 
nature (Spiess et al., 2006; Pereira et al., 2010).   
It should be noted however that the experiments do not rule out any secondary effects 
that could arise due to additional mutations such as altered ATP hydrolysis activity, 
conformational restrictions, oligomeric stability among others.  Such changes, although 
unlikely to occur because of the mutations being in apical domain helices 10 and 11, 
could lead to a functional compromise or enhancement that in turn affects the growth of 
the cells.  While purification of the mutants and direct client binding assays (e.g. citrate 
synthase aggregation assay) will be required to establish whether or not these residues 
support client binding, we attempted a pull down assay as a preliminary step to test if 
proteins isolate with the potential client-site mutants.  The apparent decrease in the 
number of pulled-down proteins for the mutants MmCCT-V273W and MmCCT-Y297A as 
compared to the wildtype controls possibly indicate a negative effect on client binding.  
However the result cannot be ascertained because a significant amount of proteins still 
seem to co-elute with the mutants.  Because it was a heterologous expression 
experiment, it is possible that the proteins that isolate with the client-site mutants are 
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because of their supposedly unhampered binding to native valine or tyrosine present on 
the tagged subunits.  The next series of experiments thus with all tagged subunits 
containing mutations should more precisely answer this question.  This assay will not 
only show a direct demonstration of the clients that isolate or not with the mutants but 
also will be helpful in answering questions such as whether or not all subunits are 
involved in binding.  
Indeed a more detailed mutagenic analysis of all nine residues and in addition, of other 
polar and charged residues in archaeal chaperonins that for example coincide with the 
proposed client binding region of mouse CCTγ or yeast CCT (Pappenberger et al., 2002; 
Dekker et al., 2011a) or are found at the structurally equivalent positions of GroEL client 
site residues (Klumpp et al., 1997; Horwich et al., 2007), will be required to fully 
delineate the basis of client binding interactions in archaeal chaperonins.  Nonetheless, 
our findings clearly indicate an essential role of residues V273 and Y297 in MmCCT 
function.  
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CHAPTER 6 
Analysis of additional archaeal 
chaperonins for their ability to replace 
GroEL 
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6.1 Background 
It was established in Chapter 4 and Chapter 5 that the archaeal chaperonin from the 
species Methanococcus maripaludis, MmCCT, and its single point mutants MmCCT-M223I 
and MmCCT-K216E complemented for the loss of GroEL in E. coli at reduced 
temperatures (Chapter 3).  We next wished to ask whether this was a generalized case 
for all archaeal chaperonins or a specialized functioning confined only to MmCCT.  
Our initial hypothesis was that the archaeal chaperonins should not be able to 
complement for the loss of GroEL in E. coli owing to approximately 2.8 billion years of 
gap in their divergence (Battistuzzi et al., 2004) and the structural and mechanistic 
differences that prevail between the groups (Chapter 1).  However, the case of MmCCT 
clearly suggested that a functional overlap between the two groups is possible, more so 
by simple genetic manipulations.  It should be considered however that M. maripaludis is 
a mesophile with a growth optimum at 37⁰C (Jones et al., 1983), similar to E. coli.  Also, 
M. maripaludis contains only one copy of cct gene and hence the chaperonin MmCCT 
exhibits a GroEL like homologous subunit arrangement, with eight fold symmetry 
(Kusmierczyk and Martin, 2003b; Large and Lund, 2009).  Archaeal chaperonins from 
almost all other genera posses more than one chaperonin gene (Large and Lund, 2009).  
It is possible therefore that the ability of MmCCT to function in E. coli is because like 
GroEL, it is a homo-oligomeric complex and that the same might not hold true for other 
divergent archaeal chaperonins.  Indeed it has been speculated that the evolution of 
Group 1 and Group 2 chaperonins has occurred in parallel to the proteome evolution to 
attain client-specific mechanisms of working (Kubota et al., 1994; Archibald et al., 2001; 
Fares and Wolfe, 2003; Dekker et al., 2011b).   
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However note that there are stark differences between the evolutionary courses of 
eukaryotic and archaeal chaperonins.  In contrast to the eukaryotic chaperonin genes 
that have been shown to have diverged very early during the evolution of eukaryotes 
(Archibald et al., 2000; Archibald and Roger, 2002a; Fares and Wolfe, 2003), the gene 
duplication events of archaeal chaperonins are combined with recurrent gene 
conversions and gene loss within individual archaeal lineages.  Such observations 
suggest a role of neutral fixation in hetero-oligomerism of archaeal chaperonins over 
specific functionalization of the diverged subunits (Archibald et al., 1999; Archibald and 
Roger, 2002b; Ruano-Rubio and Fares, 2007).  Indeed while it has been shown that all 
eight subunits of eukaryotic chaperonins are essential in yeast (Stoldt et al., 1996), 
subunits of archaeal chaperonin H. volcanii have been found to be individually 
dispensable (Kapatai et al., 2006).   
Moreover, functional homo-oligomeric assembly of paralogs of several archaeal 
chaperonins have been successfully shown to occur in E. coli.  For example, expression of 
α-only and β-only chaperonins from T. acidophilum and Thermococcus strain KS-1 have 
been shown to form homo-oligomeric complexes in E. coli with optimal ATPase activities 
at particular temperatures that can effectively protect various proteins against thermal 
aggregation and also promote in vitro refolding (Waldmann et al., 1995b; Yoshida et al., 
1997; Hirai et al., 2008).  Similar observations have been also noted for α and γ subunits 
of M. mazei (Klunker et al., 2003) and the two subunits of A. pernix K1 (Lee et al., 2013).   
Although, there also have been certain cases like for the chaperonins of Sulfolobus sp. S7 
(Yoshida et al., 1998) and P. occultum (Minuth et al., 1998), where despite being 
assembled into functionally active homo-oligomers in E. coli, the chaperonin complexes 
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are thermally unstable.  Nonetheless, all the above examples suggest that the hetero-
oligomeric nature of archaeal chaperonins might not limit the cross-over of function 
between archaeal and bacterial chaperonins that has been demonstrated by MmCCT.  It 
was intriguing hence to find out whether or not other archaeal chaperonins could 
replicate the results obtained of MmCCT.   
Consequently, the aim of the project was to test the ability of chaperonins from distinct 
archaeal species to replace GroEL function in E. coli.  Taking into account the above 
discussed points, this part of the project had following objectives: 1) To select 
chaperonins from distinct archaeal species and test their GroEL-complementing ability 
in E. coli. 2) To construct M223I and K216E mutants of these archaeal chaperonins and 
test them for the same.   
The archaeal species to be tested were selected on the basis of one or more of the 
following criteria: 1) Genetic tractability 2) Previous successful examples of expression 
in E. coli and 3) Availability of the cloned chaperonin gene.  The chaperonins from 
following species were chosen for the experiments.  
Methanosarcina mazei:  M. mazei is an anaerobic mesophilic methanogen containing 
three different thermosome genes annotated as α, β, and γ.  The α and γ chaperonins 
have been shown to express and assemble independently in E. coli (Klunker et al., 2003).  
The peculiarity of this species is that it contains both Group 1 and Group 2 chaperonins; 
along with the three thermosome genes, a Group 1 chaperonin (Mma-groESL) gene 
probably acquired by lateral gene transfer is also found (Klunker et al., 2003; Figueiredo 
et al., 2004).  As discussed in Chapter 1 (section 1.2.4), in addition to an overlapping set 
of protein interactors, Mma-GroESL and the thermosomes have been shown to 
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exclusively associate to various archaeal proteins.  Also of interest was that a fraction of 
the sole thermosome interactors were of prokaryotic origin, out of which some were 
found to be homologues of GroEL clients, thought to be acquired by horizontal gene 
transfer (Hirtreiter et al., 2009).  It was interesting hence to test whether these 
thermosome proteins could complement for GroEL function. 
Thermoplasma acidophilum:  T. acidophilum is a thermoacidophile containing two 
thermosome genes α and β and as noted above, both the genes have been shown to 
express and assemble into functionally active homo-oligomers in E. coli with comparable 
biochemical properties as to the corresponding hetero-oligomers (Waldmann et al., 
1995b; Bigotti and Clarke, 2005; Hirai et al., 2008).  However in its native form, the 
oligomer shows a strict α-β repeat (Ditzel et al., 1998).  We chose to express both the 
subunits together in E. coli to test their GroEL-complementing ability.  
Haloferax volcanii:  This species is an extreme halophile and contains three chaperonin 
genes annotated as cct1, cct2 and cct3 (Kuo et al., 1997; Large et al., 2002).  Interestingly, 
all three cct genes have been shown to form homo-oligomeric complexes in H. volcanii 
and both cct1 and cct2 genes have been reported to be able to sustain growth of H. 
volcanii independently (Kapatai et al., 2006).  Because cct1 gene was shown to be more 
efficient in supporting growth than cct2, cct1 gene was chosen for analysis.   
All three species selected were from a different family than the Methanococcus and of a 
different nature i.e. a methanogen, a thermophile and a halophile.  Moreover, while 
single cct genes were individually tested for M. mazei and H. volcanii, both α and β cct 
genes were expressed together for T. acidophilum.  Such distinctive features were 
employed to facilitate generalization of the results to the archaeal Group 2 chaperonins.  
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The characteristics of the archaeal chaperonins chosen and their nomenclature used 
henceforth are given in Table 6.1.  The standard TAB21 expression system using pET 
vectors was employed for the analysis. 
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Table 6.1: The archaeal species chosen for GroEL-complementation analysis and 
their characteristics. 
Archaeal 
species 
Number of 
CCT 
subunits in 
native host  
Nomenclature  Subunits 
chosen for 
analysis 
Source and 
References 
Methanosarcina 
mazei 
Three 
(α, β, and γ) 
MmaCCT-α 
MmaCCT-β 
MmaCCT-γ 
MmaCCT-α 
and 
MmaCCT-γ  
(MmaCCT-
β unable to 
assemble 
in E. coli) 
F.U. Hartl group, 
Max Plank Institute, 
Germany. 
(Klunker et al., 
2003; Figueiredo et 
al., 2004) 
Haloferax 
volcanii 
Three 
(1, 2 and 3) 
HvCCT-1 
HvCCT-2 
HvCCT-3 
HvCCT-1 
 
Laboratory 
colleague 
(Kapatai et al., 2006; 
Large et al., 2007) 
Thermoplasma 
acidophilum 
Two 
(α and β) 
TaCCT_α 
TaCCT_β 
Both 
subunits in 
tandem as 
TaCCT_αβ 
A. R. Clarke group, 
University of Bristol. 
(Bigotti and Clarke, 
2005) 
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6.2 Results 
6.2.1 Cloning of chaperonin genes in a pET expression plasmid 
The constructs containing cct genes from M. mazei (Mmacct-α and Mmacct-γ), H. volcanii 
(Hvcct-1) and T. acidophilum (Tacct-αβ) were obtained in pET22, PrV and pET27 vector 
backbones respectively.  The first step hence was to clone them into appropriate pET 
expression vectors.  Because the TAB21 strain contained a kanamycin resistance gene 
(KanR) in itself, pET expression vectors bearing selectable markers that are different 
from Kanamycin were essential.  From the available wide range of pET expression 
plasmids, pET21, pET22, pET31 and pET32 containing ampicillin resistant (AmpR) genes 
and a T7lac promoter qualified for the given criteria (pET system manual, Novagen).   
The M. mazei cct gene constructs were already in pET22 plasmid and hence proved 
directly acceptable for further analysis.  For Hvcct-1, the gene sequence was excised 
from the parent PrV plasmid using unique restriction sites NdeI and EcoRI and 
introduced into the pET21 expression plasmid using a cloning vector pOK12 as shown in 
Figure 6.1B.  The pET21 plasmid was chosen because of the availability in the 
laboratory.  The pET27 plasmid containing T. acidophilum chaperonin genes had KanR as 
a selectable marker.  Hence using restriction sites NheI and HpaI unique to pET27 and 
pET21 plasmids, a fragment swap was performed to yield pET21- Tacct-αβ (Figure 6.1).  
The resulting four constructs namely pET22- Mmacct-α, pET22- Mmacct-γ, pET21-Hvcct-
1 and pET21-Tacct-αβ were tested for their ability to express, assemble and complement 
for loss of GroEL in E. coli TAB21 strain as discussed below. 
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Figure 6.1 
Schematic diagram showing cloning of archaeal chaperonin genes into pET expression 
plasmids. 
 
 
 
238 
 
6.2.2 Characterization of MmaCCTs, HvCCT-1 and TaCCT-αβ in E. coli 
6.2.2.1 Protein expression by SDS-PAGE 
The pET constructs of all archaeal chaperonins were transformed into TAB21 and grown 
in IPTG-induced and non-induced conditions.  The protein samples were collected and 
first tested for expression of the chaperonins by SDS-PAGE.  The MmaCCT-α and 
MmaCCT-γ proteins were highly overexpressed under IPTG induction as shown in 
Figure 6.2.  The expression of MmaCCT-α was consistently observed to be higher than 
that of the MmaCCT-γ.  The HvCCT-1 expressed well in IPTG induced state albeit in an 
anomalously slowly running position (Figure 6.3).  The discrepancy between the 
molecular mass deduced theoretically from the protein sequence of HvCCT-1 (~60kDa) 
and the one observed on the gel has been routinely observed and attributed to the 
excess of negatively charged acidic amino acids (calculated Pi = 6.2) that affects the 
mobility of the protein on SDS-polyacrylamide gels (Large et al., 2002; Kapatai et al., 
2006).  The expression of TaCCT-αβ under IPTG induced conditions was lower than 
MmaCCTs or HvCCT-1.  However, a time dependent analysis confirmed correct 
expression of TaCCT-αβ (Figure 6.4).  Unexpectedly, protein samples from non-induced 
cultures also showed over-expression of a protein.  The over-expressed protein in the 
non-induced sample ran at slightly lower position on the gel as compared to the over-
expressed protein in the induced samples (Figure 6.3).  However when checked for 
assembly by native-PAGE as described in the next section, both the samples showed 
assembly of chaperonin complex of similar molecular masses suggesting that the over 
expressed protein in the non-induced samples could be truncated TaCCT or one of its 
individual subunits.    
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Figure 6.2 
Expression of M. mazei chaperonin alpha and gamma subunits in E. coli. 
Crude extracts from E. coli TAB21 cells overexpressing CCT proteins in IPTG (1 mM) induced 
(+) and non-induced (-) conditions as analyzed by 10% SDS-PAGE and Coomassie staining.  
Arrowheads point to the positions of the overexpressed proteins. 
(1) TAB21/pET21 empty vector 
(2) TAB21/pET21-Mmcct-WT 
(3) TAB21/pET22-Mmacct- α-WT 
(4) TAB21/pET22-Mmacct- γ-WT 
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Figure 6.3 
Expression of H. volcanii and T. acidophilum chaperonins in E. coli. 
Crude extracts from E. coli TAB21 cells overexpressing CCT proteins in IPTG (1 mM) induced 
(+) and non-induced (-) conditions as analyzed by 10% SDS-PAGE and Coomassie staining.  
Arrowheads point to the positions of the overexpressed proteins.  
(1) TAB21/pET21 empty vector 
(2) TAB21/pET21-Mmcct-WT 
(3) TAB21/pET21-Hvcct- 1 
(4) TAB21/pET21- Tacct-α_β 
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Figure 6.4 
Expression of T. acidophilum chaperonins TaCCT-α_β in a time-dependent manner. 
Crude extracts from E. coli TAB21 cells overexpressing CCT proteins prepared at different 
time intervals after IPTG induction as indicated, analyzed by 10% SDS-PAGE and Coomassie 
staining.  Arrowhead points to the position of the overexpressed proteins.  
(1) TAB21/pET21 empty vector 
(2) TAB21/pET21-Mmcct-WT 
(3) TAB21/pET21- Tacct-α_β 
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6.2.2.2 Native-PAGE analysis: 
The protein samples once checked for their expression were then subjected to native gel 
electrophoresis to test their correct assembly.  MmaCCT-α and MmaCCT-γ assembled 
into their complexes as demonstrated by discrete bands on native-PAGE gel (Figure 6.5).  
Protein bands were not observed for HvCCT-1 (Figure 6.6, No.3), suggesting either 
failure in oligomeric assembly or formation of unstable complexes that fell apart rapidly.  
Several variations in lysis protocols, pH and buffers were adopted to ensure that the 
results were not limited by technical errors.  Ultimately it was concluded that HvCCT-1 
did not form functional oligomers in E. coli.  TaCCT-αβ demonstrated weak assembly 
under IPTG induced conditions (Figure 6.6, No.4).  However, a rather stronger band with 
equivalent molecular mass was consistently observed under non-induced conditions 
(Figure 6.6, No.4).  The result suggested that the over-expressed protein seen in non-
induced conditions during SDS-PAGE analysis was probably that of TaCCT.  The possible 
reasons for higher expression of protein in the non-induced cultures could be attributed 
to how the construct has been made and will be discussed at length later.  
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Figure 6.5 
Assembly of M. mazei chaperonin alpha and gamma subunits in E. coli. 
Soluble fractions of E. coli TAB21 cells expressing CCT proteins in IPTG induced (+) and non-
induced (-) conditions as analyzed by 7.5% Native PAGE and Coomassie staining. Red and 
black arrows show CCT and GroEL proteins respectively.  
(1) TAB21/pET21 empty vector 
(2) TAB21/pET21-Mmcct-WT 
(3) TAB21/pET22-Mmacct- α-WT 
(4) TAB21/pET22-Mmacct- γ-WT 
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Figure 6.6 
Assembly of H. volcanii and T. acidophilum chaperonins in E. coli. 
Soluble fractions of E. coli TAB21 cells expressing CCT proteins in IPTG induced (+) and non-
induced (-) conditions as analyzed by 7.5% Native PAGE and Coomassie staining. Red and 
black arrows show CCT and GroEL proteins respectively.  
(1) TAB21/pET21 empty vector 
(2) TAB21/pET21-Mmcct-WT 
(3) TAB21/pET21-Hvcct- 1 
(4) TAB21/pET21- Tacct-αβ 
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6.2.2.3 Complementation analysis: 
All the archaeal chaperonins were then investigated for their ability to rescue growth of 
E. coli in absence of the GroEL and GroES using TAB21 strain.  Because Hv-CCT1 did not 
assemble, it was not expected to complement.  However, it was included in the analysis 
as it could serve as a negative control.  The complementation assay was done in the 
same way as discussed in Chapter 3.  None of the archaeal chaperonins tested could 
rescue growth of E. coli in presence of glucose at 30⁰C (Figure 6.7).  The experiments 
were repeated at a lower temperature (26⁰C) and higher temperatures (37⁰C and 42⁰C) 
and with longer incubation times, however no change in the results was seen.  The 
positive controls MmCCT-WT and MmCCT-M223I worked as expected each time, 
confirming right experimental conditions.  All strains grew well in presence of 
arabinose, where native GroEL functioning is restored.  Complementation experiments 
were repeated several times with the same results. 
These findings suggested that none of chaperonin proteins tested were able to replace 
the GroE function in E. coli.  However, we speculated that if the same mutations that 
improved the function of MmCCT in GroE depleting E. coli cells were introduced in these 
archaeal chaperonins, a similar effect could arise.   
246 
 
 
Figure 6.7 
Solid medium growth analysis of M. mazei, H. volcanii and T. acidophilum chaperonins 
Dilutions (10-1 to 10-7) of TAB21 cells expressing the CCT proteins as indicated, grown on LB 
agar plates containing arabinose (groE induction) at 37⁰C (A) and on 0.2% glucose (groE 
repression) and 1mM IPTG (cct induction) at 30⁰C (B).  
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6.2.3 Analysis of MmaCCT-α-M223I and MmaCCT-α-K216E mutants. 
Single point mutations, M223I and K216E in MmCCT significantly increased its ability to 
complement for GroEL and GroES in E. coli (Chapter 3).  These two residues are highly 
conserved across all archaeal chaperonins as shown in Chapter 3 (Figure 3.8).  Because 
M. mazei is a mesophile as M. maripaludis, it can be speculated that chances of MmaCCTs 
to replicate MmCCT results would be higher than the other archaeal chaperonins.  
Indeed, a sequence alignment of MmCCT with MmaCCTs, TaCCTs and HvCCTs showed 
maximum similarity between MmCCT and MmaCCT-α (~30% identity and ~50% 
similarity) (Table 6.2).  Thus, MmaCCT-α was selected for the initial analysis.  If the 
results obtained were positive for MmaCCT-α chaperonin, the experiments could be 
extended for the other archaeal chaperonins.   
Using site-directed mutagenesis, equivalent mutations were introduced at the conserved 
M226 and K219 positions of MmaCCT-α (Figure 6.8).  The resultant MmaCCT-α-M226I 
and MmaCCT-α-K219E constructs were subjected to SDS-PAGE, Native PAGE and 
complementation analysis in the similar manner as the discussed in the previous 
sections.   
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Table 6.2: Sequence similarity scores of archaeal chaperonins (ClustalW) 
No. Name Length Name Length Score 
1 MmCCT 1632 MmaCCT-alpha 1656 61.0 
2 MmCCT 1632 MmaCCT-beta 1704 53.0 
3 MmCCT 1632 MmaCCT-gamma 1629 59.0 
4 MmCCT 1632 HvCCT-1 2033 56.0 
5 MmCCT 1632 TaCCT-alpha 1656 57.0 
6 MmCCT 1632 TaCCT-beta 1659 56.0 
 
 
 MmCCT          LVDKERVSAQMPKKVTDAKIALLNCAIEIKETETDAEIRITDPAKLMEFI  262 
 MmaCCT-α   IIDKERVHTNMPEKVKDAKIALLNTAIELKDTEVDAEISITSPDQLQSFL  265 
 MmaCCT-γ      IVDKERVHTGMPEVVKDAKVLLLSVPIELKKTETKAEIKITTPDQMQLFL  267 
 MmaCCT-β       VIDKVALDKKAPLKIVNPNIALIDAPMETAKTANKAKLQISTVSDIENFV  284 
 
 
Figure 6.8 
Sequence alignments of residues 212-262 of MmCCT with equivalent regions of MmaCCTs. 
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6.2.3.1 Protein expression of MmaCCT-α mutants by SDS and Native PAGE 
To determine whether the mutants expressed and assembled into their oligomers, 
lysates of TAB21 cells transformed with pET22-Mmacct-α-M226I and pET22-Mmacct-α-
K219E were analyzed by SDS-PAGE and Native-PAGE.  Both MmaCCT-α-M226I and 
MmaCCT-α-K219E mutants were highly over-expressed similar to the wildtype protein 
expression (Figure 6.9).  Moreover both the mutants showed clear oligomeric assembly 
as demonstrated by native-PAGE analysis (Figure 6.10).  The mutants hence were 
further subjected to standard GroEL-complementation analysis. 
6.2.3.2 Complementation analysis 
The TAB21 cells expressing MmaCCT-α-M226I and MmaCCT-α-K219E were tested for 
their ability to retain growth in groE repressed conditions at 30⁰C.  As seen in Figure 
6.11B, both the mutants were inefficient in rescuing growth of E. coli when grown on 
glucose, similar to the results obtained for MmaCCT-α wildtype protein.  Again, 
experiments were repeated with varying parameters however the same results were 
obtained reproducibly.  The results showed that these mutations did not measurably 
increase the ability of MmaCCT-α-M226I and MmaCCT-α-K219E to function.  This is 
therefore a distinct difference to the results obtained with MmCCT.  However the results 
do not rule out the possibility that co-expression of different M. mazei CCT subunits 
could be required for serving all potential clients and hence supporting growth.  Even if 
the additional mutations were functionally co-operative, lack of MmaCCT-β or MmaCCT-
γ subunit could have been responsible for misfolding of a group of particular clients and 
hence cessation of growth.  Attempts were hence made to clone M. mazei CCT subunits 
together or in different combinations under a pET expression vector however these 
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were not successful.  The reasons were predominantly related to 30% – 40% identity 
shared by the alpha and the gamma subunit that led to recombination events and hence 
problems in cloning.  Because the beta subunit has been shown to be insoluble in E. coli 
anyway (Klunker et al., 2003), the experiments were not continued.   
Subsequently, a random mutagenesis approach was also attempted wherein vectors 
carrying the M. mazei chaperonin genes were passaged using XL-1 Red mutator strain 
and the resultant random mutants were tested for their function in E. coli.  The GroEL-
complementation experiments did result into two clones expressing randomly mutated 
MmaCCT-α, that supported E. coli growth at 30⁰C.  The phenotype of the cells was indeed 
carried with the plasmid ruling out strain-specific changes but no mutations were found 
in the Mmacct- α gene or the T7 promoter.  The results thus probably indicated changes 
in the plasmid backbone and the resultant secondary effects such as increase in the copy 
number or increased expression of the proteins that in turn would allow growth of E. 
coli to a certain extent.  While these observations were interesting in their own right, 
they did suggest that isolation of functional variants of MmaCCT-α that allow GroEL 
complementation was rather difficult highlighting the inefficiency of this archaeal 
chaperonin to replace GroEL.   
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Figure 6.9 
Expression of M226I and K219E mutants of M. mazei chaperonin alpha subunit in E. coli. 
Crude extracts from E. coli TAB21 cells overexpressing CCT proteins in IPTG induced and non-
induced conditions as analyzed by 10% SDS-PAGE and Coomassie staining. 
(1) TAB21/pET21 empty vector 
(2) TAB21/pET22-Mmacct- α-WT 
(3) TAB21/pET22-Mmacct- α-M226I 
(4) TAB21/pET22-MMacct- α-K219E 
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Figure 6.10 
Assembly of M226I and K219E mutants of M. mazei chaperonin alpha subunit in E. coli. 
Soluble fractions of E. coli TAB21 cells expressing CCT proteins in IPTG induced (+) and non-
induced (-) conditions as analyzed by 7.5% Native PAGE and Coomassie staining. Red and 
black arrows show CCT and GroEL proteins respectively.  
(1) TAB21/pET21 empty vector 
(2) TAB21/pET22-Mmacct- α-WT 
(3) TAB21/pET22-Mmacct- α-M226I 
(4) TAB21/pET22-MMacct- α-K219E  
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Figure 6.11 
Solid medium growth analysis of M. mazei CCT-α mutants, M226I and K219E in TAB21. 
Dilutions (10-1 to 10-7) of TAB21 cells expressing the MmCCT proteins as indicated, grown on 
LB agar plates containing arabinose (groE induction) at 37⁰C (A) and on 0.2% glucose (groE 
repression) and 1mM IPTG (cct induction) at 30⁰C (B).  
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6.3 Discussion 
We show here that archaeal chaperonins from species other than M. maripaludis are 
unable to complement for the loss of GroEL in E. coli.  Chaperonins from three different 
species, M. mazei, T. acidophilum and H. volcanii, were selected and subjected to the 
analysis.   
The MmaCCTs and HvCCT-1 proteins expressed well in E. coli however only MmaCCTs 
assembled into their functional complexes.  HvCCT-1 subunits did not form functional 
oligomers possibly because of the requirement of higher salt concentrations.  This was 
not very surprising because it has been observed rather generally for many proteins 
from H. volcanii and other typical halophilic enzymes from extremely halophilic archaea 
that despite being soluble in E. coli, such proteins remain inactive and unstable.  The 
recovery of these proteins is usually carried out from inclusion bodies, followed by 
denaturation and refolding in hypersaline solutions (Rao and Argos, 1981; Connaris et 
al., 1998; Allers, 2010). 
Expression of T. acidophilum CCTs was relatively weaker under IPTG induced conditions 
however this was expected.  It had been observed that when TaCCT-α and TaCCT-β 
subunits were expressed in tandem in E. coli, the expression of alpha subunit dominated 
despite the two genes being driven by separate (T7) promoters (Bigotti and Clarke, 
2005).  The gene construct used for this study was hence modified in a way that a lac 
promoter and a spacer region were inserted upstream of Tacct-α and Tacct-β genes 
respectively.  Such an alteration led to a stringent control on the over-production of 
TaCCT-α and enhanced expression of TaCCT-β, together ensuring formation of 
heterooligomers (Bigotti and Clarke, 2005).  The fact that the expression was lower in 
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induced samples only confirmed that the major population was of heterooligomeric 
TaCCT-αβ complexes.  However it should be noted that an unexpected protein band of 
molecular weight slightly lower than 60KDa was found in non-induced samples.  The 
Native-PAGE gels confirmed correct bands of assembled proteins yet again the 
expression was stronger in non-induced conditions.  Because these bands corresponded 
to the correct size of a chaperonin complex (when compared to positive control, 
MmCCT), it was assumed that the unexpected band observed during SDS-PAGE was that 
of TaCCT.   It has been shown that TaCCT-β subunit when expressed in E. coli on its own 
results in a slightly lower molecular weight protein on SDS-PAGE as compared to TaCCT-
α or TaCCT-αβ complex (Waldmann et al., 1995b).  It can be speculated thus that the 
expression of TaCCT-β occurs in absence of IPTG induction, possibly due to a strong but 
not a stringent T7 promoter.  This is consistent with the protein expression observed in 
non-induced conditions for MmaCCTs.  The reason for expression of only TaCCT-β and 
not TaCCT-α probably relies on the fact that the construct had been genetically 
manipulated to strictly control expression of TaCCT-α subunit and enhance the 
expression of TaCCT-β subunit, as mentioned earlier (Bigotti and Clarke, 2005).  Because 
the subject of interest was to study the extent to which heterooligomeric TaCCT-αβ 
could complement for the loss of GroEL in E. coli, the events occurring in non-induced 
conditions were not studied further and all experiments were carried out in presence of 
IPTG.      
The final complementation analysis showed that none of the chaperonins tested could 
rescue the growth of E. coli cells under groE repressed conditions at any temperatures.  
Furthermore, the supplementary mutations - M226I and K219E in the case of M. mazei 
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chaperonin also did not change the outcome.  The results are indeed consistent with the 
hypothesis of functional divergence between the two groups of chaperonins.  The case of 
MmCCT thus becomes an exception here where native GroEL-clients, vastly diverged 
from archaeal proteins are potentially served by a Group 2 chaperonin and its point 
mutations.  It can be recalled that growth of the cells expressing MmCCT in GroE 
depleting conditions (TAB21) or in absence of GroE (Ai90) was very slow at 37⁰C 
emphasizing a certain degree of insufficiency of this chaperonin to replace GroE that 
perhaps exaggerates with the case of other archaeal chaperonins.  The underlying 
reasons for the GroEL-complementing ability of MmCCT have been difficult to decipher.  
However these results suggest there could exist at a certain level similarity between 
properties of GroEL- and MmCCT- clients, which probably reduces with the divergent 
clients of other extremophilic archaeal chaperonins.  Such a speculation is consistent 
with the homo-oligomeric nature of MmCCT, where lineage-specific gene duplications 
characteristic to almost all other archaeal species have not occurred (Archibald et al., 
1999; Archibald and Roger, 2002b).   
However we also suspect that the native heteromeric property of the other archaeal 
chaperonins tested here might not be an exhaustively limiting factor for their inability to 
replace GroE function.  This is because firstly, there are several examples where every 
single subunit of heteromeric archaeal chaperonins has been individually shown to form 
functional homo-oligomers in E. coli (Yoshida et al., 1997; Klunker et al., 2003; Hirai et 
al., 2008; Lee et al., 2013) as against only two out of eight subunits for human TRiC 
(Sergeeva et al., 2013).  Secondly, subunits of various archaeal chaperonins have been 
shown to have a certain degree of functional redundancy.  This is demonstrated by for 
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example the ability of homo-oligomeric CCT1 or CCT2 to substitute for the loss of two 
other native chaperonins in H. volcanii (Kapatai et al., 2006) or the temperature-
dependent interchangeable functions of two chaperonins from T. kodakarensis, CpkA 
and CpkB (Fujiwara et al., 2008).  All these studies suggest that in contrast to the distinct 
roles of each subunit for TRiC (Spiess et al., 2004; Dekker et al., 2011a), an overlap of 
function in addition to a certain degree of species-specific diversification exists for 
duplicated subunits of heterologous archaeal chaperonins, as has also been proposed by 
evolutionary studies (Archibald and Roger, 2002b; Ruano-Rubio and Fares, 2007).   
We speculate therefore that instead of very client-specific limitations, general 
conditional changes that might have occurred for species-specific properties like thermo 
or salt tolerance might be responsible for their inability of the tested archaeal 
chaperonins to rescue growth of GroE depleting E. coli cells.  For example HvCCT1 did 
not assemble possibly because of low salt concentrations.  The result thus does not rule 
out the possibility that the native chaperonin if fully assembled could bind and fold 
GroEL clients.  Accordingly for TaCCT_αβ, it is possible that the chaperonin adapted to 
work at higher temperatures behaves differently at a lower temperature.  Indeed the 
optimal temperature for the ATP hydrolysis activity of the alpha homo-oligomer of 
TaCCT has been shown to be at 60⁰C (Hirai et al., 2008).  It is intriguing as to why the 
mesophilic M. mazei chaperonins were not able replicate the function of MmCCT.  While 
it is possible that this is because all three chaperonin subunits have evolved to meet the 
diverse chaperoning requirements also indicated by acquisition of Group 1 chaperonin 
by lateral gene transfer (Figueiredo et al., 2004), we suggest that the complementation 
experiments conducted here are not completely exhaustive.  Further mutagenesis 
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experiments could lead to identification of genetic variants of some of these archaeal 
chaperonins that would allow them to replace GroEL function, as has been the case for 
M223I and K216E mutants of MmCCT.  
Collectively, the data suggests that for archaeal chaperonins to substitute the functioning 
of GroE is rather difficult because they have evolved for working on a diverse set of 
proteins.  Although they assemble and presumably become functional in E. coli, not all 
bacterial client proteins are acted upon by archaeal chaperonins suggesting a client 
specific mechanism of chaperonins.  However, the case of MmCCT clearly suggests that a 
functional cross-over is possible.  Hence, in sum it can be speculated that although the 
archaeal chaperonins cannot easily replace GroEL function in bacteria, small structural 
changes can improve their complementing ability suggesting a similar mechanism of 
action of both groups but with difference that is almost certainly related to client 
specificity.   
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CHAPTER 7 
Towards complementation analysis of 
Group 2 chaperonin mutants in archaea 
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7.1 Background 
The results described in Chapter 3 and 4, established that mutants MmCCT-M223I and 
MmCCT-K216E of M. maripaludis chaperonin substantially improved the growth 
phenotype of the groELS-depleted strain of E. coli when compared to the phenotype of 
the strain expressing wildtype MmCCT.  However, the precise nature of these mutations 
and their effects on chaperonin function was uncertain.  It was speculated that the 
changes due the point mutations could either be client-specific, for example a more 
negatively charged cavity for GroEL-clients; or they could be chaperonin-specific that 
would improve the chaperonin function in general irrespective of the clients.  However, 
the mutants did not show extensive biochemical disparity when compared to the 
wildtype MmCCT (Chapter 4), suggesting a more client-specific change.  If this was the 
case, the same point mutations - M223I and K216E - could affect the chaperonin 
function for the native archaeal clients.  This can be tested by introducing the same 
mutations back into the native hosts and deleting the endogenous genes.  
This chapter describes the initial experiments that it is hoped will further culminate in 
testing the effects of the chaperonin mutations M223I and K216E in archaeal species.  
The chapter first describes preliminary cloning work to express the mutants in the 
parent species, M. maripaludis, for planned experiments in collaboration with Dr. James 
Chong, University of York.  The later part describes attempts to establish a chaperonin 
knock-out system in the archaeal species H. volcanii that would allow growth-based 
analysis to study the mutants in H. volcanii chaperonin HvCCT-1.  The potential of both 
the approaches are described in final discussion section.  The experiments with H. 
volcanii were done prior to the work for M. maripaludis expression because of an 
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existing set up in the laboratory; however the later has been described first to maintain 
the flow of the story.  
7.2 Experimental approach to complementation analysis in  
M. maripaludis  
An efficient and markerless mutagenesis protocol has been developed in recent years for 
genetic manipulation in M. maripaludis (Moore and Leigh, 2005).  The cloning required 
for the same has been done so that this method can be used for the analysis.  The 
method utilizes the principle of homologous recombination and a hypoxanthine 
phosphoribosyltransferase (Hpt) based negative selection.  The Hpt encoding MMP0145 
gene renders the species M. maripaludis susceptible to nucleotide base analogue 8-
azahypoxanthine (8-aza-2,6-diaminopurine).  For markerless mutagenesis, an hpt 
knock-out strain of M. maripaludis (MM900) and a non-replicating vector (pCRPrtNeo) 
have been constructed (Moore and Leigh, 2005).  The pCRPrtNeo vector contains the hpt 
gene for negative selection, a Neomycin marker (NeoR) for positive selection and a 
cloning site where the gene of interest, carrying the desired mutation/s, is inserted 
(Figure 7.1).  Here, gene of interest being Mmcct with either M223I or K216E mutation.  
For point mutagenesis, only a selected part of the gene (usually 1000 – 1200 bases) with 
the site of mutation in the middle is cloned into the vector (Figure 7.1).  For this, using 
primers, XbaI-MmCCTinternal-For and MmCCTinternal-NotI-Rev, 1.2 Kb long sequences 
from Mmcct WT gene or Mmcct gene containing mutations M223I and K216E in the 
middle were first amplified (Figure 7.2A, Lanes 1,2 and 3) and cloned into XbaI-NotI cut 
pCRPrtNeo vector (Figure 7.2A, Lane 4).  The final constructs were checked for their 
correct inserts by screening digestions using XbaI and NotI (Figure 7.2B). 
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When the cells of MM900 strain are transformed with pCRPrtNeo carrying the gene of 
interest, the vector will integrate into the genome with a single recombination step 
between the homologous regions of the gene on the vector and on the chromosomal 
DNA, rendering the cells neomycin resistant (Figure 7.3).  If these cells are then grown in 
absence of the antibiotic, a second recombination is a possible event where the vector 
can recombine out of the chromosome and can either return into the wildtype genotype 
or incorporate the mutated sequence that was introduced with pCRPrtNeo (Figure 7.3).  
In either case the cells become resistant to base analogue 8-azahypoxanthine with the 
loss of hpt gene.  Single colonies are then screened by PCR to identify the mutated strain.  
The method has been schematically shown in Figure 7.3.   
The constructs containing the gene sequences of MmCCT flanking the mutation M223I 
or K216E in pCRPrtNeo have been made (as shown in Figure 7.1 and 7.2) and sent to Dr. 
James Chong’s group, University of York where the experiments are currently being 
conducted.  These constructs will be used to introduce the mutations M223I and K216E 
in the chromosomal DNA of M. maripaludis by the markerless mutagenesis method as 
described above.  There are two possible outcomes to the experiment:  
1) Positive clones containing the mutations are identified.  This would suggest that the 
mutated CCT is still able to show some function in M maripaludis. The extent to which 
the additional mutations affect the phenotype of the cells would be tested by 
competition experiments wherein the growth of both, the wildtype and the mutant 
strain, will be simultaneously monitored by solid and liquid media analysis.   
2) Clones containing the mutations are not identified.  In this case, it would become 
necessary to test whether the cessation of growth is because of the additional mutations 
or because of any inconsistencies in the recombination process.  A different approach 
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with straight selection would be required to determine clearly whether or not the 
mutations are detrimental to the strain.  In such a scenario, a method would be adopted 
where effects of Mmcct mutants will be studied in an Mmcct knock-out strain sustaining 
on a copy of Mmcct gene on a self-replicating vector.  This method will be fairly similar 
to the plasmid shuffling method discussed in Chapter 3, and will rely on displacement of 
wildtype plasmid with the externally introduced plasmid containing mutant Mmcct.  
Direct growth-based results would yield a clear picture as to whether or not the mutants 
Mmcct-M223I or K216E allow growth of native host M. maripaludis.  
While the above experiments are being pursued at the University of York, an attempt 
was also made to establish a similar system in the species H. volcanii in the laboratory.  
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Figure 7.1 
Schematic diagram to explain construction of pCRPrtNeo containing Mmcct gene sequence 
for markerless mutagenesis in M. maripaludis. 
A. Vector pET21 containing MmCCT gene was used as the DNA template for the cloning.  
B. Vector pCRPrtNeo as the recipient for markerless mutagenesis in M. maripaludis 
C. Cloning strategy  
(Plasmid maps drawn using Plasm software.) 
 
 
265 
 
 
Figure 7.2 
Agarose gel electrophoresis showing the construction of pCRPrtNeo Mmcct gene 
constructs for markerless mutagenesis in M. maripaludis 
(A) Agarose gel analysis of amplified Mmcct wt gene (Lane 1), Mmcct-M223I (Lane 2) and 
Mmcct-K216E (Lane 3) using primers, XbaI-MmCCTinternal-For and MmCCTinternal-NotI-
Rev.  Lane 4 shows XbaI-NotI cut pCRPrtNeo vector (~6.5 Kb) 
(B) Agarose gel analysis showing XbaI-NotI digests to confirm correct 1.2 Kb Mmcct wt (Lane 
1), Mmcct-M223I (Lane 2) and Mmcct-K216E (Lane 3) inserts into pCRPrtNeo.  
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Figure 7.3 
Schematic diagram to explain the technique of markerless mutagenesis in M. maripaludis. 
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7.3 Experimental approach to complementation analysis in 
H. volcanii  
H. volcanii, an obligate halophilic archeaon originally isolated from Dead Sea, is an 
emerging model for in vivo and in vitro archaeal studies and has been routinely used in 
our laboratory in the past (Large et al., 2002; Kapatai et al., 2006; Large et al., 2007).  
Archaeal genetics has benefited immensely since the discovery of this organism as it 
offers advantages of  simple cultivation techniques (Dyall-Smith et al., 2006), shuttle 
vectors (Lam and Doolittle, 1989), selectable markers (Allers et al., 2004), efficient gene 
knock-out system (Bitan-Banin et al., 2003) and a whole annotated genome sequence 
(Hartman et al., 2010).  Moreover, a tryptophan induced tna promoter has been specially 
developed for H. volcanii in our laboratory (Large et al., 2007).  This promoter (which 
normally drives the gene encoding the enzyme tryptophanase) can be strongly induced 
in the presence of tryptophan and be tightly switched-off in its absence. 
H. volcanii possesses three chaperonin genes referred to as cct1, cct2 and cct3 (Kuo et al., 
1997; Large et al., 2002).  It is established that while the functioning of these genes is 
essential for survival, either cct1 or cct2 alone can sustain growth of the organism in 
respective double knock-outs, with the complementation efficiency of cct1 being better 
than cct2 (Kapatai et al., 2006).  Taking this into account we hypothesized that a 
mutational analysis of an array of cct1 gene mutants targeting specific regions, that have 
some anticipated role in the total working of chaperonin, (for example Hvcct1-MtoI and 
Hvcct1-KtoE) could be conducted that in turn will delineate the structure-function co-
relation of this chaperonin and give insights into the functional properties of Group 2 
chaperonins in general.  The first step towards such analysis in H. volcanii was 
development of a gene expression system that will specifically allow phenotypic analysis 
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as a net effect of a mutation in cct1 gene without masking the effects by the 
chromosomal cct genes.  A Haloferax strain lacking all three cct genes, when introduced 
with a mutant cct1 gene, will grow only if the mutant is functional.  However, the strain 
lacking all three genes will perish because at least one out of cct1 or cct2 is essential for 
growth.  Consequently, the aim of this part of the project was to construct a triple knock-
out Haloferax strain that contains an externally introduced cct2 gene under an inducible 
promoter which could be turned off when an external cct1 mutant is introduced, 
allowing its analysis when all other cct genes are non-functional (Figure 7.4).  
The system hence generated would permit the analysis of conditional lethal mutants in 
essential gene cct1 (when the cct2 gene is switched off) by simple manipulation of 
growth conditions.  As a matter of fact, instead of the cct2 gene, cct1 gene can also be 
incorporated under the inducible promoter to construct the desired system.  However, 
as the mutations to be introduced later in the system are also in the cct1 gene, 
homologous recombination between the wild type and the mutant is a possible event, 
known to occur, that could replace the mutant gene to the wild type.  To avoid any such 
occurrences cct2 gene was chosen to create the triple knock-out strain.     
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Figure 7.4 
Cartoon representation of a triple knock-out strain of Haloferax volcanii 
The diagram represents a triple knock-out strain of H. volcanii that can sustain on an 
externally introduced cct2 gene under a tryptophan-inducible ptna promoter.  The cct2 gene 
could then be turned off when an external cct1 mutant (cct1*) is introduced. The system 
altogether will allow analysis of mutant cct1 genes when all other native cct genes are non-
functional. 
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7.3.1 Experimental design 
For construction of the desired gene expression system, the strain used is Haloferax 
volcanii H26 that lacks the pyrE2 gene essential for uracil biogenesis.  The vector used at 
every stage is p131 containing ampicillin resistance cassette and a pyrE2 gene under its 
own promoter. This plasmid does not contain an archaeal origin of replication and hence 
is an integrative, non-replicative plasmid.  The use of H26 strain and p131 enable the 
application of a pyrE2 based gene knock-out method as discussed in the following 
section (Bitan-Banin et al., 2003).  
1. Construction of a single knock-out strain lacking cct3 gene - H26:∆cct3.  
This step has already been accomplished previously in the laboratory using the same 
gene knock-out method as described below.  
2. Construction of a double knock-out strain - H26:∆cct2∆cct3 
As described for markerless mutagenesis in previous section, the gene knock-out 
method utilizes the principle of homologous recombination and a pyrE2 based selection.  
In H. volcanii the pyrE2 gene codes for the physiological enzyme orotate phosphoribosyl 
transferase.  This is a key enzyme in uracil biosynthesis and a deletion of pyrE2 gene 
results in inability to synthesize uracil.  Hence the H26 strain (∆pyrE2) of H. volcanii, 
used for the study, is a uracil auxotroph.  Firstly, a non replicative plasmid (p131) 
containing pyrE2 gene and a cloned chromosomal DNA fragment containing flanking 
sequences of the target gene (here cct2 gene) is transformed into the ∆pyrE2 strain. The 
transformants are then plated onto medium lacking uracil and the uracil prototrophs are 
selected.  The uracil prototrophs are a result of integration of the plasmid and hence the 
pyrE2 gene into the chromosome (Figure 7.5).  Concomitantly, a homologous event 
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between the flanking sequences on the plasmid and those around the native target gene 
is expected.  The cells are then grown in liquid cultures to allow integrative 
recombination events, between the plasmid-inserted flanking sequences and the 
chromosomal flanking sequences, that could result either into reconstitution of the wild 
type gene (containing pyrE2) or a deletion of the target gene (loss of pyrE2) (Figure 7.5). 
The cells are then plated onto selective medium again.  This time the selection is based 
on the fact that the cells that can synthesize de novo uracil are sensitive to the toxic 
uracil analogoue 5-fluoroorotic acid (5-FOA).  The cells that still contain the integrated 
plasmid, and hence pyrE2, would metabolize 5-FOA to produce 5-fluorouracil and die. 
While the cells that have lost the integrated plasmid and hence pyrE2, will survive but 
will need uracil in their growth medium (Figure 7.5) (Bitan-Banin et al., 2003; Sato et al., 
2003). Employing the above method, deletion of cct2 from the strain H26:∆cct3 requires 
following steps: 
A) Construction of p131-5’3’flankcct2, plasmid p131 containing flanking sequences of 
cct2 gene. 
B) Transforming p131-5’3’flankcct2 in H26:∆cct3 and selecting the popped in plasmid 
containing strain on uracil lacking medium (POP IN) 
C) Allowing integral recombination by growing the transformants and selecting the 
popped out strain on 5-FOA and uracil containing medium (POP OUT) 
D) Screening of selected colonies by colony-PCR using primers specific to cct2 gene 
E) Confirmation of the positively screened colonies by western blotting using anti-
thermosome antibodies that will contain CCT1 protein but not CCT2 and CCT3 
proteins. 
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Figure 7.5: 
Schematic diagram to demonstrate the pyrE2 based gene knock-out system for the 
disruption of cct2 gene in the strain H26:∆cct3 strain 
Flanking sequences (blue) just upstream and downstream of the cct2 gene (yellow) are 
cloned into the p131 vector to give rise p131-5’-3’flankcct2.This plasmid when transformed 
in H26:∆cct3 strain, integrates into the chromosome by homologous single recombination 
events (single recombination event because circular plasmid) between the flanking 
sequences of the chromosomal cct2 gene and the plasmid (POP-IN). The strain containing 
popped in plasmid now also contain pyrE2 gene and hence selected on medium lacking 
uracil. The transformed colonies, further grown on medium lacking uracil may now undergo 
integral double recombination events i.e simultaneous recombination at 3’ and 5’ flanking 
region, which can result in either the reconstitution of the wild type cct2 or knocked out cct2 
gene (POP-OUT). The popped-out colonies are selected on plates containing 5-FOA and 
screened by colony PCR to isolate knocked out cct2 strains.  
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3. Construction of a triple knock-out strain containing cct2 gene under an 
inducible promoter ptna - H26:∆cct1∆cct2∆cct3 ptna-cct2-pyrE2+ 
The triple knock-out strain will be created by swapping the chromosomal cct1 gene in 
H26:∆cct2∆cct3 with an external cct2 gene under the ptna promoter using the same 
gene knock-out method, but with a double homologous recombination event (Figure 
7.6).  Firstly, a plasmid vector will be constructed containing the cct2 gene (ptna 
promoter) and pyrE2 gene (under its own promoter), both placed between the cct1 
flanking sequences.  The plasmid will be linearised using specific enzymes prior to the 
transformation.  When the double knock strain will be transformed with this construct, a 
double recombination event will take place between the flanking sequences of cct1 gene 
on the vector and on the chromosome.  The process will yield a triple knock-out strain 
with cct1 gene replaced by an external cct2 gene and pyrE2 gene, that can be selected on 
uracil lacking medium (Figure7.6).  This strain would now allow study of phenotypic 
effects of externally introduced wildtype or mutant cct1 gene in absence of the native 
CCTs.  The construction of the above system requires following steps: 
A) Construction of the plasmid p131 containing upstream and downstream flanking 
sequences of cct1 gene sandwiching the cct2 gene and the pyrE2 genes.  
B) Transformations of H26:∆cct2∆cct3 with linearised p131-5’cct1 flank-ptna-cct2-
pyrE2-3’cct1 flank and selection of the transformants on uracil lacking but 
tryptophan containing medium. 
C)  Screening of the transformants by PCR using primers specific to cct1 gene and 
confirmation by western blotting. 
275 
 
 
 
 
 
 
276 
 
Figure 7.6  
Schematic diagram demonstrating construction of a triple knock-out strain containing 
externally introduced cct2gene under tryptophan induced ptna promoter   
The plasmid p131-5’cct1 flank-ptna-cct2-pyrE2-3’cct1 flank will be transformed in the 
H26:∆cct2∆cct3 strain. As the plasmid will be linearised prior to transformations using 
specific restriction enzymes, a double recombination event will take place between the 
flanking sequences of cct1 gene on plasmid and the chromosome (violet regions), replacing 
the chromosomal cct1 gene by cct2 under ptna and pyrE2 gene under its own ferridoxin 
(pfdx) promoter. The transformants will be selected on uracil lacking medium, screened and 
confirmed, to finally give the desired strain i.e. H26:∆cct1∆cct2∆cct3 ptna-cct2-pyrE2+        
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7.3.2 Results 
7.3.2.1 Western blot to check cct3 deletion in H26:∆cct3 strain 
H26:∆cct3 strain had already been created in the laboratory (Georgia Kapatai, former 
PhD student).  The strain was confirmed for its uracil auxotrophy and further that it 
lacks CCT3 protein expression by western blotting using anti-thermosome antibodies. 
The controls, DS70 strain and H26 strain that express of all three cct genes constitutively 
show a clear band of CCT3 which is absent in H26: ∆cct3 strain (Figure 7.7).  
7.3.2.2 Construction of a double knock-out strain - H26:∆cct2∆cct3 
I. Construction on p131-5’3’Flankcct2 plasmid: 
The first step in construction of the double knock-out was to generate a non-replicative 
plasmid containing flanking sequences of cct2 gene.  DNA sequences upstream and 
downstream of the cct2 gene were amplified individually from H26 chromosomal DNA 
using primers (5’flankingcct2-FOR and REV, 3’flankingcct2-FOR and REV) containing 
specific restriction sites. The two fragments were called 5’Flankcct2 - upstream of the 
cct2 gene containing Ecor1/BamH1 sites (474bp) and 3’Flankcct2 - downstream of the 
cct2 gene containing BamH1/Xba1 restriction sites (524bp) (Figure 7.8).  The fragments 
were individually cloned into the plasmid vector p131 in between Ecor1 and Xba1 sites 
as shown schematically in Figure 7.9 to give final plasmid construct p131-3’5’flankcct2.  
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Figure 7.7 
Western blot showing lack of CCT3 expression in H26:∆cct3 strain.  
Figure shows the expression pattern of cct genes in strain DS70, H26 and H26:∆cct3 strains.  
As seen, the H26:∆cct3 strain lacks CCT3 protein as compared to the controls. 
 
 
 
 
 
Figure 7.8 
Agarose gel electrophoresis of the PCR amplified 5’-flanking and 3’-flanking regions of the 
cct2 gene 
Lane1: Hyper Ladder  
Lane2: cct2 5’ flanking sequence (474bp)  
Lane3: cct2 3’ flanking sequence (524bp) 
 
279 
 
 
Figure 7.9 
Schematic diagram to explain the construction of p131- 5’3’flankcct2 cloning vector. 
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II. Transformations of the p131-5’3’flankcct2 into H26:∆cct3  
(POP-IN and POP-OUT selection) 
The plasmid p131-5’3’flankcct2 was passaged through JM110 E.coli strain (dam-dcm-) to 
demethylate the DNA prior to transformations into H26:∆cct3 strain.  The transformants 
were selected for uracil prototrophy on minimal medium plates.  Colonies arising from 
these transformations resulted from integration of the plasmid into the chromosome 
(POP-IN).  A couple of individual colonies were grown in liquid cultures allowing a 
second recombination that could result into either reconstitution of the native cct2 gene 
or the desired knock-out strain (POP-OUT).  To select for the loss of pyrE2 gene, 
dilutions of these cultures were grown on MGM medium (rich media including uracil) 
containing 50μg/ml 5-FOA.  Wild type strain DS70 that contains pyrE2 gene was used as 
a negative control.  As expected, while no colonies came up for DS70 strain due to 
toxicity, several colonies came up on the test plates.  These colonies were subjected to 
colony PCR using cct2 gene internal primers.  However, all the colonies (~200 colonies 
screened) were found to contain the band for cct2 gene indicating that reconstitution to 
original was preferred over popping out of the gene.   
Because of the availability of yet another strain in the laboratory, H26:∆cct2trun∆cct3, 
which is a partial double knock-out (Figure 7.10), it was decided to use this as the 
starting strain instead of H26:∆cct3.  The H26:∆cct2trun∆cct3, previously created 
(Georgia Kapatai, PhD thesis) for the same experiment, contains a truncated version of 
cct2 gene and hence should lessen the chances of cct2 gene reconstitution.  Using the 
same method as described above, the H26:∆cct2trun∆cct3 was transformed with plasmid 
p131-5’3’flankcct, popped-in colonies were selected on minimal media and further 
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grown in liquid cultures.  The popped-out colonies were selected on MGM plates 
containing 5-FOA.  Similar to results obtained for previous experiment, several colonies 
came up on 5-FOA containing plates confirming loss of pyrE2 gene.  The obtained 
colonies were screened by PCR using cct2 gene internal primers (Figure 7.11A).  Out of 
~50 colonies tested, few candidates showed faint bands or no bands at all (For e.g. 
colony 7, d, h, i and k in the figure).  These colonies were selected, grown again on 
selective media and subjected to confirmatory colony PCR reactions using 2 sets of 
primers.  Set 1 comprised of a 5’flank-forward primer 474 bp upstream of the 5’ flank 
region of cct2 and a 3’flank-reverse primer 524bp downstream of 3’ flank region of cct2 
gene (Red arrows, Figure 7.11B).  Set 2 were the same cct2 gene internal primers (cct2 
gene FOR and REV) at the start and end of the gene (Green arrows, Figure 7.11B).  The 
cct2 knock-out should give a ~1000 bp band with set 1 primers and no band with the set 
2 while the H26:∆cct2trun∆cct3 colonies, used as a control, should give ~2400 bp band 
with set 1 and ~1400 with set 2 primers (Figure 7.11B). 
As seen in Figure 7.11C, the potential cct2 knockout candidates – clones i and k, show a 
1000bp band with primer set 1 and no band with primer set 2.  The parent strain that 
contains the truncated version of cct2 gene gives a band of ~2000bp with primer set 1 
which is a bit lower than expected (~2300bp).  However, it gives expected 1300bp 
product with primer set 2.  The results suggest that clones ‘i’ and ‘k’ are successful 
products of the experiment and do not possess cct2 gene.  It should be noted that 
western blotting cannot confirm the absence of CCT2 protein expression in the knockout 
candidates because the parent strain itself contains truncated version of cct2 gene that is 
unable to produce CCT2 protein, thus leaving no difference between the two strains. 
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Figure 7.10  
Cartoon representations of the genotypes of the three cct genes in different strains  
The H26:∆cct2trun∆cct3 has a truncated version of cct2 gene where a fragment of 400bp is 
deleted from the middle of the gene. 
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Figure 7.11 
Screening and confirmation of cct2 knockout candidates by colony PCR 
A) Agarose gel electrophoresis of the colony PCR products obtained using internal cct2 gene 
primers. The test colonies are numbered 1 to 18 in upper lane and a to r in the lower 
lane. C1 and C2 correspond to the controls H26:∆cct3 and H26:∆cct2trun∆cct3. 
B) Schematic diagram showing the expected sizes of DNA fragments in the parent strain 
and cct2 knock-out. The red and green arrows represent primer set 1 (5’flankcct2-
FOR/3’flankcct2-REV) and 2 (cct2gene-FOR/cct2gene-REV) respectively. 
C) Agarose gel electrophoresis of confirmatory colony PCR reactions of two potential knock-
out colonies i and k, along with the parent strain, using both sets of primers labelled as 1 
and 2 respectively.  
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7.3.2.3 Construction of the triple knock-out - H26:∆cct1∆cct2∆cct3: ptna-cct2 
The first step in making the triple knock-out strain was to construct a plasmid vector 
containing cct2 gene (under ptna promoter) and pyrE2 gene inside the flanking 
sequences of cct1 gene.  Owing to previous attempts of making a triple knock-out strain, 
such a plasmid was already made in the laboratory (Dr. Andrew Large, former post-doc).  
This plasmid was called pOK-5’C1-PTC2-3’C1 (pyrE2 – ptna – cct2 in cct1 locus under 
pOK12 background) (Figure 7.6).  The plasmid was linearized using HindIII restriction 
enzyme prior to transformations in the knock-out strain.  Two double knock-out strains, 
H26:∆cct2∆cct3i and H26:∆cct2∆cct3k, obtained from the previous step were 
transformed with the linearised plasmid pOK12-PTC2.  A no-DNA negative control and a 
positive control, a vector p354 were also incorporated.  The p354 vector contains pyrE2 
gene and an archaeal origin of replication which allows the strain to grow in the minimal 
medium.  This control ensured robustness of the transformation procedure.  The 
transformed cultures were grown on a set of plates containing 1) minimal media 2) 
minimal media + 5mM tryptophan 3) minimal media + 5-FOA (Figure 7.12).  Selection 
takes place on the basis of the ability of the strain to grow in absence of uracil in the 
medium because of the acquired pyrE2 gene (Figure 7.6).  Also, considering that the 
triple knock-out strain would only have ptna-promoter driven cct2 gene for sustenance, 
tryptophan would be required in the medium for expression of cct2 gene.  Plates 
containing 5-FOA were used as a negative control.   
With the initial experiments, growth was observed on minimal media plates for all the 
transformants including the no-DNA negative control.  A possible carry forward from the 
rich regeneration medium during the transformation was thought to be an issue.  Hence 
the experiments were repeated with regeneration carried out in minimal medium.  
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While the results for the positive and the negative controls were as expected, the strain 
transformed with pOK-5’C1-PTC2-3’C1 grew on minimal medium plates without 
tryptophan (Figure 7.12).  Although, colonies did appear on tryptophan containing 
plates, such a result was considered ambiguous due to presence of almost the same 
number of colonies on respective minimal media plates.  The experiment was repeated 
several times ensuring that there was no tryptophan contamination in minimal media 
via any source.  However the outcome was similar to as described above.   
These results were rather unanticipated because the ptna is a tightly regulated 
promoter and would require tryptophan in the media for cct2 gene expression and 
hence growth.  It was speculated thus that a single recombination event between either 
of the flanking sequences of cct1 gene instead of a double recombination event could 
have taken place where despite the integration of pyrE2, intact cct1 gene would still be 
present, allowing growth on minimal medium.  This suggested that the plasmid pOK-
5’C1-PTC2-3’C1 was perhaps not linearised prior to the transformation despite being 
digested using the HindIII enzyme.  Attempts were made using another single-cutter 
enzyme, SpeI for linearising the plasmid however it resulted into unexpected band 
patterns.  The results suggested either an error in the construct pOK-PTC2 possibly by 
accidental disruption of the restriction sites during its handling or less likely, certain 
random recombination events in the cells that would inhibit the process.  If former was 
the case either the whole plasmid used had to be sequenced or a new plasmid had to be 
constructed.  However because of the amount of time that the process required and 
because the experimental system set up at the University of York should be able to test 
the mutants MmCCT-M223I and MmCCT-K216E in its host species M. maripaludis, the 
project with H. volcanii was not carried further.  
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Figure 7.12 
The expected and obtained results of transformations in double knock-out strains.  
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7.4 Discussion 
The overall aim of this part of the project was to test the effects of mutants MmCCT-
M223I and MmCCT-K216E in archaeal species.  As described in section 7.1.1, a 
markerless mutagenesis method will be used to introduce these mutations in the native 
strain M. maripaludis, the required plasmid constructs for which have already been 
made and sent to Dr. James Chong’s laboratory where further experiments will be 
pursued.  This study will enable us to investigate the effects of mutants MmCCT-M223I 
and MmCCT-K216E in their native hosts.  The questions that would be answered are (a) 
are these mutants functional in M. maripaludis i.e. is growth observed when the wildtype 
gene is replaced with the mutant gene; (b) if growth is not observed, does it imply that 
expression of the mutant genes is actually deleterious to cells i.e. do these mutants 
actually reduce organismal function?; (c) if growth is observed, then do these mutants 
function as well as wildtype or in a different manner?   
Because the residues, M223 and K216, are highly conserved among all archaeal 
chaperonins and are located in the most diverged apical domain (Chapter 3), it is likely 
that the corresponding mutations M223I and K216E would affect the chaperonin 
function in the native host.  Based on its relatively lower ATPase activity and the 
tendency to spend more time in the open conformation (Chapter 4), it can be speculated 
that the chaperoning function of mutant MmCCT-M223I may possibly be compromised 
in the native host.  However it is also possible that such an effect is not very extensive 
because the change from methionine to isoleucine is rather less drastic and that the 
mutant does not completely replace GroEL function (Chapter 3).  It is intriguing thus to 
know how the mutant MmCCT-K216E with a satisfactory biochemical profile and its 
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ability to restore complete GroEL function would behave in its native host, particularly 
when the substitution is from a positively charged residue to a negatively charged 
residue in a cavity that is dominated by positive charges (Cong et al., 2010).  We 
speculate that both the mutants would confer a rather negative effect on the chaperonin 
function in the native host and that the effects of MmCCT-K216E mutant would be more 
extensive that MmCCT-M223I.   
The second part of the project was to develop a triple knock-out strain that would allow 
analysis of conditional lethal cct1 gene mutants in H. volcanii.  As described, attempts to 
construct a double knock-out strain from H26:∆cct3 were initially unsuccessful.  A 
preference for reconstitution to wild-type strain rather than a cct2 knock-out strain was 
observed despite the fact that theoretically, the frequency of both the events should be 
the same.  Such a bias could be because of the tendency of the cells to oppose the 
changes due to loss of the cct2 gene (Kapatai et al., 2006) thus increasing the chances of 
cells with intact cct2 gene to be selected on 5-FOA plates.  The use of H26:∆cct2trun∆cct3 
presumably decreased such selection competition between the cells and hence resulted 
into successful construction of the double knock-out strain.  The approximate frequency 
of the potential cct2 knock-out colonies was 1 in 25, which was rather low when 
compared to certain other gene knock-out studies in H. volcanii using the same method 
(Bitan-Banin et al., 2003; Altman-Price and Mevarech, 2009).  However, the observed 
lower frequency was consistent with the results obtained for similar cct knock-out 
experiments done in the lab (P. Gowarinathan, PhD thesis), highlighting the difficulty in 
knocking-out of the chaperonin genes from H. volcanii.  Indeed the trials to create a 
triple knock-out strain did not reach to completion owing to certain unexplained errors 
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in the construct or the recombination events.  Nevertheless, the results remain open-
ended with a perfectly delineated protocol to achieve a triple knock-out strain in future. 
In essence, both the studies described here, once completed, would generate a platform 
to test a range of chaperonin mutants in their native hosts.  The experiments with H. 
volcanii in particular, if successful, would establish a first ever in vivo system for direct 
genetic dissection of the properties of an archaeal chaperonin.  Not only the system 
would permit extensive mutagenic studies of archaeal chaperonins but will also be able 
to validate their structural and biochemical conclusions derived only from in vitro 
studies.  Equally important, a comparative analysis would become possible wherein the 
effects of the same chaperonin mutation can be simultaneously studied in both, their 
native hosts and E. coli (using the TAB21 or Ai90 system).  Such parallel experiments 
would facilitate identification of point-mutants that behave differently in archaeal and 
bacterial hosts.  Subsequent phylogenetic and biochemical analysis of such mutants 
could reflect on the basis of structural differences between the archaeal and bacterial 
chaperonins.  And such structural-functional correlations in turn can give useful insights 
in understanding the divergence between the two groups of chaperonins.   
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